View recent copies of Ag & Vet Weekly with important stories on research and development (R&D), mergers and acquisitions (M&A), finance, government grants and regulation, share price movements, industry news and personnel appointments in Australian Stock Exchange listed agriculture and veterinary companies.

All articles include the company name, technology and indication and many have senior personnel in the headline. The easiest way to search is by opening a dialogue box by typing Control F or Command F.

Costa H1 Revenue Up 9% To $771m; Profit Down 10% To $44m; Apiam Revenue Up 22% To $192m; Profit Down 52% To $2.2m; Tasfoods H1 Revenue Up 12% To $38m; Loss Down 29.5% To $3.8m; Clean Seas Revenue Up 5% To $69.4m; Profit Down 31% To $6m; Bubs Revenue Down 33% To $60m, Loss Up 853% To $109m; Original Juice Revenue Up 19% To $53m; Loss Down 0.4% To $3m; Next Science H1 Revenue Up 87% To $16m; Loss Up 31% To $13m; Wellnex Revenue Up 50% To $28m, Loss Up 86% To $14m; Seafarms Revenue Up 33% To $26m; Loss Down 82% To $15m; Althea Revenue Up 22% To $20.5m; Loss Up 13% To $14m; Cann Group Revenue Up 115% To $13.8m; Loss Up 27% To $34m; Wide Open Revenue Up 24% To $11.5m, Loss Up 36% To $15m; Murray Cod Revenue Down 13.5% To $11m, Loss Down 18.5% To $7m; RLF Revenue Up 6.4% To $11m; Loss Up 12% To $4m; Next Science Raises $12m, Plans For $6.5m More; Avecho ‘Commitments’ For $6m Phase III Trial; Bio-Gene $2.5m Placement, Plan For More, Trading Halt; MGC Share Plan Raises $834k Of Hoped-For $2.7m; $1.85m Shortfall; Epsilon Quits Marijuana Cultivation; Bega To Pay Tasfoods $11m For Betta Milk, Meander Valley Dairy; Anatara Doses Garp For IBS Patients; L1 Capital Takes 13.55% Of Nufarm; Vanguard Takes 5% Of Costa; Wilson Below 5% Of Ridley Corp; Dr Julian Chick Replaces Cann Group Chair Allan McCallum; Bubs Appoints Reg Weine M-D On $730k Pa; Melanie Laing Replaces Ridley’s Patria Mann, Prof Van Barneveld; Pharmaust Appoints Dr Michael Thurn CEO On $270k PA

Ag & Vet Weekly Final Editorial; Bega Revenue Up 12% To $3.4b, Profit To $230m Loss; A2 Milk Revenue Up 10% To $1.5b; Profit Up 27% To $144m; Cobram Revenue Up 21% To $170m; Loss To $7.7m Profit; Ecofibre Revenue Up 8% To $32.5m; Loss Up 172% To $40m; Ecofibre Placement Raises $5m, Share Plan For $1m More; Costa $30m Revenue Warning; Delays H1 Results 1 Week; Elders Profit Warning: Down 8-12% To $165-$175m; Select Harvests: ‘Crop Not Impacted By NSW Varroa Mite’; ASX Suspends Cann Global On Fees; Epsilon Pays $4m Loan, Borrows Further $2.85m; Pharmaust: 11 Monepantel MND Patients ‘Stable’; Avecho Takes ‘Capital Raising’ Trading Halt To Suspension; Paul Benhaim, Raw With Life Below 5% Of Elixinol; Aileen Stockburger Next Science Chair, Grant Hummel Director; Botanix COO Howie Mckibbon Promoted To CEO, On $624k PA

Ridley Revenue Up 20% To $1.3b; Profit Down 1.4% To $42m; Memphasys: Vitrolife 1st 150 Unit Felix IVF Order For Japan; Farmers For Climate Action: Record High Insurance Premiums; Fonterra Completes $740m Capital Return; $46m Buy-Back; Goodbye Sustainable Nutrition; Anatara Receives $923k Federal R&D Tax Incentive; Ecofibre Extends Jeff Bruner Texinnovate Earn-Out Term; MGC Cimetra ‘Non-Toxic, In Pigs’; Vasilios Votsaris Takes 11% Of Original Juice; Agrifutures Rural Women’s Award Gala Dinner; Pharmaust Requests ‘MND Trial Data’ Trading Halt

Fonterra Expects Earnings Up 100% – $964m To $1.19b; Apiam Revises Unaudited Profit Down 41% To $2.3m; Fonterra Farmgate Milk Midpoint $6.49/KgMS; Synlait Reduces Milk Forecast To $6.44/KgMS; Federal Court Approves Elixinol Sustainable Nutrition Acquisition; Memphasys Appoints Vitrolife Japan Felix IVF System Distributor; Next Science: ‘Xperience Reduces Total Knee Inflammation’; NZ High Court Approves Fonterra $742m Capital Return; Althea, Peak Processing Extends Electric Brands Supply; Pharmaust Doses 3rd Monepantel For MND Cohort; Dimensional Entities Below 5% Of Select Harvests; Shenasaby, Callahans Increase, Diluted To 5.25% In Botanix; Synlait Appoints Glenn Laing Director Of Manufacturing

Apiam Unaudited Revenue Up 23% To $193m; Bubs Receipts Down 23.5% To $69.8m; Ecofibre Receipts Up 8% To $33.9m; Wellnex Receipts Up 30.5% To $23.3m; RLF Record Receipts Up 24.7% To $12.5m; MGC Receipts Down 33.5% To $4.1m; Sustainable Nutrition Receipts Up 2.7% To $3.9m; Sustainable Nutrition 99.8% Vote For Elixinol Takeover; Queensland $3.9m For 24 Agricultural Business; Ecofibre $9m Under Armour Supply Deal; MGC Share Plan For $2.7m; Roots: $165k First State Loan; Australian Agricultural Denies Directors Leak To Joe Lewis; Pharmaust Epichem Liquidation; Auscann Expands EU Cannabis Corp Marijuana Collaboration; MGC Slovenia Psilocybin Mushroom Permit; Bio-Gene Wins Flavocide US Patent; Roots Patent For Root Zone Temperature Control; Epsilon Rebrands THC Pharma, Tetra Health As ‘Epsilon’; Wellnex Extends Painaway Purchase Deadline; Carr, Lin, Willis, AZ Below 5% In Bubs; Cobram Director Prof Jonathan West Dies; Select Harvests $275k CEO David Surveyor ‘Retention’ Payment; Next Science Loses Director Judith Mitchell; Bio-Gene: Alex Ding, Tim Grogan In; Robert Klupacs, Richard Jagger Out; Original Juice Loses Director Jianping (Rocky) Zhou; MGC Loses Co-Co-Sec Arron Canicais

Abares: Farm Sector Debt $110b; Original Juice Co Receipts Up 16% To $42m; Tasfoods Receipts Up 10.3% To $38.6m; Next Science H1 Receipts Up 119% To $13.5m; Cann Group Marijuana Receipts Up 131% To $15m; Murray Cod Receipts Down 12% To $11.4m; Wide Open Receipts Up 26% To $11m; Australian Agricultural Seeks Joe Lewis Legal Advice; Bubs 63% Resist Ex-Chair, Ex-CEO Spill; Cann Group Rights Raise $4.5m Of Hoped-For $11.7m; Wellnex Rights Raise $467k Of $5.3m; RLF Sells Commonwealth Bank 50k Carbon Credits For $1m; Fonterra Shareholders Vote For $735m Capital Return; Fonterra Up-To $46m Buyback; Bio-Gene, STK Crops Deal; Wide Open: ‘4 Years Of Growth, Regeneration Doubles Sales’; Correction: Botanix Pharmaceuticals; Pharmaust Doses Monepantel For MND 3rd Cohort; Bio-Gene Flavocide, Qcide In US Vector-Borne Disease Program; RLF Hillston Soil Carbon Project; Althea: Ireland To Pay $542 For 50ml Marijuana CBD12:THC10; Cann Group Marijuana Harvest ‘Twice Previous Years’; MGC: Premier Sole Investor In Raising; Terragen Appoints Robyn Smith CFO, Co Sec

Queensland $79m For Start-Ups, Innovation; Ozfish Trials Sustainable Bag-To-Yield Native Oysters; Western Australia $5m For Wide Open Buntine Protein Factory; Ecofibre: 132t Hemp Seed Damaged In US Transit; Botanix Raises $12.5m To Buy Royalties; Althea, Tweed Marijuana Drinks; Federal Court Elixinol, Sustainable Nutrition August 7 Date; L1 Takes 12% Of Nufarm; Scobie Dickinson Ward Increases, Diluted To 16% Terragen; Sam Brougham, Stamina, Crofton Diluted To 6% Of Terragen; Premier Takes 9.9% Of MGC; Brett Hall Replaces Climate Action Farmers Chair Charlie Prell; Oscar Pearse Replaces NSW Farmers Director Helen Carrigan; Charles Darwin Uni: Paul Burke Appointed Rina Head

Farmers For Climate Action El Niño Webinar; Meat And Livestock Australia: Seaweed 28% Methane Reduction; Bubs: Alice Fails To Meet Contractual Obligations; Althea Marijuana Receipts Up 51% To $33.1m; Cobram: CBA Extends Debt Facility To $93m; 12.5m Litre Harvest; MGC Hopes For $1.245m; $95k Convertible Note; Total $1.34m; Pharmaust: Monepantel Suppresses MND Biomarkers; Memphasys Granted 2 Australian Felix Patents; Wilson Asset Management Takes 6.7% Of Select Harvests; Costa Group Appoints Marc Werner Deputy CEO; Ming Lim-Pollard Replaces Fonterra Milk Panel’s Bruce Hassal

Paine Schwartz Offers $1.6b For Costa; Abares Sustainability Report Backs Australian Agriculture; Terragen Plan Raises $466k Of Hoped-For $1m; Total $4.2m; Bubs Strategic Review; $5.7m Alpha, Willis, Alice Legal Dispute; Cann Unaudited Revenue Up 111% To $13.5m; Wellnex Adds Wakey Wake, Nighty Night Products; Wide Open: ‘Still Hunting A Buntine Protein Partner’; Pharmaust: ‘Monepantel May Suppress MND Inflammation’; Pharmaust: Lymphoma Dog Survives 365 Days; EGM 18% Dissent; Ecofibre: EOF-Bio Hemp For Endometriosis, Ovarian Cancer Pain; Ridley Corp Buys-Back 3.7m Shares For $7m; MGC: AMC Pharma Buys $1.5m Artemic; Hits LSE One Farthing; Dimensional Entities Takes 5% Of Nufarm; Spheria Takes 6% Of Bega; Sam Brougham, Stamina, Crofton Diluted To 9% Of Terragen; Mike Barry Replaces Terragen Chair Travis Dillon; MGC Terminates Unnamed Executive; Elders Loses Director Diana Eilert; Paul Rossiter CFO; Leonard Math Replaces Roots Co Sec Sarah Smith

Queensland 2023-’24 Agriculture Record $23.44b Valuation; Bega Sells Port Melbourne For $115m; Expects $160m Ebitda; Federal $392m Industry Program Design Discussion Paper; Wellnex: Haleon UK, Ireland, UAE Soft Gel Paracetamol Deal; Next Science Expects $6.6m Q2 Sales, Higher Than Forecast; Bubs Expects 2023 China Revenue Down 74.5%; Bio-Gene Flavocide US Patent For Aphids; Nufarm: Norway Okays Aquaterra Omega-3 Fish Feed; Federal Court Elixinol, Sustainable Nutrition Meeting; Tasfoods Sells Shima Wasabi For $700k To Hillwood Berries; Pharmaust Doses Monepantel MND Cohort 3; Results Trading Halt; MGC Pharma EGM Passes Resolutions; 21% Oppose Options; Wide Open To Release 14m Escrow Shares; Perennial Takes 9.8% Of Ecofibre; Next Science To Lose Director Bruce Hancox; Cann To Lose Chair Allan McCallum; Dr Julian Chick Deputy; Auscann Appoints Ex-MGC Chair Brett Mitchell Director

Federal $50m For Wilga Low-Emissions, Carbon Sequestration; Bubs Forecast US Revenue Up-To $22m, Chris Lotsaris US G-M; Cann Group $880k Levin Health Marijuana Deal; Elixinol Extends Sustainable Nutrition Loan; Avecho: ‘TPM-Marijuana Caps 99.5% Stable At 2 Years’; Bubs Board Spill EGM; L1 Capital Takes 10.9% Of Nufarm; Host-Plus Takes 5.1% Of Nufarm; Tiga, Thorney Below 5% In Sustainable Nutrition; Nufarm Appoints Federico Tripodi, Adrian Percy Directors

NZ Court Orders Fonterra $725m Capital Return EGM; Cobram Expects Crop 20-25% Below Forecast; Wellnex Placements, Rights To Raise $27.5m; Cann Group: 1-For-4 Rights Offer For $11.7m; Seafarms Continues Project Sea Dragon, Pending Funding; Microbiogen Showcases Waste-To-Animal Feed; Auscann Sells $6.7m Perth Facility To Optral; Cann Group: Haleon Cancels Satipharm Marijuana Trial Deal; Harry Hall Replaces Next Science M-D Judith Mitchell, On $655k

Abares: 14% Agriculture Drop Due To Lower Rainfall; El Niño; Bureau Of Meteorology Issues El Niño Alert; Terragen Raises $3.7m; Plan For $1m More; Synlait, A2 Infant Formula Re-Registered In China; Memphasys: ‘Felix Beats Others For Frozen Sperm’; Pharmaust Monepantel ‘Safe’ For MND; Starts Cohort 3; Avecho Completes TPM Marijuana Gummies Development; Anatara Plans Stage II Garp IBS Trial; Creso To Import Swiss MDMA, Psilocybin; Roots Tells ASX: Israel 35-Day Rule Delayed EGM 7 Months; Elders Keeps M-D Mark Allison, Loses Director Matthew Quinn; Australian Agricultural Loses Co Sec Bruce Bennett

Select Harvests H1 Revenue Down 11% To $61m, Profit To $96m Loss; Rabobank Forecasts Lower Winter Harvest; Synlait To Divest Dairyworks, Talbot Forest Cheese; Synlait Revises Forecast Milk Prices; USPTO Allows Avecho TPM Patent; MGC Delivers 1st Cannepil To UK Patients In Zam Trial; Wellnex Extends Voluntary Suspension; Bubs Ex Chair Dennis Lin, CEO Kristy Carr Call Board Spill; Qbiotics Loses Neville Mitchell; Dr Steven Ogbourne Executive; Ridley CEO Hildebrand $1m, 1.5m ‘Retention’ Rights, 50% STI Rise; MGC Brett Mitchell, Nativ Segev Go; Layton Mills In; Adviser, Broker; Anna Palairet Replaces Fonterra COO Fraser Whineray; Food Agility ‘Paddock To Profit’ Conference

Wellnex To Raise $27.5m, Buy Pain Away For $22m; Immersion: Nissui Invests In Asparagopsis Seaweed; Elixinol Plan Raises $1m; Total $2.25m; Fonterra Farmgate Milk Midpoint $7.56/KgMS; RLF $3.3m 2nd Vietnam Distribution Deal; Clover Corp Lowers Revenue Guidance To $77m To $82m; Terragen: Mylo Improves Milk Yield, Reduces Cycle Time; Avecho Licences TPM For Cancer To Arthur Group; Pharmaust Ready For 3rd MND Monepantel Dose; Nanollose Receives $374k Federal R&D Tax Incentive; Agrifutures: Bookings Open For Rural Women’s Awards Night; Allan Gray Takes 14% Of Nufarm; L1 Capital Takes 9.8% Of Nufarm; Citigroup Below 5% In Costa; Wilson Takes 5.35% Of Ridley; Original Juice: Adam Brooks Director, Ashley Bottrell Co Sec; CFO Josephine Lorenz Replaces Elixinol Co Sec Teresa Cleary; Robin Johnston Replaces Bubs CFO Iris Ren

Nufarm H1 Revenue Down 10% To $1.9b; Profit Up 51% To $149m; Elders H1 Revenue Up 9% To $1.7b, Profit Down 46% To $49m; Aust Agricultural Revenue Up 13.5% To $313m, Profit Down 97% To $5m; Apiam To Pay 10 Vets $650k HECS Debts; Freezem Black Soldier Flies For Feed, Waste Reduction; Prevatex Prevotella Copri For Dog Gut Disease; Creso Raises $2.5m; ASX Query: ‘Unequivocally’ Merits Listing; Althea: Ireland Approves THC20:CBD1 Medical Marijuana; Creso: Gotro Singapore Range; 1st South Korea Marijuana Sale; Roots: US Patent; $158k UAE Supply Deal; Avecho Manufactures TPM-CBD For Insomnia Trial; Nanollose Files Australian Jelli Grow Cellulose Patent; Creso 47% Oppose Blumenthal, Everblu Options; Wellnex Requests ‘Acquisition, Capital Raising’ Trading Halt; Regal Reduces To 10% Of Apiam; Paul Jensz, Agfood Takes 13.3% Of Tasfoods; Mark Kerr Diluted To 11.5% In Avecho; Epsilon Appoints Peter Giannopoulos CEO On $495k PA

Select Harvests Almond Crop Down 40%; Avecho Rights Raise $2m Of Hoped-For $11m; Althea: UK NHS Approves Marijuana For Pain; Ecofibre: Marijuana For Gynecological Disorders US Patents; Biogene: Grain R&D Corp To Support Flavocide; Original Juice Hopes For $3.5m National Australia Bank Loans; Original Juice China, Malaysia Supply Deals; Pharmaust: Monepantel Broad Anti-Cancer Effect, In-Vitro; Stable Monepantel Earns Pharmaust Fight MND $119k; Epsilon Marijuana Permit Renewed; Creso Tells ASX: Psilocybin, Health House Pushed Price 50%; Creso Health House Acquisition Approved; Citigroup Takes 6.8% Of Costa; Bubs ‘Terminates’ CEO Kristy Carr, Chair Dennis Lin; A2: Kevin Bush US CEO; Blake Waltrip, Eleanor Khor, John Roberts; Alex Ding, Chris Ramsay Replace Biogene’s Robert Klupacs

ARC Launches Canberra Crop Development Training Centre; Seafarms: Canstruct Halts Creditor Deed Distribution; Original Juice Q3 Receipts Up 25% To $11.6m; Cobram: ‘15% Reduced Oil, Higher Crop Yield’; Pharmaust ‘Over-Subscribed’ Placement Raises $2.5m; Health House 96% Vote For Creso Takeover; Cann Group Dried Marijuana Flower On Sale In Germany; Pharmaust Completes Monepantel MND Dosing; MGC Malta Marijuana, Cimetra Factory Wins EU Approval; ASX Suspends Wide Open On Compliance; Kate Mitchell Replaces A2 Director Julia Hoare; Creso: 2 Psilocybin PTSD Trial Patients ‘Total Remission’; Creso ‘Melodiol’ Name Change, 15.5m Shares, 47.8m Options AGM

Federal Government Celebrates World Veterinary Day; Veterinary Association: ‘Education To Improve Diversity’; Synlait Profit Warning, A2 Comments; Tasfoods Q1 Receipts Up 4% To $18.4m; Bubs Q3 Receipts Down 40% To $13.1m; Ecofibre Q3 Receipts Up 3% To $6.8m; Wellnex Q3 Receipts Up 72%To $6.1m; Cann Group Q3 Receipts Up 220% To $4.1m; Canaccord Underwrites $1m Elixinol Share Plan; Biogene’s Flavocide, Qcide Effective Combination Insecticides; Wide Open Takes ‘Clarification’ Halt To June 30 Suspension; Vanguard Takes 5% In Bega

Agriculture Innovation Mission Climate Summit; Creso 131m Shares, 752m Options, $2.8m Notes EGM; Pharmaust: 2 Dogs ‘Partial Response’, 8 ‘Stable Disease’; Pharmaust Receives 10,000 Monepantel Tablets; Synlait Requests ‘Guidance Revision’ Trading Halt; Wide Open Requests ‘Clarification’ Trading Halt; Insignia Takes 8.6% Of Botanix; Regal Funds Below 5% In Clean Seas; Premier Fund Managers Takes 5.6% Of MGC Pharma; Agrifutures: Evoke Ag 2024 Conference In Perth; Susan Park Replaces Botanix Co Sec Simon Robertson; Sarah Prince Replaces Elixinol Co Sec Kim Bradley-Ware; Synlait Appoints Cathy Gamlen People, Culture Head

MGC Raises $4.4m, $2.8m Notes, Term Sheet; Roots Raises $650k; $200,000 Loan; Rights Offer For $750k More; Creso: ‘$2m Raise Includes $369k For Debts’; Althea Record Receipts Up 62% To $8.9m; Clean Seas Buys $5.7m Automated Feed Barge; Wellnex 2023 Guidance Up 55% To $29m; 2024 Up 63% To $47m; Agrifutures 2023 Horizon $220k Scholarship Winners; MGC UK Approves Marijuana Cannepil For ‘Named Patients’; L1 Capital Takes 7.5% Of Nufarm; Pharmaust: CEO Wanted; Katrina Rathie Replaces Bubs Chair Dennis Lin; Reg Weine; Seafarms Loses Directors Terutaka Kuraishi, Hisami Sakai

New South Wales Agriculture, Industry, Innovation Ministers; Avecho Rights For $11m; Botanix Placement Raises $10m; Elixinol Raises $2.25m In Placement, Share Plan; Sustainable Nutrition Okays Elixinol Capital Raise; Memphasys 1st Japan Felix Sale, 1st India Felix Live Birth; Nanollose Increases Nullarbor Cellulose To 30% In Fibre; Fonterra Farmgate Milk Midpoint $7.74/KgMS; Seafarms: Canstruct Wants Sea Dragon Deed Terminated; Botanix: FDA Mid-Cycle Review Okays Sofpironium Bromide; Roots Takes ‘Capital Raising’ Halt To Suspension; Auscann Sells Perth Premises For $6.75m; Slovenia Approves MGC Psilocybin Research; Elixinol Loses Paul Benhaim, Oliver Horn; Ron Dufficy M-D

$15b Reconstruction Fund Corp Bill Approved – Royal Assent; Dr Boreham’s Crucible: Memphasys; Abares: Agriculture Spends $2.2b On R&D; Synlait H1 Revenue Down 2.6% To $718m; Profit Down 83% To $4.5m; Fonterra Completes $956k Soprole Sale To Gloria Foods; RLF Hires Carbon West For Carbon Capture Program; Seafarms Signs Project Sea Dragon Deed; Suspension Ends; Wide Open: ‘Lupin Buntine Potential For Food’; Tasfoods, Udder Way Partner To Sell Milk In Tasmania; Original Juice Converts $790k Batman Loan To Shares; Pharmaust: 1 MND Patient ‘Stable’ At 6 Months; Enrols Cohorts; L1 Capital Takes 6.4% Of Nufarm; Paine Schwartz, ‘Australian Football’ Take 14.8% Of Costa; Dimensional Below 5% In Ridley; Miles Brennan Replaces Terragen CEO Jim Cooper, On $250k PA; Nanollose Appoints Emily Spano Co-Co Sec; Memphasys Appoints Hassan Bakos Operations Director

Queensland 2050 Net Zero Emissions Agriculture Roadmap; Food Agility Launches Pilot Emission Program; RLF Launches Grain Carbon Capture Program; Seafarms $3.5m To Restore Project Sea Dragon; Nanollose Extends Birla Cellulose, Grasim Deal To 2025; MGC Artemic Wins US FDA O-T-C Listing, $3m AMC Order; Health House: Court Orders Creso Acquisition Vote; Roots EGM Approves 12-To-1 Consolidation; 7% Dissent; A2 Milk Completes $138m, 21.7m Share Buyback; Food Revolution Changes Name, Code To Original Juice Co, OJC; Allan Gray Takes 12.8% Of Nufarm; Citigroup Reduces To 5.7% Of Costa; Tattarang Dr Andrew ‘Twiggy’ Forrest Below 5% In Ridley; Perennial Takes 8.8% Of Ecofibre; Tiga, Thorney Diluted To 6.2% In Sustainable Nutrition; Wexford, Nash Diluted Below 5% In Sustainable Nutrition; NFF’s Fiona Simson Wins Rabobank Leadership Award; Bubs Appoints Paul Jensen Director; Synlait Loses Nigel Macdonald, Glenn Laing Acting Ops Head; Joanne Ford To Replace Wide Open Director Stuart McAlpine

Fonterra H1 Revenue Up 23% To $12b; Profit Up 50% To $507m; Clover H1 Revenue Up 49% To $44m, Profit Up 81% To $3.6m; Synlait Profit Warning, Recovery Extended To 3 Years; Federal $6m For Methane Emission Reduction Projects; RLF $8.8m Taipan Philippines Crop Nutrition ‘Target’; ASX Censures Creso; Creso Responds; Botanix Pleads ‘Schultz, FDA, Webinar’ To ASX 28% Price Query; MGC Enrols 1st Patient In Zam Cannepil Users Trial; Nanollose Wins US Nullabor Fibre Patent; Wellnex: Chemist Warehouse Joins Marijuana J-V; L1 Capital Takes 5.25% In Nufarm; Citigroup Reduces To 6.8% Of Costa Group; Schroder Reduces To 5.2% Of Ridley; Joshua Fletcher Replaces Tasfoods Co Sec Shona Croucher

Labor, Greens Advance $15b Reconstruction Fund Corp Bill; Abares Outlook: Agriculture To Be Worth $90b; S&P Indices: Ridley, Synlait Up; Queensland $7.5m For Aquaculture; Emma Gibbons Wins Agrifutures Qld Women’s Gong, Westpac $15k; Creso $2.5m SBC Convertible Notes, Pays Obsidian; Roots ASX Query: $1.8m Placement, Share Plan, 12-To-1 Consolidation; MGC Draws Further Mercer Street $743k; Pharmaust Lymphoma Dog Survives 240 Days; Anatara Revises ‘Garp’ IBS Trial, Mucpharm Licence; Auscann To Divest 52% Of Cannpal; MGC Cimetra Inflammation Mechanism-Of-Action In-Vitro Study; Food Revolution EGM Approves 4-To-1 Consolidation; Citigroup Takes 8% Of Costa; AA Trust (Tavistock) Takes 51.1% Of Australian Agricultural; Perpetual Takes 8.7% Of Clover; Next Science Founder, CTO Dr Matthew Myntti Below 5%; Select Harvests M-D Paul Thompson Goes

Tasfoods Revenue Up 2% To $71.6m, Loss Up 53% To $16.5m; Bubs H1 Revenue Down 6% To $31.5m, Loss Up To $44.4m; Food Revolution H1 Revenue Up 12% To $24m, Loss Up 17% To $1m; Seafarms H1 Revenue Up 4.8% To $16m, Loss Down 67% To $12.5m; Althea H1 Revenue Up 26% To $11.8m, Loss Up 33% To $9.4m; Next Science Revenue Up 31% To $17m; Loss Up 36% To $19m; Murray Cod H1 Revenue Up 25% To $6m, Loss Down 88% To $365k; Elixinol Revenue Down 24.5% To $7.05m, Loss Down 40% To $10.65m; Creso Revenue Up 40% To $8.7m, Loss Up 9.2% To $33m; Epsilon Revenue Up 26% To $7m, Loss Down 15.4% To $12.6m; RLF H1 Revenue Down 15.7% To $2.8m, Loss Down 5% To $3.2m; Elders Buys Emms Mooney Livestock, Real Estate; Cann Settles $5.5m Southern Facility Sale To Sativite; Wide Open: $12m NAB Loans For Plant-Based Drinks; MGC UK Broker Change; Rowan Harland, Arron Canicais Co Co Secs; Pharmaust Monepantel MND Trial Interim Analysis; Pharmaust Monepantel For Cancer Euro Patent; Roots 12-To-1 Consolidation EGM; Citigroup Takes 6.5% Of Costa; Perpetual Takes 7.4% Of Clover; RLF Appoints Raj Aggarwal Carbon Strategist; Select Harvests Loses Directors Fiona Bennett, Fred Grimwade; Memphasys Appoints Dr David Ali Business Development Director; Leonie Guiney Replaces Fonterra Milk Price Panel Brent Goldsack

Bega H1 Revenue Up 11% To $1.7b, Profit Down 74% To $7.3m; Costa Revenue Up 11% To $1.4b, Profit Down 19% To $33.6m; A2 Milk H1 Revenue Up 18.6% To $710m, Profit Up 24% To $67m; Apiam H1 Revenue Up 25% To $93.7m, Profit Up 69% To $2.8m; Cobram H1 Revenue Up 1.8% To $72m, Loss Up 91% To $10m; Clean Seas H1 Revenue Up 9.7% To $34.2m, Loss Up 61%To $3.5m; Ecofibre H1 Revenue Up 6.4% To $16.5m, Loss Up 163% To $17.6m; Cann Group H1 Revenue Up 83% To $5.8m, Loss Up 128% To $18.8m; Wide Open H1 Revenue Up 37% To $5.4m, Loss Up 44% To $7.7m; Fonterra Farmgate Milk Midpoint $7.77kg/MS; Fonterra Approved To Sell Chile Soprole To Gloria Foods; Bega To Relocate Canberra Dairy Manufacturing To Penrith NSW; Avecho, Lambert Expand Soft-Gel Marijuana Trials; Roots Extends $210k Loan; Pharmaust Starts 2nd Motor Neurone Disease Cohort Dosing; Ecofibre Loses Director Jon Meadmore

Seafarms Suspension For Project Sea Dragon Administration; Federal $9.3m For Loam Bio Carbon Storage; Ridley H1 Revenue Up 25.4% To $638m, Profit Down 7.2% To $21m; Creso ‘Firm Commitments’ For $2m Placement; Elixinol Awarded Cannacare $835k; Wide Open Wins $350k Commonland Grants; Synlait: China A2 Milk Infant Formula Re-Registration Audit; Wellnex Delivers 1st Pharmacy Own Products To CH2; Botanix Denies Sweating Profit Forecast, Retracts ‘Scenarios’; Creso To Release 134.1m Voluntary Escrow Shares; Fonterra To Lose COO Fraser Whineray

Seafarms Unhappy With $15.3m Canstruct Ruling; Cobram Australian Olive Oil Yield ‘In Line With Expectations’; One Month To Abares Outlook 2023 Conference; Wide Open Oat Milk For WH Smith Shops; Tasfoods To Distribute Juice Guys Drinks In Tasmania; Memphasys Felix ‘Beats DGC For Sperm Separation’; Creso, Halucenex Explore Psylocibin For Australia; Elders Pleads Schultz, Briefings To ASX 7% Fall Query

Bega To Sell Vitasoy 49% For $51m; Apiam Buys 5 NSW Clinics For $11.2m Cash, Scrip; Bubs H1 Receipts Up 17% To $46.0m; Tasfoods Receipts Up 2.8% To $71.7m; Food Revolution H1 Receipts Up 6% To $18m; Althea H1 Receipts Up 49% To $14.8m; Next Science Receipts Up 12% To $15m; Murray Cod H1 Receipts Up 40% To $6m; RLF H1 Receipts Up 1% To $6m; Cann H1 Receipts Up 78% To $5.8m; Wide Open Agriculture H1 Receipts Up 26.2% To $5.3m; Creso Receipts Up 29% To $8m, 2.01 Quarters Cash; Elixinol Receipts Down 28% To $7m; Epsilon Receipts Down 24% To $3.8m; Nufarm 47% Rem Report 1st Strike, 51% Block Greg Hunt Rights; Food Revolution Name Change, Consolidation, Kennett EGM; Althea Takes $2.2m Obsidian Convertible Loan; Althea Takes $2m Loan; Welcomes Canada Marijuana Change; Creso La Plata Loans; Buys Abby & Finn; MGC, Mercer Reduce Minimum Conversion Price To 1¢; Peter Findlay Replaces Bega CEO Paul Van Heerwaarden; Ex-Creso, Roots James Ellingford Charges Adjourned; Tom Cairns Replaces MGC CFO Angela Marie Graham

Melbourne Uni Study: $476b Nitrogen Reduction Benefit For $19b; Clean Seas H1 Revenue Up 9.7% To $34.2m; Ecofibre H1 Receipts Up 8.7% To $18.1m; Wellnex H1 Record Revenue Up 54% To $13.2m; Select Harvests ‘Record Low’ Almond Price Of $6.225/Kg; Roots Rights Raise $21k, Shortfall $1m, Requests Trading Halt; Creso $350k Record Marijuana Order; Manitoba Expansion; Creso Requests ‘Debt Restructure, Acquisition’ Trading Halt; Synlait Appoints Abby Ye China Head, Food Service Director

Special Summer Catch-Up Edition

Cann Sells Southern Facility, Assets For $5.5m To Sativite; Norges Bank Takes 5% Of Bega; Marcelo Mora Epsilon Co Sec, Sonny Didugu, Li Lin, Mark Audet; MGC Draws Further Mercer Street $800k; Norges Bank Below 5% In Bega; Phoenix Takes 5.6% Of Nufarm; Creso EGM 24.25% Oppose James Ellingford Shares; Auscann Loses Director Krista Bates; MGC: Directors Fees Reduced By 55%, Evan Hayes Goes; Sustainable Nutrition Revenue Up 80% To $3.4m, Loss $5.2m; JYSF Takes 11.1% Of Wellnex; Pharmaust Completes 1st Monepantel MND/ALS Cohort; Wellnex H1: Revenue Up 53.4% To $13.2m; Creso Draws Down Obsidian $500k; Zelira: Creso Repays $1.75m Health House Loan; Cann Group Appoints Peter Koetsier CEO On $350k PA; Washington H Soul Pattinson Reduces To 19.4% In Clover; Norges Bank Takes 5.2% Of Bega; Creso, Mernova To Sell 7 Marijuana Products In Canada; Seafarms Chair Ian Trahar Backs Sea Dragon, Takes 29.2%; Vasilios Votsaris Takes 10.5% Of Food Revolution; Avecho Takes TPM-Vitamin K To US FDA Pre-IND Meeting; Anatara Has 1.87 Quarters Of Cash; Aware Super Below 5% Of Nufarm; Federal Government Appoints Cathy McGown Agrifutures Chair; Agrifutures $49k Rural Women’s Acceleration Grant; IFM, Bonafide Takes 18.5% Of Clean Seas; Cann Group ‘Satipharm CBD Not Superior To Placebo For Sleep’; Pharmaust Takes Monepantel For MND To Higher Dose

Synlait H1 Results Warning, Full Year Unchanged; Synlait Revises Forecast Milk Price To $8.56/KgMS; Avecho: Ethics Approval For Phase III Marijuana Insomnia Trial; Avecho, Perrigo To Develop Ibuprofen-TPM Gel; Clean Seas Renews $32.15m CBA Loan; Roots Appoints ES France Distributor; Pharmaust: Partial Response In 2 Dogs; Nufarm: 272k M-D Greg Hunt Rights AGM; Central T Corrects RLF Holding To 6.9%; Cobram Appoints Toni Brendish Director

Fonterra, Nestlé Sell Dairy Partners For $195m; Select Harvests: 30,000mt 2023 Crop Forecast; M-D David Surveyor; Next Science $10m Walker Group Convertible Notes; Althea Share Plan Raises $873k; Total $2.4m; Apiam Completes $6.5m Hunter Equine Acquisition; Wellnex Acquires Mr Bright; Pharmacy Own Launch; Roots $160k 2nd Elite Agro United Arab Emirates Order; Pharmaust $654k Federal R&D Tax Incentive; Repays Radium; Anatara EGM 47% Oppose Advisor Options; Roots Extends $1m Rights Offer Closing Date; Elders Takes 11.3% Of PGG Wrightson For $35.2m; Central T Takes 14.2% Of RLF; Jeff Kennett Replaces Food Revolution Chair Norman Li; Wide Open: Jay Albany CEO On $248k; Dr Ben Cole Executive; Select Harvests Appoints Michelle Somerville Director; Synlait Loses Boyd Williams

Abares: ‘Bumper Year’ Production At $85b, Exports At $72b; Queensland $14.25m For Sugar Research; Cann Group Share Plan Raises $8.2m; Wide Open Sends Buntine Protein Samples, Scale-Up; Fonterra Guidance Up 17%, Farmgate Midpoint $8.50kg/MS; Roots Wins Israel ‘Certificate Of Design Registration’; MGC: ‘Cimetra Reduces Lung Inflammation, In Mice’; MGC Delivers $1.5m Artemic To AMC; Creso’s Halucenex Doses 1st Psilocybin PTSD Patient; Creso Tells ASX: ‘We Shall Confirm Related Parties’; MGC Marijuana CBD, CBG ‘Kill Glioblastoma Stem Cells, In-Vitro’; Botanix: US FDA Confirms Sofpironium Bromide Sweat Review; Roots Loses Director James Ellingford, Too; Nick Haslam Replaces Anatara Director Sue MacLeman; Joshua Fletcher Replaces Tasfoods CFO, Co Sec Shona Croucher

Elixinol To Acquire Sustainable Nutrition For $4m Scrip; Creso, Roots James Ellingford Bailed, Leaves Creso; Cobram California Olive Oil Yield Down ‘As Expected’; Nanollose: Orta Manufactures Nullarbor-20 Denim; Apiam Pays $6.5m Cash, Scrip For Hunter Equine; Pharmaust Doses 1st Monepantel MND Trial Cohort; Botanix Share Plan Raises $961k; Total $6m; Roots Rights For $1m; Roots Appoints Unicorn Oman Distributor; Wide Open AGM Up-To 42% Oppose 2.75m Director Options; Bubs AGM 27% Oppose 1.7m Director Rights; Murray Cod AGM Just Loses Virtual Meetings Resolution; Nanollose Remuneration Report Faces 17% Dissent; Creso Directors’ 21m Shares, 10m Options, 4m Rights EGM; FIL Below 5% Of Synlait; RAH Takes 8% Of Roots, Sells All For $25k Profit; Regal Below 5% In Elixinol; Epsilon Appoints Mark Audet CFO, Replaces Co-Co Sec Louisa Ho

Select Harvests Revenue Down 31% To $200m, Profit Down 69% To $5m; Anatara Rights Raise $525k; Total $1.4m; $308k Shortfall; Agrifutures Horizon Scholarship Applications Open; Clover AGM 35% Block ‘Fully Virtual Meetings’; Apiam AGM 25% Oppose M-D Employee Equity Plan; Ridley AGM 19% Oppose Re-Election Of Rhys Jones; Fonterra ‘Flexible Shareholding Capital Structure’; RLF To Release 6.1m Voluntary Escrow Shares; Apiam To Release 2.2m Voluntary Escrow Shares; Creso To Take Health House For ‘$4.6m’, Repay Zelira Loan; Creso ‘No Longer The Subject Of ASIC Investigation’; Roots Extends Loans; Tattarang, Dr Forrest Take 18.5% Of Australian Agricultural; Wilson Takes 5.7% Of Select Harvests; Commonwealth Super Below 5% In Select Harvests; FIL (Fidelity) Reduces To 5% Of Synlait

Fonterra Sells Soprole To Gloria Foods For $956m; Nufarm Revenue Up 17% To $3.8b, Profit Up 118% To $133m; Elders Revenue Up 33% To $3.5b; Profit Up 9% To $163m;Australian Agricultural H1 Revenue Up 14% To $163m, Profit Down 38%; Wellnex 4-Month Revenue Up 60% To $8.8m; Nufarm $950m Loan Refinancing; ARC Launches Tropical Aquaculture Hub; RLF Opens Vietnam Office; Nhan Lu Manager; Elders 107k Retiring M-D Mark Allison Rights AGM; Pip Greenwood To Replace A2 Chair David Hearn Next Year; Boaz Wachtel Replaces Creso Chair James Ellingford

NSW Court Approves Tassal-Cooke Scheme; Goodbye Tassal; Abares Conference 2023: ‘Global Uncertainty, Local Challenges’; Rabobank Extends Elders Loan To $300m, Term; Botanix Opens $3m Share Plan; Cann Group, GSK O-T-C Marijuana Capsules Deal; Althea, Nimbus To Sell Each Other’s Marijuana Products; Creso, Sierra Sage ‘Green Goo’ Cosmetics For Canada; Ecofibre AGM Blocks Constitution Change; Pharmaust AGM Passes All Votes; 14.5% Dissent; Althea 8.35m M-D Joshua Fegan Rights AGM; A2 Milk Starts 37m Share Buyback; IOOF, Insignia Take 6.1% Of Botanix; Founder, CTO Dr Matthew Myntti Reduces To 5.95% In Next Science; SG Hiscock Takes 7.2% Of Althea; $1m David Surveyor To Replace Select Harvests M-D Paul Thompson; Fonterra Appoints Neil Beaumont CFO; A2 Appoints Chopin Zhang Supply Chain Chief

Queensland Launches ‘Agtech Month’; Abares: Cut Subsidies, Tariffs To Reduce Emissions; Queensland $3m For Agriculture Innovation; Althea Q1 Receipts Up 82% To $8.1m; Murray Cod Q1 Receipts Up 144% To $3.3m; RLF Q1 Receipts Up 57% To $2.2m; Creso: ‘Commitments’ For $7.6m Convertible Notes; Botanix Raises $5m, Share Plan For $3m More; Althea ‘Commitments’ For $1.5m; Plan For $2.5m More; Tassal Shareholders Approve Cooke Takeover; A2 Milk: ‘US FDA Allows Import Of Synlait-Made Formula’; Fonterra $25m To Settle Farmer Class Action; Bega: Vita International $27.5m Vitasoy Offer ‘Less Than Fair Value’; Nanollose Turns Waste Into 183m Of Nullarbor Fabric; Sustainable Nutrition: Australian Superfood Misses $1.15m Scrip; Wellnex To Launch Retail Website; Health Canada Amends Creso Mernova Marijuana Licence; Murray Cod 14m Directors’ Options AGM; Perpetual Reduces To 8.7% In Costa; Citigroup Takes 5.5% Of Costa Group; Tiga, Thorney Increase, Diluted To 7.8% Of Anatara; All Change At Epsilon: Xiao Cui Replaces Chair Steven Xu; Cobram Loses Director Paul Riordan; Murray Cod Appoints Wendy Dillon CFO; Executive Pay-Out; Australian Agricultural Appoints Glen Steedman CFO; Synlait Appoints Charles Fergusson Sustainability Head

Cann Group Share Plan To Raise Up-To $10m; Federal $615k For Terragen, Victoria Mylo Methane Study; Federal Government Signs Methane Pledge; NFF Support; Memphasys Japan, Canada Human Felix Studies; Botanix Receives $3.7m Federal R&D Tax Incentive; Cann Group Receives $4.3m Federal R&D Tax Incentive; Clover DHA Omega-3 ‘Improves IQ Of Premature Babies’; Creso Breaks ASX Rule, Dispose 14.5m Alvin Blumenthal Shares; Select Harvests’ Mountview Almond Orchard ‘On Market’; Wellnex: 15m Directors’ Performance Rights AGM; Wide Open 3m Directors’ Options, 67% Directors Pool Hike AGM; Nanollose Chair Dr Wayne Best Rights, Options AGM; Bubs 1.7m Director Rights, Directors Pool 67% Hike AGM; MGC Artemic: ‘May Reduce Long Covid-19 Symptoms’; Botanix Requests ‘Capital Raising’ Trading Halt; Creso Requests ‘Capital Raising’ Trading Halt; Vinva Below 5% Of Nufarm; Paine Schwartz, ‘Australian Football’ Take 13.8% Of Costa; Vasilios Votsaris Takes 9.6% Of Food Revolution; Pete Findlay To Replace Bega CEO Paul Van Heerwaarden; Cann Group To Lose 6-Year CEO Peter Crock; Sarah Gentry Replaces Australian Agricultural’s Tom Keene; Epsilon CFO Nicholas Marshall Goes; Stuart Cameron Director; A2 Loses Coo Shareef Khan, Chief Supply Chain Officer Wanted

Costa Citrus Costs Hit Forecast Earnings; Bega: Vita International Hopes To Take 100% Of Vitasoy J-V; Wellnex Placement, Share Plan Raise $6m; Anatara Placement For $865k, Rights Offer For $832k; Roots Placement For $650k; Media Reports On Creso, Ex-Chair Adam Blumenthal; Microbiogen Opens Sydney Micro-Organisms Lab; Next Science Combines Collagen With Blastx; Botanix: 13m Directors Rights, 5m Options AGM; Vanguard Takes 5% Of Elders; Synlait Appoints Naiche Nogueira, Paul Mallard Executives; Food Revolution Loses Rejected Director Minna Rong; Botanix Promotes CCO Howie McKibbon To COO For FDA Review

Apiam Buys Harradine & Associates For $2.6m Cash, Scrip; Ridley M-D Quinten Hildebrand 717k Rights AGM; Botanix BTX1702 10% ‘Safe And Well-Tolerated’ For Rosacea; Wellnex J-V Onelife Buys Medipharm; Cann Group Recruits Marijuana Sleep Trial; Food Revolution AGM Dumps Minna Rong, Misses 1st Strike; Allan Gray Takes 11.8% Of Nufarm; Vanguard Takes 5% Of Nufarm; Ex-Chair Alan Beasley Takes 9% Of Epsilon; Fonterra Appoints John Nicholls To Management Board; Quirin, Scott Replace Creso Founder Blumenthal; Name Change

A2 Milk, CSFA Renew 5-Year China Distribution; Bubs: US FDA ‘Clear Permanent Path’ For Infant Formula; Epsilon: $600k Missing From $1.55m Placement; Pharmaust Doses 1st Monepantel MND Patient; Creso Recruits Phase II Psilocybin PTSD Trial; Anatara Halts 100-Patient 3FDC Trial For ‘Insufficient Sample Size’; ASIC Registers Cooke-Tassal Takeover Scheme Booklet; Cann Group: Mildura Marijuana Licence Extended; Anatara Receives $480k Federal R&D Tax Incentive; Australian Retirement Below 5% In Nufarm; CFO Deborah Ambrosini Replaces Cann Co Sec Geraldine Farrell; MGC Appoints New UK Advisor; Executive Changes

Abares: ‘Farm Debt Rising With Sector Confidence’; Synlait Revenue Up 21% To $1.7b, Loss To $34m Profit; Bubs, Zhitong J-V; Heilongjiang Ubeite Diary Trademark Deal; TGA Fines Cannatrek, MGC, Little Green $972k On Marijuana Ads; Botanix Files Sofpironium Bromide For Sweating US NDA; Tassal: NSW Supreme Court Approves Cooke Scheme Meeting; Roots UAE Heat Exchange Probe Order Shipped; A2 Milk: 37m Share Buyback; Seafarms Requests ‘Audit’ Suspension; Fil Below 5% In Bega; Regal Funds Takes 11.5% Of Apiam; Memphasys Director Andrew Goodall Reduces, Diluted To 18%; Memphasys Chair Allison Coutts Buys 1m Shares, Takes 8.8%; Watercrest, Stuart Cameron, Karantzias Take 9% Of Epsilon; Regal Funds Reduces To 6% Of Elixinol; Costa Group Loses M-D Sean Hallahan, Harry Debney Interim CEO; Australian Agricultural: David Harris M-D, CEO On $700k Pa; Evonne Collier Replaces Apiam Director Mike Van Blommestein; Bega Appoints Gunther Burghardt CFO

Fonterra Revenue Up 12% To $20b, Profit Up 24% To $513m; Synlait Completes Greenhouse Gas Reduction Projects; Avecho: TPM-CBD Increases Bio-Availability, In Dogs; Memphasys Underwritten Rights Raise $1.76m, Total $3.4m; MGC Draws Further Mercer Street $831k; MGC: No Adverse Covid-19 Events In Cimetra-Dosed Group; Paradise Increases; Diluted To 7.9% In Select Harvests; Chair Alison Coutts Increases, Diluted To 8.7% In Memphasys; Cann Appoints Robert Barnes, Dr Julian Chick Directors; Nufarm Appoints Alexandra Gartmann Director; Epsilon: Alan Beasley In, Patrick Xu Out, Xu Share Sale

Clover Revenue Up 17% To $71m, Profit Up 19% To $7.1m; Wellnex Share Plan For $2m; Select Harvests Expects Almond Crop Volume 29Kt At $6.75/Kg; RLF Veridium ‘Seed Priming’ To Increase Yield; Synlait: China A2 Milk Infant Formula Licence Renewed; Creso Starts Canada Psilocybin PTSD Trial; Althea Launches 2 Medical Marijuana Products; Agrifutures Rural Women’s Award, Grant Applications Open; Seafarms: ‘Publication Wrong, No Plans To Sell’; Apiam M-D Dr Chris Richards 14% Pay Rise To $448k PA; AA Trust (Tavistock) Takes 50.1% Of Australian Agricultural; First Sentier, Mitsubishi Reduce To 5.9% Of Tassal; Morgan Stanley Below 5% Of Tassal; Shenasaby, Callahans Diluted To 6.5% Of Botanix; Gayle McGarry, Caperi Below 5% Of Botanix; Auscann To Lose CEO Layton Mills; Select Harvests Appoints Margaret Zabel Director

Abares: Record $70b Agricultural Export Earnings; Fonterra: Forecast Earnings Guidance Up 40% To 52.5 Cents; Nufarm Acquires Granbio Energy Cane For $37m; Auscann Lends Eurocann $3.75m; Sells Wangara For $7m; Wellnex To Acquire Mr Bright For $1.5m Scrip; Wellnex: July, August Revenue Up 47% To $4m; Wide Open, My Foodie Box Ready-To-Eat Plant-Based Products; Wide Open Appoints Growhub Indonesia, Malaysia Distributor; Creso Lends Target Health House $700k; Pharmaust Enrols 1st US Dog In Monepantel Lymphoma Trial; Mitsubishi Takes 9.8% Of Tassal; Morgan Stanley Takes 8.6% Of Tassal; Jodi Scott Takes 12% Of Creso; Agrifutures: Stephanie Trethewey Wins Rural Women’s Award

A2 Milk Revenue Up 20% To $1.3b, Profit Up 52% To $109m; Apiam Revenue Up 24.5% To $157m, Net Profit Down 9% To $4.5m; Bubs Revenue Up 127% To $89m, Loss Down 85% To $11.4m; Clean Seas Revenue Up 36.5% To $66m, Loss To $8.7m Profit; Food Revolution Revenue Up 5% To $44m, Loss Up 37% To $2.8m; Althea Revenue Up 78% To $20.5m; Loss Down 19% To $12m; Seafarms Revenue Down 6% To $20m, Loss Up 192% To $75m; Wellnex Revenue Up 15-Fold To $18.6m, Loss Down 70% To $7.5m; Murray Cod Revenue Up 31% To $12.7m, Loss Up 651% To $8.7m; RLF Revenue Up 25% To $10.7m, Loss Up 140-Fold To $3.5m; Wide Open Revenue Up 115% To $9m, Loss Up 43% To $11m; Cann Group Revenue Up 49% To $6.4m, Loss Up 5% To $26.5m; MGC Revenue Up 57% To $4.7m, Loss Up 8% To $17m; Creso Revenue Up 43% To $4.3m; Loss Down 63% To $6m; Botanix Placement Raises $7.5m; Epsilon Placement Raises $1.65m; Creso Completes Sierra Sage Acquisition; Creso: Walmart Buys $315k Sierra Sage Skincare Herbs; Roots $225k Short-Term Loan; First Sentier Takes 8.4% Of Tassal; Morgan Stanley Takes 7.2% Of Tassal; ASX Suspends Auscann For Transaction, Recompliance; A2 Milk Appoints David Wang Director; Cann Loses Director John Sharman

Federal ‘Critical Technologies’ List Consultation Opens; Bega Revenue Up 45% To $3.0b, Profit Down 69% To $24.2m; Costa H1 Revenue Up 16% To $709m, Profit Down 9.2% To $40.3m; Cobram Revenue Down 0.2% To $140m, Profit To Loss Of $696k; Tasfoods H1 Revenue Up 0.1% To $34m, Loss Up 280% To $5.4m; Ecofibre Revenue Up 5% To $30.2m, Loss Up 110% To $14.7m; Next Science H1 Revenue Up 38% To $7.8m, Loss Up 57% To $9.5m; Pharmaust Revenue Up 58% To $3.4m, Loss Up 28% To $1.7m; Fonterra Farmgate Milk Price Down To $8.24/kgms; Next Science: Canada Approves Xperience; Wide Open Agriculture Signs Coles For Dirty Clean Foods; MGC Draws Down Mercer Street $1.1m; Creso Canada Amendment For Psilocybin PTSD Trial; Roots Files 2 US RZTO Patents; First Sentier, Mitsubishi Take 6.8% Of Tassal; Morgan Stanley Takes 5.6% Of Tassal; Ex-Chair Lazarus Karasavvidis Reduces To 8.35% Of Wellnex; Martin Glenister Reduces To 8.35% In Wellnex; Australian Agricultural Acting CEO Dave Harris On $600k Pa; Chris Rowe To Replace Fonterra CFO Marc Rivers; Synlait: Adam Maxwell Ingredients Head, Martijn Jager Goes

Canada’s Cooke To Take Tassal For $1.1b; Ridley Revenue Up 13% To $1.05b, Profit Up 70% To $42.4m; Tassal Revenue Up 33% To $789m, Profit Up 60% To $55.3m; Tassal $497m ‘Sustainability-Linked Loan’; Ridley To Buy-Back $20m Shares On-Market; Federal Staff For Samoa, France Animal Health; Roots $190k United Arab Emirates, Israel Contracts; Roots Sells Netafim $7k RZTO Turkish Blueberry Test System; Memphasys $1.6m Placement; Rights Offer For $1.76m More; Nanollose, Codi Extend Wet Wipe Deal 3 Years; MGC: Marijuana Cannepil ‘Does Not Impair Simulated Driving’; AMC Orders $1.45m Of MGC Artemic; Pharmaust To Begin US Monepantel Dog Cancer Trial; Argo Below 5% In Tassal; Julie Raffe To Replace Ridley Director David Lord; Auscann Appoints Director Chris Mews CFO; Creso Appoints Kolby Tullier Impactive ‘Brand Ambassador’

A2 Milk: FDA ‘Defers Infant Formula Approval’; Anatara Bromelain Poultry Trial ‘Inconclusive’; Fonterra Earnings At ‘Top End’ Of Forecast; Creso Investors Back Sierra Sage Acquisition; Memphasys Extends ‘Capital Raising’ Suspension; Blackrock Below 5% In Elders; Epsilon Loses Executive Director Dr Rob Jenny; Elders Loses CFO Tania Foster, Paul Rossiter Acting CFO

Clean Seas, CH4 Trial Seaweed, Kingfish Co-Production; A2 Milk Awaiting US Import Approval; Creso H1 Receipts Up 69% To $4m; Creso $7m Placement To Buy Sierra Sage Herbs; Creso To Acquire Health House For $4.6m Scrip; Fonterra Director Nominations Opens; ASX Removes Palla From Official List; Ecofibre Appoints Mark Bayliss Director; Roots Loses Director Peter Hatfull

Government, NSW Farmers Criticize ‘FMD Political Point-Scoring’; Clean Seas Receipts Up 50% To $67.4m; Food Revolution Receipts Up 9% To $36m; Wellnex Receipts Up 1,307% To $17.9m; Murray Cod Receipts Up 36% To $13m; Next Science H1 Receipts Down 10% To $6m; RLF Receipts Up 23% To $10m; Wide Open Receipts Up 84% To $8.8m; Cann Receipts Up 371% To $6.5m; MGC Receipts Up 130% To $6.1m; Bubs Retail Rights Raise $22.9m; Total $63m; MGC Pays $1.2m Scrip For 40% Of Zam, $14.3m Mercer Facility; Costa Berry Farms In Varroa Mite Surveillance Zone; Korda Mentha: Palla Pharma To Delist On August 2; Australian Agricultural: AGM 10% Oppose Constitution Amendment; Memphasys Court Suspension To Follow Capital Raising Halt; Creso Takes Capital Raising Halt To Suspension; Tattarang, Dr Andrew ‘Twiggy’ Forrest Take 11.5% Of Bega; Apiam M-D Dr Chris Richards Increases, Diluted To 22%; Regal Reduces To 7% Of Elixinol; Synlait Restructures; Staff, Departments Go; Fonterra Appoints Emma Parsons Strategy, Optimization M-D

Victoria ‘Secures’ SVG Thrive $50m Melbourne Agriculture Fund; Federal 2021 Environment Report Warns On Climate Change; Bubs Receipts Up 107% To $91m; Tasfood H1 Receipts Up 2.7% To $35m; Ecofibre Receipts Down 4.5% To $31.4m; Pharmaust Receipts Up 64% To $4m; Cann Group Takes NAB Revolving Loan Facility; Bega Tells ASX 25% Fall Queries: ‘Milk Prices Not Material’; Creso Expands Psilocybin PTSD Trial; SSRIs Included; Wellnex, Onelife Marijuana Joint Venture; Cooke Takes 10.5% Of Tassal; Wilson Below 5% In Ridley; C2 Capital Diluted To 11% Of Bubs; Perpetual Takes 6.2% Of Clover Corp; Petstock Increases, Diluted To 12.3% In Apiam; Ian Olifent, GGP Increase, Diluted To 12.4% In Wellnex; New South Wales Farmers Elects Xavier Martin President; Epsilon Loses CEO Jarrod White, Steven Xu Executive Chair; MGC Appoints Robert Clements CCO; Agrifutures: Elders Partners For Evoke Ag Meeting

Federal $29.3m For $88.5m Industrial Transformation Centres; Australian $1.5m For Indonesian Foot & Mouth Disease; Althea Marijuana Receipts Up 113% To $22m; Nera: Pharmaust’s Epichem To Recycle Shell’s Plastic; Bega: Strong Milk Prices; FY 2022 Ebitda Constant, FY 2023 Wider; Select Harvests: Bee Shortages Likely; Costa Pleads Schultz To ASX 9% Fall Query; Citrus Warning; Providence To Sell Creso Anibidiol In South Korea; Creso EGM To Vote On Sierra Sage To Take Up 70.4%; MGC Claims ‘Statistical Significance’ Of Artemic For Long Covid; Cooke Takes 8.9% Of Tassal; Vasilios Votsaris Takes 8.3% Of Food Revolution; Fonterra To Lose Director Donna Smit

Bubs Placement, Insto Rights Raise $40.1m; Retail For $22.9m More; Charles Darwin Uni Trials Australian Indigenous Rice; Synlait Increases Base Milk Price 5.6% To $8.61/KgMS; Bubs: FDA Post-Operation Fly Formula Pathway; 180k More Tins; Bubs H-E-B, Meijer Deals, 2 US Subsidies; Select Harvests Tells ASX ‘Varroa Mite Not Material ’Til Later’; Clean Seas Buys Back $239k Unmarketable Parcels; Botanix Expedites US Sofpironium Bromide NDA; 2 Trials Enroled; Epsilon, Valens Extend Southport Marijuana Deal; Creso Appoints Gotro Singapore Distributor; MGC, Caba Tech Work On Zam Healthcare Data; South Africa Approves MGC Cimetra Covid-19 Study; Import; Cooke Takes 7.6% Of Tassal; Walker, Auckland Trust Increase, Diluted To 39% In Next Science; Wide Open Appoints Matthew Skinner CFO

Select Harvests: Bees’ Varroa Mite ‘Extremely Serious’ Risk; US Target Orders 30k Bubs Tins; Canada’s Cooke Aquaculture Bids $1b For Tassal; Memphasys, Monash IVF Enrol 1st Felix Study Couple; Fonterra: NZX, EEX Pay $31.7m For 67% Of GDT; Cobram Harvest Yields 9.5ml Olive Oil; Wellnex: Unaudited Revenue Up 6.6% To $19.5m; Ecofibre Takes $14.5m Nubridge Loan; Cann Group Mildura Marijuana Manufacturing Licence; Creso, China Chemical & Pharma Taiwan Animal Health Deal; Creso: Weed Pool Cannabis Orders $12.4k Marijuana Vapes; MGC, South Florida Uni Cimetra Covid-19 Trial; Sustainable Nutrition 2nd ‘Lost Customer’ Suspension Extension; Regal Takes 9.35% Of Apiam; Bega Appoints CFO Pete Findlay COO; New CFO Wanted

Mandalay To Raise $50m For Sustainable Agriculture; Apiam Retail Rights Raise $8.4m; Total $20.25m; Apiam Pays $8.3m For Whittlesea Vet Practice; Fonterra Farmgate Milk Price Up To $8.63/KgMS; Abares: Strong Farm Performance, High Costs To Come; Bubs: US Takes 180k More Tins Of Infant Formula; Wide Open Agriculture Opens Lupin Buntine Protein Factory; Seafarms Reviews Project Sea Dragon Review; Food Revolution Expands Juice Lab, Original Juice Co Brands; Blackrock Takes 5% Of Elders; Allan Gray Takes 11% Of Nufarm; Heytesbury Sells Australian Agricultural Holding; Yarra Capital Below 5% Of Tassal; Australian Agricultural Loses M-D Hugh Killen, Dave Harris Interim

US Shortage Takes Bubs Revenue To $100m, Earnings Up 100%; Bubs Sells Walmart 85k Tins Of Infant Formula; Pictor: Johne’s Disease Test To Save NZ Dairy $72m A Year; Roots Sells $42k Root Zone System; Condensation Irrigation; Creso: $15k 1st Order Of New Marijuana Strains; MGC Marijuana ‘Kills Glioblastoma In Cell Lines’; RLF To Release 1.6m ASX Escrow Shares; Tattarang, ‘Twiggy’ Forrest Take 17% Of Aust Agricultural; Fonterra To Lose Directors John Shewan, Kim Ellis; Murray Cod Loses Director David Crow; Synlait To Lose Co Sec Deborah Marris

Federal Government, Abares: Record $65b Ag Exports; RLF Signs $2.4m Total Agree Cambodia Distribution; Nanollose Takes Lee Mathews Nullarbor To Copenhagen; Bubs: Kroger, Albertsons US Baby Formula Distributors; Memphasys To Meet FDA; Covid Slows Felix Sales; Fonterra To Buy-Back Up-To $45m Shares; MGC Marijuana Trial For Dementia ‘Safe’, Too Small For Efficacy; Tassal Pleads ‘Research Report’ To ASX 13% Fall Query; Palla Liquidators: ‘Nothing For Shareholders’; Avecho Requests Aveo ‘Cleansing, Court Orders’ Suspension; Blackrock Below 5% In A2 Milk; Blackrock Below 5% In Elders; Regal Funds Takes 5% Of Apiam; Regal Funds Reduces To 5% Of Clean Seas; Regal Below 5% In Althea; Janet Cameron Takes 22.3% Of Tasfoods; Regal Funds Reduces To 9.2% Of Elixinol

Bubs To Supply US 1.25m Tins Of Baby Formula; Murray Watt Agriculture; Ed Husic Industry, Science; Apiam Institutional Offer Raises $11.9m; $8.35m To Go; Wellnex Notes Raise $6.2m Of Hoped-For $7.5m; RLF $1m Plant Nutrition Deal With China’s Hebei Veyong; Synlait Increases Base Milk Price 3% To $8.46/KgMS; Elders Sells 30% Stake In Stockco For $20-22m; Cann Harvests 1st Mildura Commercial Marijuana Crop; Cann Receives Victoria $500k For Regional Jobs; Creso, Optimi Psilocybin, Mushrooms Deal; Sustainable Nutrition Extends ‘Lost Customer’ Suspension; Citigroup Below 5% In Nufarm; CVC Takes 14.5% Of Tasfoods; Tasfoods Loses Chair Craig Treasure, Withdraws Rights Vote; Nufarm Loses Sumitomo Director Toshkazu Takasaki; Ecofibre Loses Director Kristi Woolrych; Epsilon Appoints Major Shareholder Patrick Xu Director; Pharmaust: Fiona Milner Epichem G-M, Ingrid Klopper BDM

Elders H1 Revenue Up 38% To $1.5b, Profit Up 34% To $91m; Select Harvests H1 Revenue Down 19% To $69m, Profit Up 58% To $2m; Apiam Rights Offer For $20.25m; Fonterra Widens Farmgate Milk Price Range To $7.54-$8.91/KgMS; Nanollose To Supply Spain’s Inditex Nullarbor Samples; Bega Port Melbourne Factory Sale, Leaseback; Wide Open: DKSH Taiwan Oat Milk Distributor; $650k Order; Wide Open Plant-Based Butine Protein For Monde Nissin; Creso, Dr Pickles Tattoo Herbal Salve Deal; Elixinol AGM: 49% Oppose CEO Rights; 22% Remuneration Report; Citigroup Takes Sumitomo Chemical’s 16% Of Nufarm; Vinva Investment Takes 5.4% Of Nufarm; Australian Retirement Takes 5% Of Nufarm; Tattarang, Dr ‘Twiggy’ Forrest Take 8% Of Aust Agricultural; Schroder Reduces To 6.23% Of Ridley; Regal Reduces To 5.5% Of Althea; RLF To Release 3m ASX Escrow Shares; Australian Agricultural Loses CFO Nigel Simonsz; CFO Wanted; Travis Dillon Replaces Select Harvests Chair Michael Iwaniw; Next Science To Lose CEO Judith Mitchell In 2023; Sustainable Nutrition Loses M-D Neale Joseph; Pharmaust To Lose CSO Dr Richard Mollard

Nufarm H1 Revenue Up 31% To $2.2b; Profit Up 61% To $99m; Australian Agricultural Revenue Up 4% To $276m; Profit Up 201% To $137m; Ag & Vet Weekly Federal Election Editorial; Agrifutures $105k Rural Women’s Award Finalists; Nanollose, Paradise Textiles Nullarbor-20 Fibre Deal; Apiam Buys Victorian Equine, Romsey Veterinary For $14m; Select Harvests: Wet Weather Impacts Almond Volume, Quality; Tasfoods Share Plan Raises $463k; Total $5.9m; Next Science Appoints Oraderm Blastx Distributor; A2 To Defend NZ Class Action; Pharmaust Radium $210k RDTI Loan; Pharmaust Receives MND Trial Monepantel Tablets; Althea: Ireland Okays CBD12:THC10 Medical Marijuana; Memphasys Pleads Schultz To ASX 28.8% Fall Query; MGC Pleads Ignorance To ASX ‘Aware’ Query; Sustainable Nutrition ‘Terminated Supply’ Suspension; Blackrock Takes 5% Of A2; Firetrail Below 5% In Nufarm; Baiyu Xu, Lands Between Take 7% Of Epsilon; Seafarms: Rod Dyer CEO On $750k; Whitcombe Replaces Brannan; David Muscat To Replace A2 CFO Race Strauss; Anatara Appoints John Machailidis COO

Fonterra Maximum Farmgate Milk Price Down To $8.61/kgMS; Australian Agricultural Pastoral Property Worth $1.17b; Cannatrek Raises $13m For Marijuana; Josh Ludski Director; Wellnex Hopes To Raise $7.5m From Convertible Notes; Pharmaust Takes Dog Lymphoma Trial To The US; Creso: Health Canada Approves Psilocybin Import; MGC: Slovenia Cannepil Patent

RLF Wins $1.2m China Sales; Nanollose, Von Holzhausen Work On ‘Vegan Leather’; Select Harvests: Bad Weather Slows Almond Harvest; Cobram Starts Australian Olive Harvest; Epsilon $2.1m Placement Facility For Southport Operations; Botanix To Pay Brickell $24m For Sofpironium Bromide; Avecho Receives $1m Federal R&D Tax Incentive; Clean Seas Unmarketable Parcel Facility; Allan Gray Reduces To 9.8% Of Nufarm; Seafarms: Ian Trahar Replaces Chair Mick McMahon; Anatara To Lose CEO Steven Lydeamore; Simon Barrile Replaces Tassal Co Sec Monika Maedler; Agrifutures $35k Rural Women’s Awards

Federal $593k For Sugar Industry; FDA Grants Botanix BTX1801 QIDP For Golden Staph; Nufarm Ukraine, Russia Exports ‘Not Material’; Auscann Lends Eurocann $5m, Partner For ‘Mutual Interests’; Tasfoods 8.7m Director Share Rights AGM; Tattarang, ‘Twiggy’ Forrest Take 10% Of Bega; Jamber Reduces To 7.45% Of Roots; MGC Appoints Angela-Marie Graham UK CFO; Memphasys: Robert Cooke Chair, Alison Coutts, Shane Hartwig

RLF $8.5m IPO For Liquid Plant Nutrition; Nanollose, Orta Collaborate On Tree-Free Denim; Bega Expects 2022 Ebitda Down 11% To $175-195m; Clean Seas ‘Record’ Q3 Revenue Up 33% To $17m; Terragen: ‘Mylo Lowers Methane, Improves Cattle Weight Gain’; Seafarms: Ian Trahar Call To Remove Chair Mick McMahon; Fonterra, Castalia Clash On Open Country Dairy Report; Federal $1m For Dairy Industry Price Tracking; Federal $828k For Red Meat Exports; Cann Group $15m NAB Loan; Renegotiates $50m Loan; Roots: Precool RZTO South Africa Distributor; J-V; Pharmaust Receives $708k Federal R&D Tax Incentive; MGC Slovenia Patent For Cimetra; Costa M-D Rights, Options; 30% Directors’ Fee Pool Hike AGM; Elixinol 2m Directors Rights AGM; State Street Below 5% In Costa; Jamber Reduces To 8.55% Of Roots; Nufarm Appoints Kate Hall Co Sec; Palla Loses Directors Sue MacLeman, Iain Ross, Stuart Black

Cannatrek Ready For 16ha Marijuana In Shepparton; Sustainable Nutrition: Dash, Remedy Supply Deal; Cann Group Mildura Marijuana Plant Operational; Spirit Super Takes 13.9% Of Tasfoods; Janet Cameron Diluted To 19.5% Of Tasfoods; CVC Diluted To 12.95% Of Tasfoods; Micro Cap Activist Fund Takes 6.4% Of Tasfoods; MGC Loses CFO Daniel Kendall, M-D Roby Zomer Interim

Roots: TK Solutions Appointed UK, Ireland, Austria Dealer; Woolworths Stocks Wide Open Dirty Clean Food Oat Milk; Pharmaust: $202k Fight-MND Grant; Alithia Trial Manager; Seafarms Tells ASX Aware Query: ‘Review Outcomes Not Known’; MGC Appoints Sciensus EU, UK Marijuana Distributor; Cann Group: GSK $170k To Evaluate Marijuana Satipharm; Cann Wins Mildura Marijuana Manufacture Federal Permit; State Street Takes 5% Of Costa

Synlait H1 Revenue Up 19% To $731m; Profit Up 338% To $28m; Elders Sells 30% Stockco Stake; Up-To $20m Profit; Tasfoods To Raise $6m; Avecho TPM-CBD Gel ‘Highly Significant For OA Pain’; Liquidators Sell Palla UK, Norway; Nothing For Shareholders; Apiam: Victoria $700k For Bendigo Vaccine Laboratory; Memphasys: India, China Felix Cartridge Orders; Botanix Receives $2.8m Federal R&D Tax Incentive; Sustainable Nutrition Hemp Proteins ‘On-Track’; Creso, Brower, Medara Latin America Marijuana Deal; Creso: Halucenex Upgrades To Grow Psilocybin Mushrooms; Cann Group: UK Approves Satipharm CBD Capsule; Perpetual Takes 5.8% Of Bega; Ex-Chair Lazarus Karasavvidis Reduces To 10.9% In Wellnex; Martin Glenister Reduces To 10.9% In Wellnex; Ron Dufficy Replaces Elixinol CEO Oliver Horn; David Fenlon; Botanix Appoints Dr Patricia Walker CMO, Dr Howie McKibbon CCO

Memphasys: ‘Samson 90% Horse Pregnancy Prediction Rate’; Next Science Share Plan Raises $4.8m; Total $14.8m; Federal Election Promise: Climate Tax Break For Farmers; Synlait Increases Base Milk Price 4% To $8.93/KgMS; Roots: Heat Probe US Patent; $17k Israel Order; Bubs Launches Supreme Infant Formula Range; Clover Claims Omega3 Improves Premature Baby IQ; Food Agility June Wagga Wagga Digital Agri-Food Summit; Creso: Market Share ‘Milestone’; Plant Yield Up; Vinva Below 5% In Elders; Lazard Below 5% In Ridley; Vasilios Votsaris Takes 7% Of Food Revolution

Fonterra H1 Revenue Up 9% To $10.1b; Profit Down 7% To $341; Clover Corp H1 Revenue Up 1% To $29.7m; Profit Down 20% To $2m; Elders Expects Up-To $216m ‘Underlying Ebit’; Memphasys: Draft Iso 13485 For Management Systems; Roots $278k Gropro RZTO Oklahoma Marijuana Deal; Wellnex To Supply Glaxosmithkline Paracetamol; Cann Group: Mildura Facility ‘Practical Completion’; Pharmaust Manufactures Monepantel For Trials; Creso To Ship 35k Marijuana Lozenges To Sierra Sage; Regal Reduces To 6.5% Of Althea; Ecofibre Appoints Michele Anderson Director

Abares: ‘Fisheries, Aquaculture Rebound With Seafood Demand’; S&P Indices: Cobram Up; Ecofibre, Seafarms, Synlait Down; Korda Mentha To Liquidate Palla Pharma; Sustainable Nutrition: Up To $1m Woolworths Deal; Vinva Takes 5% Of Elders; Tattarang, Dr Andrew ‘Twiggy’ Forrest Take 9% Of Bega; Ethical Partners Below 5% Of Bega; Auscann Loses CFO Charles Altshuler; New CFO Wanted; MGC Joint Co Sec Rachel Kerr Moves To Sales

Tasfoods Revenue Up 4% To $70m, Loss Up 68% To $10.7m; Clean Seas H1 Revenue Up 40% To $31m, Loss Down 90% To $2.2m; Seafarms H1 Revenue Up 3% To $15.4m, Loss Up 188% To $37m; Wellnex H1 Revenue Up 1100% To $8.5m, Loss Down 82.4% To $2.2m; Murray Cod H1 Revenue Up 15.5% To $4.8m, Profit To $3m Loss; Creso Revenue Up 154% To $6.2m, Loss Down 6.3% To $30m; Epsilon Revenue Down 21% To $5.5m, Loss Down 15.4% To $9m; MGC H1 Revenue Up 246% To $2.6m, Loss Up 28% To $7.6m; Sustainable Nut H1 Revenue Up 104% To $1.6m, Loss Up 165% To $2.8m; Nanollose Produces 250kg Of Tree-Free Yarn; Bubs: ‘Daigou’ Milk Formula Dealer Willis 4.8%, Pending Sales; Clover: ‘Ex-Staffer, Pharmamark To Pay $1.4m To Settle Dispute’; Avecho Begins TPM-CBD Osteoarthritis Trial; Creso: Canada Approves Psilocybin For PTSD Trial; Palla Liquidation: ‘Nothing For Shareholders’; Lazard Reduces To 5% Of Ridley; Cobram: Trenton Gallagher US CFO, Conor Churchin US COO

Next Science Raises $10m, Plan For $5m More; Creso Raises $5m; Fonterra Farmgate Milk Price Up-To $9.26kgms; Bega H1 Revenue Up 113% To $1.5b, Profit Up 29% To $28m; A2 Milk H1 Revenue Down 2.5% To $616m, Profit Down 50% To $56m; Costa Revenue Up 5% To $1.22b, Profit Down 32% To $42m; Apiam H1 Revenue Up 23% To $75m, Profit Down 33% To $1.7m; Cobram H1 Revenue Down 3% To $70m, Loss Down 21% To $5m; Bubs H1 Record Revenue Up 84% To $34m, Loss Down 95% To $602k; Food Revolution H1 Revenue Down 2.2% To $22m, Profit To $1m Loss; Ecofibre H1 Revenue Down 5.4% To $15.5m, Loss Up 20.7% To $6.7m; Althea H1 Revenue Up 84% To $9.4m, Loss Down 14.85% To $7m; Next Science Revenue Up 160% To $12m; Loss Down 22% To $13m; Elixinol Revenue Down 38% To $9.3m, Loss Down 84% To $17m; Wide Open H1 Revenue Up 127% To $4m, Loss Up 46% To $5.3m; Pharmaust H1 Revenue Up 52% To $1.7m, Loss Up 48% To $1.2m; Terragen H1 Revenue Down 18.7% To $1.5m, Loss Down 15% To $2.9m; Nanollose Requests ‘Nullarbor Pilot Spin’ Trading Halt; Pharmaust Appoints Ergomed For Monepantel Covid-19 Trial; Pharmaust: ‘Monepantel Effective For Leukaemia, In-Vitro’; Sandra Yu To Replace A2 Milk Director Bessie Lee; Terragen Loses Director Dr Paul Schober

Sea Forest: Federal $1.5m For Anti-Methane Seaweed Trials; Ridley H1 Revenue Up 8% To $509m; Profit Up 95% To $22.6m; Tassal H1 Revenue Up 43% To $419m, Profit Up 31.6% To $36.4m.; Fonterra Sells 67% Of Global Dairy Trade; Wellnex, Australian Dairy J-V For A2 Infant Formula; Pharmaust’s Epichem: ‘Promising Results’ On E-Waste Project; Aa Co 12,525ha Central Queensland Lease; Palla ‘Fails To Attract A Buyer; To Begin Wind-Down’; Anatara Ready For 3fdc Depression Trial; Cann Group Trials Marijuana For Sleep Disturbance; Firetrail Reduces To 6% Of Nufarm; ‘Twiggy’ Forrest Takes 5% Of Aa Co; Cann Global Completes 25-To-1 Consolidation

Federal ‘Patent Box’ Bill To Cut Tax To 17%; Opposition; Auscann FDA Guidance For Cpat-01 For Dog Osteoarthritis; Roots $12k Green Tech RZTO Azerbaijan Deal; Creso O-T-C Marijuana Lozenge For Sars-Cov-2; Creso’s Halucenex Canada Psilocybin Supplier; Althea: Dr Reddy’s To Acquire Distributor Nimbus Health; Little Green To Release 55.5m ASX Escrow Shares; Vinva Below 5% In Nufarm; Fil Reduces To 5.6% Of Bega; Tiga Takes 7% Of Sustainable Nutrition; Dr Gui Min Replaces Qikai Lu As Bright Dairy Synlait Director

Bubs H1 Receipts Up 73% To $39.2m; Tasfoods Receipts Up 3.5% To $70m; Food Revolution H1 Receipts Up 2% To $17.3m; Ecofibre H1 Receipts Down 6.4% To $16.7m; Wellnex Life H1 Receipts Up 1839% To $9.6m; Next Science Receipts Up 223% To $13.6m; Elixinol Receipts Down 31.5% To $9.65m; Murray Cod H1 Receipts Up 23% To $4.3m; Wide Open Agriculture H1 Receipts Up 163% To $4.2m; MGC H1 Receipts Up 312% To $3.6m; Creso Receipts Up 71% To $6.4m; Epsilon Receipts Down 28% To $5m; Pharmaust (Epichem) H1 Receipts Up 31% To $1.7m; Sustainable Nutrition H1 Receipts Up 133% To $1.6m; Nufarm: Nuseed, BP 10-Year Carinata Biofuel Agreement; Creso To Buy Sierra Sage For $29.5m Scrip; Sandbox ‘Virtual Land’; Avecho, Team Saas $1.4m US TPM-Marijuana Edibles Deal; Pharmaust Formulates Monepantel For MND Trial; Cann Global AGM 32% Rem Report 1st Strike; Feldman Shares; Vinva Takes 5% Of Nufarm; Vasilios Votsaris Takes 6% Of Food Revolution; Founder CIA Mann Below 5% Of Sustainable Nutrition; Pharmaust Loses Epichem CEO Colin La Galia; Paul Townsend, Terrie Morgan Replace Nufarm Co Sec Fiona Smith

Federal $68m For Agriculture Traceability; Nufarm Notes Raise $497m; Synlait Increases Base Milk Price 15.6% To $8.64/KgMS; Fonterra Farmgate Milk Price Up-To $8.65kgMS; Cann Group H1 Receipts Up To $3.24m; Terragen H1 Receipts Down 21% To $1.2m; Cann Group: TGA GMP Licence; Food Revolution 100% Plant-Based Smoothies; Creso Applies For Canada Psylocibin PTSD Trial; Allan Gray Takes 10.8% Of Nufarm; Firetrail Reduces To 7% Of Nufarm; M-D Mathew Ryan Takes 14.8% Of Murray Cod; SG Hiscock Takes 6% Of Althea; Select Harvests To Lose Director Nicki Anderson; Synlait Appoints Paul McGilvary Director, Loses Chris France; Agrifutures: Evoke Ag Conference Back In 2023 – Adelaide

Nufarm Notes Offer For $487m; Clean Seas H1 Revenue Up 40% To $31.3m; Althea H1 Marijuana Receipts Up 111% To $9.9m; Murray Cod Directors Exercise $4.5m Options; Buy, Sell Shares; Australian Super Increases, Diluted To 9.3% Of Murray Cod; United Super, CBus Take 5.6% Of Select Harvests; Peters Buys Andrew Goodall $1.4m Memphasys Note; Cann Group: Rua Investors Approve Zalm Acquisition; Creso Appoints William Lay, Micheline Mackay, Bruce Linton; Cann Global: Ex-Chair Pnina Feldman Shares; Consolidation

Special Summer Catch-Up Edition
Tasfoods Settles Ex-Chair Shane Noble Litigation; James Schwarz, Jamber Take 11% Of Roots; Clean Seas Renews $32.15m CBA Loan; MGC Starts Artemic For ‘Long Covid’ Study; Wide Open Share Plan Raises $611k; Seafarms Loses Director Paul Favretto; Cann Global AGM: $312k Shares For Ex-Chair Pnina Feldman; Select Harvests Carina West Co-Waste Fire; Sustainable Nutrition Director James Hood Diluted To 6.3%; Ex-Chair Cameron Petricevic Below 5% In Sustainable Nutrition; Tattarang, Dr Andrew ‘Twiggy’ Forrest Take 6.6% Of Bega; Director Paul Benhaim Reduces To 9.2% Of Elixinol; Ecofibre Extends Loan Terms; Sustainable Nutrition Ex-Director Charles Mann Reduces To 9.2%; Wide Open: Metro To Distribute Oat Milk In Hong Kong, Macau; Creso To Release 47m Shares From Voluntary Escrow; MGC: India Grants Artemic Rescue Import Approval; Wellnex H1: Revenue Up 18.5% To $8.84m; Ethical Partners Reduces To 5.7% Of Bega; Chair Ross Anderson Takes 8.9% Of Murray Cod Australia; Cobram ‘Oversubscribed’ Share Plan Raises $2m; Total $52m; Creso: Halucenex Applies For Canada Special Access Program; Fonterra Decreases Milk Collection Forecast By 25mkg; Roots: $13k Super Mini System 1st Revenue; Korda Mentha Requests Bids For Palla

Palla Pharma In Administration; Sustainable Nutrition $7.7m Raising, $3m For Aust Superfood; Murray Cod Share Plan Raises $1.5m, Total $31.5m; Roots Placement Raises $1m; Pharmaust: Epichem Wins $1m Extension With DNDI; Cobram Founder Robert, Katherine McGavin Diluted To 17%; Wilson Takes 6.5% Of Ridley; Janet Cameron Takes 22% Of Tasfoods; Auscann Dermacann APVMA Submission, US Launch; Auscann: Tod McGrouther Chair, Loses Dr Adams, Geoff Starr

Abares: $78b ‘Record Agriculture Production Volume, Value’; Cobram Estate Raises $50m, Share Plan For $1m More; Epsilon Raises $2.9m; Synlait, NZ, Danone, Agresearch Work On Soil Health; Wide Open Appoints MKMI Gulf States Oat Milk Distributor; Memphasys, Monash IVF Begin Felix Sperm Separation Trial; Auscann: FDA Confirms Dog OA Marijuana CPAT-01 Trial; Wellnex, Australian Dairy J-V For Organic A2 Milk Formula; Roots Requests Capital Raising Trading Halt; Palla Pleads ‘Shareholder’ To 41.2% Fall; Cann Receives $2.2m Federal R&D Tax Incentive; Terragen To Release 10m Shares From ASX Escrow; Blackrock Takes 6% Of Elders; Perpetual Takes 14.6% Of Costa; Director Paul Benhaim, Raw With Life Diluted To 9% In Elixinol; Anatara Appoints Simon Erskine CDO, Michael Pryor BDM

Wide Open $20m Placement, Share Plan For $2m More; MGC Raises $10m; Abares: Record Winter Crop Production Forecast; Fonterra Farmgate Milk Price Up-To $8.65kg/MS; Memphasys Completes Samson Sperm Data Collection; Pharmaust Manufactures 2k Small Monepantel Tablets; Creso: Canada Halucenex Psychedelics Licence ‘Upgrade’; Epsilon, Valens Deal Extended 2 Months; Cann Swaps Zalm Shares For Rua Shares; Nanollose AGM: 16.5% Oppose 1m Directors’ Options; Ocean Grown AGM: 13% Oppose Company Name Change; Perpetual Takes 6% Of A2 Milk; Blackrock Below 5% Of A2 Milk; Perpetual Takes 13.2% Of Costa Group; Lazard Below 5% Of Costa; Lazard Reduces To 7.6% Of Ridley; Seafarms Loses Director Chris Mitchell; Select Harvests Appoints Travis Dillon Director; Goodbye Ocean Grown Abalone, Hello Rare Foods Australia

Select Harvests Revenue Up 16% To $288m, Profit Down 40% To $15m; Apiam $3.6m For Fraser Coast, North Hill Vet Clinics; Memphasys: 1st Felix Sale To China’s Diagens For IVF; A2 Milk To ‘Vigorously Defend’ Shine Class Action; Wide Open $750k Woolworths Oat Milk Deal; Palla Pharma Sells Coolaroo Site For $33m, Leaseback; Roots: Cherry Irrigation RZTO Southern Africa Distributor; Creso ASIC Query; Raided Chair Adam Blumenthal Stands Aside; Ridley AGM: 32% Oppose Director David Lord; MGC Avoids 2nd Strike, 25% Oppose Director Fee Pool Hike; Wide Open Requests Capital Raising Trading Halt; MGC Receives $1m Of $4.2m US Cimetra Order; M-D Mathew Ryan Reduces, Diluted To 11% Of Murray Cod; Min Chen Replaces Synlait Bright Dairy Director Min Ben; CFO Shona Croucher Replaces Tasfoods Co Sec Marta Button; Food Revolution Appoints Ashley Bottrell CFO

Federal $5.1m For 60 School Leavers To Try Agriculture; Murray Cod Raises $30m; Nufarm Revenue Up 13% To $3b, Loss To $65m Profit; Elders Revenue Up 22% To $2.6b, Profit Up 22% To $150m; AFP, ASIC Raid Everblu Capital; Creso, Roots; Creso Pleads Schultz To ASX 18% Fall Query, ASIC; Roots To Appoint Avital For Seribia RTZO Sales; Apiam $4.8m For Agnes Banks Equine Clinic; US EPA Okays Apiam Partner Aurora Xtend21; Pharmaust Expands Dog Lymphoma Trial To New Zealand; Pharmaust Monepantel Trials ‘On-Track’ For 2022; A2 Milk 25% Oppose Director Warwick Every-Burns; Fonterra Capital Structure Special Meeting, AGM; Nufarm $698k M-D Greg Hunt ‘Deferred Rights’ AGM; Althea: 900k M-D Joshua Fegan Performance Rights AGM; Tassal M-D Mark Ryan Updated Pay Starts On $861k; MGC Releases 15m Voluntary Escrow Shares; Macquarie Group Takes 5% Of A2 Milk; Tattarang, Dr Andrew ‘Twiggy’ Forrest Take 6.5% Of Ridley; Abares Appoints Dr Jared Greenville Executive Director

Murray Cod $30m Placement, $3m Plan For Expansion; Nanollose Closer To Fabric Production; Metal Contamination; Auscann Plans Marijuana Spinal Cord Injury Symptoms Trial; Creso: Halucenex Psilocybin Testing; Elders Releases 3m Voluntary Escrow Shares; Challenger Below 5% Of Elders; Aware Super Takes 6.2% Of Nufarm; Vanguard Below 5% In Bega, Costa, Elders, Tassal; Creso Loses 3-Day Consultant Dr Brian Walker MLC

Goodbye Huon; Court Okays JBS Takeover; Delisting; Memphasys Completes Felix Validation And Verification; Next Science, Tela Bio US ‘White Label’ Deal; Pharmaust Rights Options Raise $514k; Ethics Approval For MGC Cimetra Dosing Study; MGC Builds Malta Cimetra Factory; $4.8m Grant; Creso, Innuana To Grow Marijuana, Swiss Distribution; Goldman Sachs Takes 8.2% Of A2 Milk; Australian Super Increases, Diluted To 10.7% In Murray Cod; Perennial Takes 7.5% Of Ecofibre; Tassal Loses Chair Allan McCallum; Seafarms: Mick McMahon Chair, Ian Brannan Director, Co Sec; Bubs Appoints Dylan Lu China M-D; Promotions; Council; Creso: WA Legalise Cannabis MLC Dr Brian Walker Advisor

JBS Takes Huon; FIRB ‘OK’; Commits To Welfare, Environment; Apiam Pays $2m For Horsham Veterinary Hospital; Bubs Launches ‘Family Nutrition Range’ Milk Powder; Fonterra Farmgate Milk Price Up To $8.48kg/MS; Cann Global Raises $1.8m; Creso $217k Scrip For Impactive Marijuana Joint Pain; Ecofibre ‘Marijuana Works For Cancer’; 1.6 Quarters Cash; Memphasys Receives $1.4m Federal R&D Tax Incentive; Epsilon Extends $4m Loan Repayment; Memphasys: China Sperm Separation Patent; Tassal Appoints Kathy Parsons Director; Bega AGM: 19% Dissent; Ocean Grown 2m Director Options, 1.6m Rights AGM; MGC Potential 2nd Strike; 100% Directors’ Pay Pool Hike AGM; Blackrock Takes 5% Of Elders; IFM Takes 17.4% Of Clean Seas; Yarra Capital Reduces To 7% Of Tassal

Cann Group Share Plan Raises $8.7m, Total $18.7m; Avecho, Lambert Trial TPM-Marijuana For Arthritis Pain; Pharmaust: 24 Dogs, 1 Partial Response To Monepantel; Pharmaust Manufactures Trial Batches Of Monepantel; Cannim Hires Epsilon To Manufacture Hummingbud Marijuana; Auscann Requests FDA CPAT-01 Meeting; Goodbye AP Hemp, Welcome The Sustainable Nutrition Group; Pharmaust 14% Oppose Incentive Scheme, Remuneration Report; Anatara 1.8m Director Options AGM; Nanollose 1m Director Options AGM; Greencape Below 5% In Elders; Kirsty Clarke Replaces Ridley Co Sec Amy Alston

Seafarms Raises Sea Dragon Cost 41% To $410m; Canstruct $95m; Roots Launches ‘Super Mini’ RZTO System; Harvest, Speedcast Reseller Deal; Ocean Grown Name Change To Rare Foods Australia; Auscann: Marijuana Dermacann Safe In Dogs At 5mg/Kg; Creso: ‘Mernova Highest Legal THC In Canada’; Murray Cod 16m Director Options AGM; MGC Tells ASX: Director Hayes 3Y Wrong; Share Trade OK; Wilson Asset Management Takes 5.4% Of Ridley; Massachusetts Financial Reduces In Ridley; Vasilios Votsaris, Batman Take 5% Of Food Revolution; Harvest Appoints Jack Rosagro Co-Co Sec

A2 To ‘Vigorously Defend’ Slater & Gordon Class Action; Synlait Launches Reusable Swappa Steel Milk Bottle; Harvest Launches US Opsivity For Labor Shortages; Avecho Starts Phase I Marijuana Absorption Trial; MGC: AMC Orders $4m Of Cimetra; Creso: $809k Marijuana Orders; Wide Open Appoints Growhub Oatup Singapore Distributor; Wide Open Sends Lupin Samples; Roots: US Allows Heat Exchange Probe Patent; Wide Open: 3.25m Director Options AGM; Seafarms Group Requests ‘Project Costs’ Trading Halt; Ap Hemp To Release 20m ASX, 6m Voluntary Escrow Shares; Paul Sherman Replaces Palla CFO Brendan Middleton

Synlait Revenue Up 5% To $1.3b, Profit To $27m Loss; Botanix Trials Cannabinoid BTX1204A For Dog Eczema; Pharmaust: Options Rights Offer For $792k; MGC: AMC Orders 1,000 Cimetra Units; Cobram 167% Directors Pay Pool Hike AGM; Perpetual Takes 5% Of A2 Milk; Spheria Below 5% In Ridley; Synlait Loses Milne; Penno Chair, Watson CEO, Stowell CFO; AP Hemp Appoints Tom Siebel Director

NSW Farmers: ‘Plants Are Not Meat Or Milk’; Fonterra Revenue Down 1% To $20b, Profit Down 9% To $580m; Clover Revenue Down 31.5% To $60.5m, Profit Down 52% To $6m; Huon: Court Okays JBS Scheme Meetings; Booklet; AGM; Auscann Appoints Cannvalate For Clinical Review; Memphasys On-Track For Samson Horse Semen Test; Food Revolution: ‘Increasing Juice Lab Distribution’; Epsilon: Valens 1st Marijuana Order For $540k; Creso, Halucenex, Acadia Uni Work On Gel Capsules; Apiam Releases 2.9m Voluntary Escrow Shares; Perpetual Takes (Reduces To) 5% Of Clover

Abares Forecasts Record $73b Year; Labor Shortages; CSIRO: $150m To Build A $20b Ag And Food Sector; Elders Refinances, Increases Loan Facility To $180m; Avecho Recruits 1st Phase I TPM-Marijuana Trial Patient; MGC: UK Approves Import, Use Of Cannepil+ For Epilepsy; Epsilon Requests ‘Valens 1st Material Order’ Trading Halt; Roots Faces AGM 26% Dissent On Stock Issues; AP Hemp Name Change AGM; Cann Group Tests Gelpell Equipment; Harvest One Payment; Creso: MHG Orders $338k Marijuana Products; Creso: Cannadol On-Line Sales, $80k Anibidiol For Polvet; MGC: German Approves Natural Artemic; Perpetual Takes 12.2% Of Costa Group; Schroder Reduces To 7.5% Of Ridley

Abares: Winter Crop Down 2% To 55Mt – Mouse Plague; Abares: ‘$264k Agriculture Innovation Grants – Apply By Oct 1’; S&P Demotes A2 Milk From ASX50; Bubs, Synlait From ASX300; Synlait: Restructure To Lose 15% Of Staff, Save Up-To $12m; Synlait To Sell Mangere Property For $29m, Leaseback; Epsilon, Valens Facility Deal, Buys Alternamed For $4.3m Scrip; Auscann Appoints Knoell CPAT-01 Advisor; Ecofibre, Southern Cross Uni Start Marijuana Sleep Trial; Aware Super Takes 5.2% Of Nufarm; Vanguard Takes 5% Of Costa Group; CMO Dr Matthew Myntti Reduces To 7.1% Of Next Science; Perennial Takes 6.5% Of Ecofibre; Creso Appoints Dr Miri Halperin Wernli, William Lay

Apiam Revenue Up 7% To $126m, Profit Up 19% To $5m; Clean Seas Revenue Up 20% To $48.5m, Loss Up 122% To $32.1m; Food Revolution Revenue Down 0.5% To $42m, Loss Down 78% To $2m; Bubs Revenue Down 28% To $39m, Loss Up 862% To $75m; Seafarms Revenue Down 25% To $21m, Loss Up 0.8% To $26m; Althea Record Revenue Up 128% To $11.5m, Loss Up 1.9% To $15m; Murray Cod Revenue Up 145% To $9.7m, Profit To $1.2m Loss; Palla Pharma H1 Revenue Down 43% To $7m, Loss Up 267% To $33m; Epsilon H1 Revenue Down 7% To $3.2m, Loss Down 26% To $4.1m; Creso H1 Revenue Up 109% To $3m, Loss Up 9% To $19m; Wide Open Revenue Up 198% To $4m, Loss Up 306% To $7.5m; Ocean Grown Revenue Up 30% To $3.3m, Loss Down 63% To $1.7m; MGC Revenue Up 43% To $3m, Loss Down 28% To $14m; AP Hemp Revenue Up 63% To $1.9m, Loss Down 26% To $4.4m; Cann Global Revenue Down 17% To $1.5m, Loss Down 41% To $5m; Pharmaust: Epichem Repays Lab Expansion Loans; Althea Also Pleads Schultz To ASX Listing Rule 15.7 Leak Query; Select Harvests Sells Lucky, Sunsol To Prolife For $1.5m; Creso, Red Light Holland End Merger; Aims At Nasdaq; Althea: Boston Beer Deal For Canadian Marijuana Drinks; MGC: India Approves Cimetra Import; Vanguard Takes 5% Of A2 Milk; Perpetual Takes 11% Of Costa; Regal Fund Takes 5.5% Of Clean Seas; Regal Funds Management Takes 7.5% Of Althea; Seafarms Appoints Mick McMahon CEO, Ian Brannan CFO; David Austin Replaces Cann Global Chair Pnina Feldman

Abares: Seafood Down 2% To $3.15b; Farming Overtakes Fishing; Bega Revenue Up 39% To $2.1b, Profit Up 239% To $72m; A2 Milk Revenue Down 30% To $1.2b, Profit Down 79% To $77m; Ridley Revenue Down 4.2% To $928m, Loss To $25m Profit; Costa H1 Revenue $612m, Profit Down 6% To $47m; Huon Revenue Up 26% To $426m, Profit To $128m Loss; Cobram Revenue Down 0.5% To $140m, Loss To $33m Profit; Clean Seas Revenue Up 20% To $48.5m, Loss Up 112% To $32m; Tasfoods H1 Revenue Up 4.6% To $34.3m, Loss Down 80% To $1.4m; Cann Group Revenue Up 369% To $4m, Loss Up 48% To $25m; Terragen Revenue Up 86% To $3.65m, Loss Up 24% To $6.1m; Althea Raises $10.6m; Apiam Buys Harbour City Vets For $2.8m; Next Science: Irrimax Xperience Surgical Wash Legal Action; Roots RZTO System For Home Gardeners; MGC Claims $33m AMC Marijuana, Cimetra Deal; Althea, Canopy Growth Marijuana Manufacturing Deal; Emmanuel Pohl, ECP Below 5% In Costa Group; Deborah Ambrosini Replaces Cann Group CFO Greg Bullock; Scott Hadley To Replace Tasfoods CEO Jane Bennett

Twiggy’s 18.5% Sparks JBS Huon Takeover Offer; Cooke Confirms Interest In Huon; Tamp To Treasurer, FIRB: ‘Block JBS Huon Bid’; Tassal Revenue Up 6% To $594m, Profit Down 50% To $35m; Elixinol H1 Revenue Down 39% To $4.8m, Loss Down 87% To $11m; Pharmaust Revenue Down 33% To $2.1m, Loss Down 2% To $1.3m; Epsilon, Tetra, Terry White Melbourne Marijuana Clinic; Creso: Halucenex Wins Canada Psychedelics Dealer Licence; Roots 32-Vote AGM, 169m CDIs To Everblu, Directors; Anatara Launches IBS-D Trial Recruitment Website; Chair Ian Trahar, Gabor Take 27.5% Of Seafarms; Janet Cameron Takes 19.8% Of Seafarms; Nippon Suisan Kaisha Diluted To 6% In Seafarms; Regal Funds Below 5% In Clean Seas; CVC Diluted To 14.7% In Tasfoods; Nanollose Chair Wayne Best, Debra Best Increase, Diluted To 6%; Winton Willesee, Azalea Increase, Diluted To 5.4% Of Nanollose; John Moursounidis Diluted Below 5% In Nanollose; Jason Maclaurin Below 5% Of Nanollose; Synlait Appoints Nigel Macdonald Operations Director; Fonterra Appoints Kate Daly M-D People, Culture

JBS Bids $425m For Huon; Bidder JBS Takes 40.5% Of Target Huon; Tattarang, Dr Andrew ‘Twiggy’ Forrest Take 18.5% Of Huon; Dr Andrew Forrest: ‘JBS Make Huon Clean, Green’; Tasmanian Alliance: Cautious Welcome To Dr Forrest; Huon, Tassal Respond To Richard Flanagan’s ‘Toxic’; Seafarms $15m Plan: $8.7m Acceptances; Total $107.5m; Cobram Opens At $1.87, Valuing It At $725m; Sustainable Seaweed Expects $100m Production By 2025; Nufarm: US Finds Nutriterra Omega-3 ‘New Dietary Ingredient’; Cann Group: Emyria O-T-C- Marijuana Deal Ends, Going Solo; Creso: Canada Approves Medical Marijuana Licence; Creso Requests ‘Canada Health Licence’ Trading Halt; MGC: EGM 15% Oppose 63m Director ‘Performance’ Rights; Yarra Below 5% In Nufarm; Tasfoods Loses CFO Donna Wilson

Ecofibre Revenue Down 43% To $29m, Profit To $7m Loss; Murray Cod Receipts Up 125% To $9.4m; Epsilon H1 Receipts Down 2% To $3m; Creso H1 Receipts Down 21% To $2m; Apiam Pays $2m For Golden Plains Group; Pharmaust’s Epichem Waste-To-Fuel Reactor ‘Operational’; Anatara ‘Successful’ Bromelain Piglet Study Not Significant; Creso: Halucenex Completing Tests On Psilocybin For PTSD; Vanguard Below 5% In A2 Milk; Vanguard Below 5%, Above 5% In Elders; Vanguard Below 5% In Costa; RIC Appoints Sally Freeman, Michael Carroll Directors; Clover Appoints Interim Andrew Allibon CFO, Co Sec

Abares: ‘Dispute Could End Wine Exports To China’; Federal $860k For Milk, Nut Markets On China Loss; Cann Group Placement, Share Plan For $20m; Pharmaust: 3 Labs Back Monepantel For Sars-Cov-2, In-Vitro; Clean Seas Receipts Up 5.35% To $45m; Bubs Receipts Down 34% To $44m; Tasfoods Receipts Up 3% To $34m; Althea Receipts Up 126% To $10.3m; Regeneus Receipts $7.7m; Wide Open Receipts Up 241% To $4.7m; Ocean Grown Receipts Up 11.5% To $3.2m; Terragen Receipts Up 82% To $2.9m; MGC Receipts Up 26.5% To $2.7m; Pharmaust Receipts Down 30% To $2.5m; Australian Primary Hemp Receipts Up 30.5% To $1.5m; Cann Group Receipts Down 20% To $1.4m; Regeneus, Kolling Work On Progenza For Osteo-Arthritis; Clean Seas Redeems $9.1m Convertible Notes; Epsilon 64% Vote Off Directors Alan Beasley, Lou Cattelan; Allan Gray Takes 10% Of Nufarm; C2 Capital Diluted To 12.5% In Bubs; A2 Milk Appoints Amanda Hart CPCO; Roots’ Chair Boaz Wachtel Stands Down, Adam Blumenthal; Miles Brennan Replaces Terragen CFO, Co-Sec Kara King

Federal $2m For Grain, Wine Markets On China Loss; Costa Raises $190m, Completes 2PH Farms Acquisition; Ecofibre Receipts Down 24% To $23m; Next Science H1 Receipts Up 83% To $6.3m; Elixinol H1 Receipts Down 28% To $5m; Auscann Starts Marijuana Dermacann For Dogs Application; MGC Tells ASX: ‘June 23 Slovenian Patent Material At July 15’; Cann Group Requests ‘Placement’ Trading Halt; Creso: Landing Strong To Provide PTSD Trial Support; Pharmaust Applies For Monepantel Patent For Viral Diseases; Mitsubishi, Morgan Stanley Take 6.7% Of A2 Milk; Bubs Loses Director Matthew Reynolds

Microbiogen Yeast Produces Animal Food, Bio-Ethanol; Food Revolution: $8m Loans; Steven Cail CEO, Jac Phillips; Select Harvests Expects Almond Crop Up 21.5% To 28,250mt; Pharmaust, WEHI Study Monepantel For HTLV-1, In Vitro; MGC Starts 252-Patient, Phase III Cimetra (Artemic) Covid-19 Trial; MGC Applies For Slovenian Marijuana Delivery Patent; Creso Completes Halucenex Acquisition; Creso Launches 2 Marijuana Sport Products In Switzerland; Greencape Takes 5% Of Elders, Again; Perpetual Takes 9.8% Of Costa; Lazard Takes 6% Of Costa; Vanguard Group Takes 5% In Costa; Thai Union Group Takes 10% Of Clover; Bubs Appoints Katrina Rathie Director; A2 Milk Appoints Yohan Senaratne, Kevin Bush Executives

Regional Investment Corporation Lends $3b In 3 Years; A2 Milk: NZ Approves 75% Mataura Valley Milk Acquisition; ACCC Approves Ridley $55m Westbury Sale; Australia Approves Qbiotics Stelfonta For Dog Cancer; Pharmaust Monepantel Tablets ‘Stable At 24 Months’; Cann Group Recovers $1.2m Of $3.5m ‘Cyber Security Incident’; Althea’s Peak $1.3m 48north Marijuana Manufacture Deal; Creso Completes Anibidiol Uruguay Import Procedures; Creso: Red Light Holland Buys $219k Netherlands Marijuana; Cann Global Receives 2 Canntab Marijuana Products; MGC 64.2m Director Rights EGM; Food Revolution Requests ‘Management Change’ Trading Halt; CBA Takes 5.2% Of A2 Milk; Vanguard Takes 5% Of Bega; Yarra Reduces To 5.3% In Nufarm; ECP Takes 5.3% Of Costa; Chair Ian Trahar, Gabor Diluted To 24% Of Seafarms; Janet Cameron Takes 15% Of Seafarms; Nippon Suisan Diluted To 13% In Seafarms; Chair Adam Blumenthal Reduces To 10% Of Creso; IFM Takes 16% Of Clean Seas; GCI CSS, Hofseth & Nevera Diluted To 6.3% Of Clean Seas; Agfood Takes 12% Of Tasfoods; Memphasys Appoints Prof John Aitken Research Director

Fonterra Sells China Farms For $153m; Apiam Pays $16m For Scenic Rim Vets; Pharmaust: 1 Of 15 Dogs MPL Tumor Regression; 6 ‘Stable’; Micro-X Launches Veterinary Rover Mobile DR; Auscann Marijuana For Tasmania Department Of Health; Creso: ‘H1 Marijuana Revenue Up 113% To $3.1m’; Ocean Grown: ‘Record’ $3.1m Abalone Harvest, Sales; Wellnex Completes Brand Solution, Pharma Acquisition; Memphasys Completes Verification, Validation To Go; Elixinol Terminates Cannacare Acquisition; Vanguard Below 5% In Bega; Vanguard Below 5% In Costa; Bonafide Wealth Takes 17% Of Clean Seas; Regal Funds Takes 7% Of Clean Seas; Ecofibre Appoints Vanessa Wallace Director; Hang Ling Leung Replaces Regeneus Co Sec Sandra McIntosh; A2 Milk Appoints Edith Bailey CMO

Costa $190m Placement For $219m 2PH Farms; Seafarms Placement For $90m, Share Plan For $15m; Huon Potential Sale; Guidance Confirmed; Wellnex Rights Raise $1.32m, Shortfall $1.56m; Next Science, Zimmer Talks On Xperience Distribution; Wide Open: Market Grocer Vic, NSW Oatup Orders; Palla Completes Ireland, Germany Co-Codamol Submissions; Palla Appoints Alloga UK Co-Codamol Supplier; Althea Ships Marijuana To South Africa; Wide Open Sells 2.3m Director Options To New Investors; Creso Requests ‘Sales, Revenue Update’ Trading Halt; Perpetual Takes 10% Of Select Harvests; Tattarang, ‘Twiggy’ Forrest Take 7.3% Of Huon; Regal Funds Below 5% Of Huon; Scobie Dickinson Ward Takes 17.6% Of Terragen; One Funds Takes 9.7% Of Terragen; Costa Appoints Harry Debney Director; John Murphy, John O’Hara Replace Tasfoods Roger McBain; Terragen Loses CFO, Co Sec Kara King; Epsilon: Louisa Ho In, Philip Leighfield Out; Nicholas Marshall

Australia, UK Free Trade Deal; Labor ‘Cautious Welcome’; Abares: $66b Record Farmgate Production; Bubs To Launch Baby Formula In The US; Wide Open Prepares $1.6m Lupin Protein Facility; Creso, Red Light Holland Marijuana Merger For Highbrid Lab; Auscann Leases R&D Facility To Source Certain; Ocean Grown: MSC Certification Underway; Nanollose EGM 16% Oppose Options; MGC: Cannepil On Irish Reimbursement Scheme; Thai Union Takes 6% Of Clover; David Jones Replaces Nufarm Director Frank Ford; MGC Loses Co Sec Nadine Barry

Abares: ‘Record Winter Crop’; Avecho: ‘TPM Increases Cannabidiol Absorption Up To 5.4 Times’; Epsilon To Supply CBD For MCRI Severe Behavior Trial; Next Science H1 Revenue $4.5m To $5.2m, Beats Last Full Year; Wide Open Expands Oatup ‘Milk’ In SA And WA; Elixinol Appoints Health House Distributor, Pharmacann Out; Creso, Halucenex Expand Proposed Psylocibin PTSD Trial; Creso US O-T-C Dual Listing; Agfood Takes 10.7% Of Tasfoods; Shane Gild Replaces AP Hemp Director Cameron Petricevic; MGC Appoints David Lim Joint Co Sec

Kraft Heinz Pays Bega $9.25m To Smooth Peanut Butter IP Fight; Synlait: Help For Flood-Damaged Farms, No Milk Lost; Synlait Increases Base Milk Price 5% To $7.09/KGMS; A2 Responds To Reports Of Slater And Gordon Legal Action; Clean Seas: Approval For Fitzgerald Bay Farm; Avecho, AB Vista Partner On TPM For Pigs; Pharmaust Phase I Monepantel MND Trial Approved; Creso Appoints Route2 Ecuador Marijuana Distributor; Bubs Pleads Schultz To ASX 29% Query; Goodbye Wattle Health, Hello Wellnex; Avecho AGM 17% Oppose 14m Director Options; Perpetual Takes 8.6% Of Costa; Thai Union Takes 5% Of Clover Corp; Clean Seas Appoints Katelyn Adams Director; Epsilon Appoints Edward Jones Marijuana Manager

Synlait Revenue, $18.5m-$28m Loss Warning; Select H1 Revenue Up 24% To $116m, Profit Down 93% To $1.3m; Apiam Pays $6.7m For 3 Queensland Veterinary Businesses; Ocean Grown Buys 143Ha At Esperance WA For $1.8m; Fonterra Increases Farmgate Milk Price; Cann Group Halves 2020-’21 Revenue Forecast To $4m-$5m; Ridley Sells Westbury Extrusion Facility For $55m; Seafarms Tells ASX: ‘Canstruct 3-Year Deal Worth $78m’; Nanollose 1st Shipment To Birla Cellulose; Memphasys Notes Raise $3m; Wide Open: Lupin Protein For Range Of Food, Drink Substitutes; TGA Approves Next Science Blastx Anti-Microbial Wound Gel; Avecho, TGA To Meet On O-T-C Soft-Gel CBD For Insomnia; Epsilon Receives $1m Federal R&D Tax Incentive; Costa AGM 7.6% Oppose Director Tim Goldsmith; Creso 15m Director, Staff, Everblu Shares; Halucenex AGM; Perpetual Reduces To 7.6% In Costa; Vanguard Below 5% In Select; Bonafide Wealth Increases, Diluted To 15.5% In Clean Seas; Clean Seas: Australian Tuna Below 5%, IFM, GCI CSS Diluted; Palla Appoints GW Executive Giles Moss CEO, On $536k

Nufarm H1 Revenue Up 83% To $1.65b; Loss To $59m Profit; Elders H1 Revenue Up 19% To $1.1b, Profit Up 32% To $70m; Tasfoods Builds Organic Poultry Farm; Refrigeration Trial; Creso Marijuana-Oat ‘Anibidiol Swine’ For Pig Stress; Creso Appoints Polvet Poland Anibidiol Distributor; Avecho Completes Marijuana Soft-Gel Design; Tasfoods AGM 49.5% Oppose Director Roger McBain; Elixinol AGM 23% Oppose 43% Directors’ Fees Pool Hike; MGC Applies For ‘Cimetra’ Slovenian Patent; Roots Takes ‘US Plant, Hemp Food Venture’ Halt To Suspension; Clean Seas Lists On Euronext Growth Oslo; Lazard Takes 5.2% Of Costa; Apiam CEO Dr Chris Richards Increases, Diluted To 24%; AP Hemp: Loses COO Role, James Hood Continues As Director

Federal Budget 2021; NSW Farmers; A2 Milk: Revenue Warning – Down 28%; Tassal Acquires Mid Farm, Sells Surplus Exmoor Land; Wattle Rights Offer For $2.9m; Creso: Halucenex Secures More Synthetic Psilocybin; Roots Requests ‘US Plant, Hemp Food Venture’ Trading Halt; Perpetual Takes 9% Of Select Harvests; Scobie Dickinson Ward Takes 16.5% Of Terragen; Heather Cameron Increases, Diluted To 19.4% Of Tasfoods; A2: Peter Nathan Out; Eleanor Khor In; Jaron McVicar Up; Synlait Loses CFO Angela Dixon, Rob Stowell Interim; Bubs Appoints Fabrizio Jorge COO; Pharmaust Dr Kim Agnew To Lead Monepantel Dog Trial

Memphasys: New IVF Products Include Stallion Sperm Test; Clean Seas Placement Raises $25m; Regeneus Placement To Raise Up-To $4.5m; Fonterra Capital Structure Review; Wide Open: Preliminary Results Back Lupin Food Protein; Palla, M&A Legal Issues Settled; Production Begins; Launch; MGC Receives $996k Artemic Rescue Order; Creso: Halucenex, Nucro-Technics Psilocybin R&D Deal; MGC Requests ‘Further Artemic Findings’ Trading Halt; Memphasys’ Prof John Aitken Wins Andrologist Gong; Regeneus Grants CEO Karolis Rosickas 25m Incentive Options; Avecho Loses Director David Segal; Tania Foster Replaces Elders CFO Richard Davey; Andrew Allibon Replaces Clover CFO, Co Sec Paul Sherman; Ocean Grown Appoints Brent Stockden Co Sec

Sea Forest Raises $34m For Seaweed To Cut Methane Emissions; Cann Group Recalls 250 Units Of 50ml Marijuana Oil; Cann Group Dispatches 20k Bottles Of Marijuana Oil To Iuvo; Synlait Upgrades Emissions Reduction Targets; Synlait Launches ‘Made With Better Milk’ Powder; FDA Approves Next Science Xperience No Rinse Anti-Microbial; Auscann (Cannpal) ‘CPAT-01 Improves Osteoarthritis In Dogs’; AP Hemp $250k Annex Foods Hemp Meal Supply; Pharmaust Monepantel Dog Plasma Levels ‘Supportive’; Memphasys Felix Sperm Separator Fix On-Track; Memphasys: 2 US Patents For Felix Sperm Separation Device; MGC Submits Artemic To Health Canada; Avecho 18m Director Options AGM; Cann Group Appoints John Sharman Director

Federal $20m For Electronic Fish Initiatives; Bega Sells Facilities To Mead Johnson Nutrition For $200m; Nanollose $2.9m Placement; AP Hemp: Coles Stocks $3m A Year More Mt Elephant Products; Auscann Receives $1.6m Federal R&D Tax Incentive; Anatara: Ethics Approval For CSIRO 3FDC Psychology Trial; Ecofibre: Hemp Research Completed 15 Months Early; Ecofibre Marijuana Sleep Trial Approved; Creso: Halucenex, Sixth Wave Psilocybin Extraction Deal; Murray Cod To Release 4.1m Voluntary Escrow Shares; MGC Buys Israel’s Medicanl CRO For $6m In Shares; Wattle Health Name Change, Acquisition AGM; Pendal Group Below 5% Of A2 Milk; Greencape Below 5% In Elders; Perpetual Below 5% Of Bega; Lazard Ceases In Costa; Auscann CEO Layton Mills Starts On $275k; Ridley Appoints Richard Betts CFO

Apiam Raises $6m; Wattle $4.75m For Brand, Pharma Solutions; Rename ‘Wellnex’; Avecho Approval For Phase I Marijuana Trial; Australian Patent For Anatara Detach For Animal Diarrhoea; Creso: Halucenex, GTR Mushroom Genome Sequencing Deal; Creso, Cannabis Queen Bilateral Distribution Deal; Nanollose Requests ‘Capital Raising’ Trading Halt; Tasfoods 2nd Strike, 855k ‘Performance’ Rights AGM; Elixinol Name Change, 43% Directors Fee Hike AGM; Yarra Takes Sumitomo Mitsui 6.5% Of Nufarm; Yarra Capital Takes Nikko’s 7.9% Of Select Harvests; Yarra Funds Takes Nikko’s 9.7% In Tassal; Petstock Takes 16.5% Of Apiam; Dr Tracey Mynott, Myeng Reduce To 5% Of Anatara; Tasfoods: Marta Button Co Sec, Janelle O’Reilly Gen Counsel; Synlait To Lose CEO Leon Clement

Dr Boreham’s Crucible: Select Harvests; Pharmaust Receives $756k R&D Tax Incentive; Cann Global Trials Marijuana For Multiple Sclerosis; Pharmaust: Monepantel Anti-Viral Against Sars-Cov-2 In-Vitro; Next Science To Release 73m ASX Escrow Shares; MGC Receives $425k Artemic Rescue Order; MGC Appoints Nadine Barry Co-Co Sec; 70m ‘Performance’ Rights; Sumitomo Mitsui Reduces To 6.6% Of Nufarm; Dr Robyn Cleland Chief Environmental Biosecurity Officer; Bega Appoints Harper Kilpatrick Director; Sean Hallahan Replaces Costa Director Harry Debney; Creso Appoints John Griese US Business Development Head

Synlait H1 Revenue Up 19% To $608m, Profit Down 76% To $6m; Swanson Reed: RDTI Registration Closes April 30; Cann Group, Er Ya Trade In Hong Kong Court For $3.5m; Food Revolution $3m Placement; Select Harvests: Almonds 50% Harvested; Rain Delay No Impact; Fonterra Completes $508m China Farms Sale; Cann Group, Emyria Fast TGA O-T-C Marijuana Registration; Pharmaust Monepantel Dog Cancer Trial Underway; Pharmaust’s Epichem Accepted Into WA Business Program; Creso Pays $70k For Mushroom Psilocybin Extraction; Cann Global: JV Canntab Marijuana Export Licence; Althea Launches Cheaper 20ml ‘Flexi’ Marijuana Oil Products; Perpetual Reduces To 8.7% In Costa; Lazard Takes 5% Of Costa; Argo Takes 5% Of Tassal; Scobie Dickinson Ward Takes 15% Of Terragen; Mark Compton Replaces Next Science Chair George Savvides

Pharmaust’s Epichem, Thermaquatica Waste-To-Fuel Deal; Palla Retail Rights Raise $5.8m, Total $18m; Creso Placement Raises $18m; Wattle H1 Revenue Up 54% To $714k, Loss Up 76% To $17m; Seafarms Appoints Canstruct For Project Sea Dragon; Food Revolution: Juice Lab In Woolworths, Metcash IGA; Roots, Hempoint Plan US Hemp Meat Venture; Auscann Receives $648k Instalment For Chile J-V Dayacann; MGC Cimetra (Artemic) Phase III Covid-19 Trial Ethics Approval; Elixinol Hemp Products Okay In UK; Toxicology Study Pending; Creso US OTC Listing; More Psilocybin; Cann Global Requests ‘Regulatory Milestone’ Trading Halt; Avanteos Takes 6.3% Of A2 Milk; FIL Takes 7.8% Of Synlait; Synlait Loses Operations Director Mark Toomey; Ridley Loses Co, Sec Legal Affairs William Linehan

Fonterra H1 Revenue Down 5% To $9b, Profit Down 22% To $362m; Clover H1 Revenue Down 28% To $29m, Profit Down 46% To $2.5m; S&P Demotes Tassal From ASX200, Next Science From All Ords; Elixinol To Pay Up To $37m For Germany’s Cannacare; Creso To Pay $500k, 47m Shares For Psychedelic Halucenex; Creso Phase II Psilocybin Trial For PTSD; Creso Launches Marijuana ‘Ritual Sticks’, $73k First Order; Palla: 1st UK Order For Codeine-Paracetamol Pills; Roots $52k RZTO Marijuana Sales Contract; Ecofibre To Release 192m ASX Escrow Shares; European Patent For Regeneus Progenza Stem Cells; Perpetual Reduces To 5.6% In Bega; Yarra Funds Becomes Substantial In Tassal; Dimensional Increases, Diluted To 5.1% Of Ridley; Credit Suisse Takes 5.4% In Huon; Sells, Transfers Below 5%; Merchant Funds Takes 13% Of Auscann; Petstock Takes 10% Of Apiam; Regal Funds Reduces To 5.6% Of Apiam; Bill Fleming To Replace Creso’s Dr Miri Halperin Wernli; Elixinol Appoints Kim Bradley-Ware Co-Co Sec

Dr Boreham’s Crucible: Auscann + Cannpal Merger; Federal $6.5m For Innovative Farming Projects; ‘Engineering Issue’ Delays Memphasys Felix Sperm Separator; Cannpal 99.9% Vote For Auscann Merger; WA Court Approves; Food Revolution: Juice Lab Launch ‘Exceeds Expectations’; Cann Group Marijuana Oil For ONJCRI Trial; Satipharm Completes; Creso Appoints Impactive US, Canada Marijuana Distributor; Cann Global Patent For Marijuana Pills; $418k Order; Murray Cod 2m Director Options EGM; Elixinol Takes ‘Potential Transaction’ Halt To Suspension; ECP Below 5% Of Costa; Vanguard Takes 5% Of Select Harvests; Washington H Soul Pattinson Takes 20% Of Clover; Ocean Grown: Rob Jorden CEO On $225k, M-D Brad Adams Director; Epsilon (THC) Loses Director Gary Radcliff

Abares Outlook Conference; Food Agility ‘Mission Food For Life’ Conference; Huon H1 Revenue Up 24% To $220m, Profit To $95m Loss; Seafarms H1 Revenue Down 31% To $15m, Loss Up 4.5% To $12.8m; Kyocera Takes Regeneus H1 Revenue To $7m, Loss To $4m Profit; Ocean Grown H1 Revenue Up 9% To $1.6m, Loss To $149k Profit; Terragen H1 Revenue Up 73% To $1.4m, Loss Up 45% To $3.4m; Creso Revenue Down 33% To $2.4m, Loss Up 101% To $31m; Pharmaust H1 Revenue Down 37% To $1m, Loss Up 72% To $832k; Synlait: Fy2021 Profit ‘Less Than Half Fy2020’; Palla $4m Placement, $8m Institutional Rights Issue; Fonterra Increases Farmgate Milk Price; Costa To Buy 600ha Land, Packing Facility From KW Orchards; MGC: Swiss Pharmacan Artemic Order Increase To $425k; Coles To Stock AP Hemp Mt Elephant Plant Milk From April; Creso Appoints Ceres US Anibidiol Distributor; Select Harvests AGM: 32% Oppose Director Fred Grimwade; Elixinol Requests ‘Potential Transaction’ Trading Halt; FIL Takes 7% In Bega; Perpetual Reduces To 10% Of Costa; Spheria Reduces To 5% Of Ridley; Scobie Dickinson Ward Takes 14% Of Terragen; Ecofibre Appoints Prof Bruce Robinson Director; Elders To Lose CFO Richard Davey

CSIRO Develops ‘Dual-Purpose Record Canola Crop’; Nufarm Unaudited 6 Month Revenue Up 18% To $1.1b; Fonterra Lifts Profit Forecast To $374m To $529m; Bega H1 Revenue Down 4.5% To $708m, Profit Up 154% To $22m; A2 Milk H1 Revenue Down 16% To $632m, Profit Down 36% To $112m; Costa Revenue Up 11% To $1.2b, Loss To $61m Profit; Ridley H1 Revenue Down 3.5% To $470m, Profit Up 2821% To $11.6m; Apiam H1 Revenue Up 9% To $61m, Profit Up 54% To $2.6; Tasfoods Revenue Up 32% To $67m, Loss Up 85% To $6.4m; Clean Seas H1 Revenue Down 9% To $22m, Profit To $21.9m Loss; Food Revolution H1 Revenue Up 24% To $22m, Loss To $32k Profit; Bubs H1 Revenue Down 33% To $18m, Loss Up 71% To $13m; Palla Revenue Down 60% To $22m, Loss Up 355% To $35m; Palla Trading Halt For $18m Placement, Rights; Elixinol Revenue Down 51% To $15m, Loss Up 26% To $104m; Murray Cod H1 Revenue Up 119% To $4.2m, Loss To $542k Profit; Wide Open H1 Revenue Up 257% To $1.75m, Loss Up 398% To $3.6m; Abares: Agriculture Growth – Meat, Horticulture Up; Victoria Supreme Court Backs Bega’s Trade Marks Rights; Select Harvests: Thomastown Non-Core, Carina West Expands; Agfood Takes 9.5% Of Tasfoods; Food Revolution Chair Dr Tao Li, Careline Reduce To 23%; Fanucci, Domenal Diluted To 7.6% Of Food Revolution; Bessie Lee Replaces A2 Milk Director Jesse Wu; Ridley Loses CFO, Co Sec Alan Boyd; Amy Alston Co Sec; Regeneus Loses Director Dr Alan Dunton; Auscann: Charles Altshuler CFO, Maria Alexakis Medical Director; Food Revolution Appoints Steven Cail CFO

Abares: Winter Crop 2nd Biggest On Record; Vietnam Approves Melbourne Export Irradiation Facility; QUT Engineers Banana Panama Disease Resistance; Tassal H1 Revenue Up 7% To $288m, Profit Down 32% To $28m; AP Hemp Share Plan Raises $1m; Total $6.2m; Palla Codeine-Paracetamol Ready For UK Sales; Pharmaust Starts 2nd Monepantel Dog Lymphoma Trial; Cann Group Buys Satipharm For $4m Scrip; Revenue Warning; Creso: Route2 Pakistan, Philippines Marijuana Distributor; Mgc Studies Nano-Marijuana For Glioblastoma; MGC: Swiss Pharmacan To Distribute Artemic For Covid-19; Federal Court Grants Cann Cleansing Notice Extension; Sumitomo Mitsui, Nikko Below 5% Of Tassal; Perpetual Takes 8% Of Select Harvests; Scobie Dickinson Ward Takes 13% Of Terragen

Federal $13m For Pest And Weed Control; Federal Dairy Program To Promote Exports; Cann Group: $3.6m ‘Cyber Security Incident’; Ecofibre H1 Revenue Down 49.5% To $14.7m, Profit To $5.5m Loss; Avecho Placement Raises $5m; Ap Hemp $250k Pa Woolworths Hemp Milk Contract; Anatara Ready For Garp IBS Diarrhoea Trial; Wattle Buys Final 20% Of Little Innoscents For $200k; Althea Ships $1m Marijuana Oil To Germany; Creso Takes-Back Swiss Distribution; MGC Opens On London Stock Exchange; Anatara Completes Unmarketable Parcel Buy-Back; Auscann Buys Back 8m Unmarketable Shares, 8k Parcels; Perpetual Reduces To 10.75% Of Costa; Ethical Partners Increases, Diluted To 6.7% In Bega; Perpetual Reduces To 6.6% In Bega; UBS AG Takes 7.4% Of Tassal; Regal Funds Takes 10% Of Elixinol; Murray Cod Appoints David Crow Director, 2m Options; Federal Government Appoints Ag Innovation Board

Dr Boreham’s Crucible: Bega Cheese; Ric Drops Loan Rates To 1.77%; Cann Requests ‘Investigation’ Trading Halt; Fonterra Increases Farmgate Milk Price; Althea H1 Receipts Up 204% To $4.7m; THC Receipts Up 44% To $6.9m; Ocean Grown Abalone Receipts Down 1.2% To $1.5m; Huon Expects ‘Substantially Lower’ 2021 Earnings; UK Approves Palla Norway Codeine Facility; MGC Raises $11.6m To List On London Stock Exchange; Wide Open, Curtin Uni Work On Lupin Protein Food; Anatara: Anr-Pf Poultry ‘Success’; $888k Federal RDTI; Cannpal: WA Supreme Court Orders Auscann Merger Meeting; Morgan Stanley Below 5% In A2 Milk; UBS Below 5% In Tassal; Yarra Funds Takes 7.7% Of Select Harvest; Tattarang, Andrew Forrest Take 5% Of Ridley; Perpetual Takes 7.6% Of Clover; AP Hemp: CIA Mann 13%, James Hood 8.2%, TTOR 5.4%; A2 Milk Appoints David Bortolussi CEO, M-D; Palla Loses Director Todd Barlow

Bega Completes $534m Lion Acquisition; Synlait Increases Base Milk Price 12.5% To $6.73/KgMS; Tasfoods 9 Months Receipts Up 36% To $67m; Bubs H1 Receipts Down 13% To $23m; Clean Seas H1 Receipts Down 18% To $20m; Food Revolution H1 Receipts Up 6% To $17m, Revenue $21m; Elixinol Receipts Down 57% To $14m; Regeneus H1 Receipts, Milestone $7.7m; Murray Cod H1 Receipts Up 99% To $3.5m; Creso Receipts Up 32% To $3.7m; Wide Open H1 Receipts Up 262% To $1.6m; Pharmaust H1 Receipts Down 27% To $1.3m; Cann Global H1 Receipts Up 85% To $1.1m; Morgan Stanley Takes 5% Of A2 Milk; Mitsubishi, Morgan Stanley Take 7.45% Of A2 Milk; Scobie Dickinson Ward Takes 12% Of Terragen; Elders Appoints Raelene Murphy Director; Select Harvest To Lose Director Michael Carroll

Huon, NSW Police: 5 Staff Charged Over $4m Fish Theft; AP Hemp $5.2m Placement; Share Plan For $1m More; Ecofibre H1 Receipts Down 28% To $17.8m; Althea Share Plan Raises $3.8m, Total $9.8m; AP Hemp: Woolworths To Stock Mt Elephant Baking Products; Creso: Virbac Animal Marijuana Order Takes H1 To $1m; Ecofibre Appoints Medisca Marijuana Ananda Distributor; Pharmaust’s Epichem Wins $200k Electronic Waste Grant; Firetrail Takes 8% Of Nufarm; Regal Funds Reduces To 8.3% Of Elixinol; Ecofibre: Robin Sheldon Joint Co-Sec, General Counsel; A2 Milk Loses Executive Lisa Burquest

Synlait Expects 35% Drop In Formula Sales; Next Science: Blastx Wins CE Mark; Wattle Sells Corio Bay Dairy To South Korea For $13.5m; Pharmaust: Epichem Extends Up-To $1m DNDI Contract; Elixinol Terminates Pet Releaf Agreement; Creso: Anibidiol Approved In Uruguay, $89k Purchase Order; Director Paul Benhaim, Raw With Life Diluted To 9% In Elixinol; Palla Loses Founder, CEO Jarrod Ritchie; Pharmaust Ethics Approval For Dog Cancer Trial; MGC Wins $5m Malta Grant For Artemic For Covid-19; Cann: 1st UK Marijuana Oil Shipment; Fonterra: China Anti-Trust Clearance For $459m China Farms; Food Revolution Share Plan Raises $498k; Palla Appoints Iain Ross Director; Avecho Begins ‘Observational’ CBD-TPM Study; Althea Appoints Lyphe UK, Jersey Distributor; Pharmaust Begins Manufacturing Human-Grade Monepantel; A2 Milk Finalizes $252m 75% Mataura Valley Milk Acquisition; Ocean Grown, Yumbah Abalone Hatchery Deal; FIL Takes 5% In Bega Cheese; Elixinol 17% ASX Price Drop Query; Regal Funds Reduce, Diluted To 10.5% Of Elixinol; Greencape Takes 5% Of Elders; Regal Funds Reduces To 9.5% Of Elixinol; Clean Seas Q2 Yellowtail Kingfish Sales Up 3%; Cann Group, Iuvo Marijuana Supply Deal, 19k Unit First Order; Perpetual Reduces To 12% Of Costa; Goodbye Tasmanian Alkaloids, Hello Extractas Bioscience; Pharmaust, Leiden Uni Monepantel Water Solubility Research; Cann Group Receives $3.2m R&D Tax Incentive; Auscann: Cannpal’s Layton Mills Replaces CEO Nick Woolf; One Funds Takes 7.4% Of Murray Cod; Althea Hits $1m Marijuana Sales In Month Of December; Chair Adam Blumenthal, Anglo, Atlantic Take 16% Of Creso; Creso: Pharma Dynamics $320k Purchase Order For Cannaqix; Nanollose, Grasim File Joint Patent For Tree-Free Fibre; MGC Appoints Nicole Godresse Head Of Sales; Wide Open 13.4m Loan Share Buy-Back

Bega Retail Rights Raise $115m, Total $401m; A2 Milk Downgrades FY21 Revenue To $1.3b-$1.5b; Synlait Requests ‘A2 Milk’ Trading Halt; Abares, ABS Database For Drought, Climate Change; Murdoch Uni, Curtin Uni Launch WA Grain Research Precinct; Costa Signs Mira (Macquarie) Lease; Wattle Health: API To Sell Uganic, Little Innoscents; Elixinol Share Plan Raises $12.3m; Total $20.5m; Althea Placement Raises $6m; Share Plan Hopes For $3m; L1, Obsidian Convert $3m Cann Global Notes For Shares; THC Raises $2.75m For Medimar, Manufacturing; Roots, Hempoint Investigate Hemp-Meat; Roots Installs My Green Fields Marijuana Heat Probes; Wide Open Prepares Oatup WA Launch; MGC: ‘Artemic Covid-19 Trial Meets Endpoints’; Anatara Unmarketable Parcel Facility; Creso Marijuana Deals: Ontario Cannabis, Martin & Pleasance; Scobie Ward Takes 10% Of Terragen; Regal Funds Reduces To 14% Of Elixinol; Nanollose Appoints Carla Woidt Fashion Consultant

Abares: ‘Agricultural Production To Hit $65b’; CSIRO Looc-C App To Measure Soil Carbon, Manage Cattle; Food Revolution: YTD Sales Up 19% To $16.4m; Roots Raises $4m; UU, Israel Deals; Cann Global Raises $3.75m; Wide Open Food-Grade Lupin; Wattle Health, Verdure To Sell Uganic In Middle East; Althea: ‘November Record Marijuana Revenue Of $847k’; Creso $288k Recreational Marijuana Orders; MGC Sells $1.3m Unmarketable Parcel Shares; Blackrock Takes 6% Of A2 Milk; Perpetual Takes 8% Of Bega; Australian Super Takes 13% Of Huon; One Funds Takes 9% Of Terragen

Dr Boreham’s Crucible: Palla Pharma; Abares: ‘Near Record Winter Grain Crop’; Synlait Raises $19m In 3x Oversubscribed Plan, Total $190m; Food Revolution Placement Raises $4m, $500k Share Plan To Go; Select Revenue Down 17% To $25m, Profit Down 53% To $25m; Synlait Reduces Emissions 5% Per Tonne Milk Solid; Fonterra Increases, Narrows Farmgate Milk Price; UN Narcotic Drugs Commission Downgrades Marijuana; UK Wants More Palla Data For Norwegian Codeine Plant; Roots: Avital Takes RZTO To The Balkans; Apiam Completes $5m Don Crosby Acquisition; Ocean Grown AGM 29% Block 10% Placement Capacity; Althea, Africann $650k South Africa Marijuana Deal; Althea, Peak Deal For Canada Marijuana Drinks; Creso $414k Animal Marijuana Orders Take 2020 Total To $975k; Terragen Releases 32.4m Voluntary Escrow Shares; Wide Open Requests ‘Lupin Protein Trial Results’ Trading Halt; Perpetual Takes 6.6% Of Clover; Challenger Below 5% In Clover; Agfood Takes 8.5% Of Tasfoods; Regal Funds Reduces To 15.1% Of Elixinol; Memphasys Chair Alison Coutts On $350k; Clean Seas Appoints Robert Gratton CEO, David Brown CFO; Apiam Appoints Eryl Baron Co-Sec; Narelle Warren Replaces MGC Joint Co-Sec Rachel Kerr

Bega To Buy Lion For $534m; Raises $284m, $117m To Go; Stax, West Coast $5m Sydney SE IPO; $4.5m ‘Cryptocurrency’; Cann Group Nabs $50m Mildura Marijuana Loan; Licences; Tasfoods Agfood Placement Raises $3m; Food Revolution: Careline Can’t Pay Final $6m; Huon Fire Frees 50k Salmon; MGC Completes $1.4m Medicinal Cannabis Clinics Acquisition; MGC, Mercer $3.5m Draw Down Convertible Note; Nanollose: 30% Oppose Director Shares; Alfie Germano Goes; Cann AGM 27% Defeat 10% Placement Capacity; Anatara AGM: 24% Oppose 10% Placement Capacity; Bubs AGM 19% Oppose Remuneration Report; Clover: 15% Oppose M-D ‘Leaving Benefit’; Loses Cheryl Hayman; Ridley: 7.6% Oppose Re-Election Of Patricia Mann; Creso 198m Blumenthal, Everblu Shares, 109m Options EGM; Opyl Receives $249k R&D Tax Incentive; Apiam To Release 1.5m Voluntary Escrow Shares; Yarra Funds Below 5% Of Elders; FIL Takes 6.7% Of Synlait; Regal Funds Takes 16.15% Of Elixinol; Elixinol Director Paul Benhaim, Raw With Life Diluted To 12.3%

Elders Revenue Up 29% To $2.1b, Profit Up 78% To $123m; Nufarm Financial Year Change: 2-Month Revenue $267m; Qbiotics: US FDA Approves Stelfonta For Dog Skin Cancer; Elixinol Placement Raises $8.2m, Share Plan For $2m More; Anatara Share Plan Raises $1.4m, Scale-Back; Total $3m; Anatara, Ridley Study Bromelain For Weaner Piglet E Coli; Auscann To Acquire Cannpal; Apiam Buys Dubbo’s Don Crosby Veterinary Surgeons For $5m; Roots: RTZO Grapevine Trial; Elders AGM To Vote On Potential 2nd Strike Board Spill; Murray Cod 14m Directors Incentive Options AGM; Food Revolution To Sell Original Juice Co In South Australia; AP Hemp: 7-Eleven To Sell ‘Mt Elephant’ Hemp Bars; Althea Licenced To Sell Marijuana In Germany; Elixinol To ASX: Pet Releaf Paid $1.5m Of $27m; Benhaim Trade Ok; Factor Extends Longmile Vet Talks, Seeks ASX Advice; A2 Milk Loses Jesse Wu; Tassal Loses Director Trevor Gerber; MGC: ‘Marijuana Kills Glioblastoma In-Vitro’

Synlait Placement Raises $170m, Plan For $19m More; Bega: High Court Dismisses Kraft-Heinz Appeal; Apiam To Market Ceva Forceris For Piglets; Mira (Macquarie) Fund Offers To Buy Costa’s Vitalharvest; Tassal Completes Billy Creek Acquisition; Auscann Sells Chile J-V For $2.1m, ‘Transaction’ Trading Halt; Ecofibre ADR Program; Cannpal Requests ‘Transaction’ Trading Halt; Elixinol Requests ‘Capital Raising’ Trading Halt; Mitsubishi, Morgan Stanley Take 7.45% Of A2 Milk; Perpetual Reduces To 6% In Bega; Elixinol’s Paul Benhaim, Raw With Life Reduce, Transfer To 15%; D&G, David Newman, Gabriel Ettenson Below 5% In Elixinol; Ed Husic Replaces Shadow Agriculture Joel Fitzgibbon; Costa Promotes COO Sean Hallahan To CEO, On $850k; Wattle Loses CEO Tony Mckenna; George Karafotias Director; Ocean Grown Loses CFO, Co-Sec Romolo Santoro

Dr Boreham’s Crucible: Murray Cod Australia; Wide Open ‘Oversubscribed’ Share Plan Raises $4.1m; CSIRO, Future Select Create Food Recycler Nutri V; CSIRO Pet-Tracking Collar; Synlait Settles Pokeno Land Court Case; Synlait Supply Agreement With Unnamed Customer; Palla Files UK Application For Codeine Tablets, Caplets; Apiam Completes $16m Ace Laboratory Purchase; Avecho: ‘Improved TPM-Propofol Safe In Rats’; THC Rebrands To Epsilon Healthcare; Pharmaust AGM: 21% Oppose 10% Placement Capacity; Opyl 1.2m Directors ‘Incentive’ Options AGM; Vanguard Diluted Below 5% In Select Harvests; Thorney, Tiga Take 9.3% Of Anatara; Nufarm Appoints Lynne Saint Director; Karolis Rosickas Replaces Regeneus CEO Leo Lee, On $250k

Natural Disaster Royal Commission Passes On Climate Change; Wide Open: Oatup World’s 1st Carbon Neutral Oat Milk; Roots Combines Fertilization, Irrigation With Heat Control; Bubs Revenue Down 34% To $9.4m, Loss Of Daigou Sales; Clean Seas Q1 Receipts Down 26% To $8.8m; Murray Cod: ‘Sales Up 21.5%, Recovering From Covid-19’; Select Harvests Rights Raise $39m; Total $120m; Tassal Buys Billy Creek Property For $7m; Kyocera Pays Regeneus $5.6m Progenza Milestone; Tassal AGM: 19% Opposition To Constitution Amendments; Avecho Pleads Schultz To ASX 100% Price Query; Cann Global Launches Marijuana Tablets In Australia; ECP Takes 5% Of Costa; Washington Soul Pattinson, Pengana Reduce To 20% In Clover; Paul Townsend Replaces Nufarm CFO Paul Binfield

Clover: ‘H1 Revenue Down 15-20%’; Apiam: Q1 Revenue Up 14% To $30m; Food Revolution Q1 Revenue Up 28% To $10m; Anatara Raises $1.7m, Share Plan For $750k More; Avecho: ‘TPM Marijuana Increases CBD Bioavailability In Rats’; Synlait, Diaryworks Sell Deep South Ice Cream To Talley’s; Ecofibre Profit Warning; Bubs 4.7m CEO Kristy Carr Options AGM; Terragen: 8m CEO Jim Cooper Options AGM; Ocean Grown 1m CEO Ignazio Ricciardi Options AGM; Nanollose 5.1m ‘In Lieu’ Shares, 2.9m Options, 4m Rights AGM; Ellerston Below 5% In Nufarm; CIA Mann Family Takes 15% Of AP Hemp; James Hood Takes 10% Of AP Hemp; Dr Green, Ms Brendish Replace Clover’s Dr Sleigh, Ms Hayman; Anatara Loses Director Dr Tracie Ramsdale; All Change At Clean Seas; Kristi Woolrych Joins Ecofibre Director; Auscann Loses CFO Quentin Megson

Fonterra Increases Farmgate Milk Price; Wide Open Launches Oatup Regenerative Oat Milk; Cannpal: South Africa Dermacann Application; Vetio US Deal; Correction: Apiam Animal Health; MGC Ships ‘High THC’ Marijuana To Brazil; Cann Global Shortfall Raises $859k; Total $2m Of Hoped-For $4.7m; Cann Global Pleads Schultz, ‘Low Price’ To ASX 100% Query; AMP Below 5% Of Costa; Vinva Below 5% In Bega; Vanguard Takes 5% Of Select Harvests; Washington Soul Pattinson, Pengana Reduce To 22% Of Clover; Ellerston Below 5% In Tasfoods; Aurora Sells Cann Group 12%; Creso Cancels L1, Lind, Chifley Convertible Notes; MGC: Artemic ‘Not Toxic In Rats’ For Covid-19; L1 Below 5% In Creso; Amber Schwarz, Jamber Below 5% In Creso

Dr Boreham’s Crucible: Apiam Animal Health; Fonterra Sells China Farms For $513.7m; Select Harvests Institutions Raise $82m, Retail For $38m More; Wide Open Placement Raises $7m, Share Plan For $1.5m More; Creso Commitments For $9.0m; Bubs Plan Raises $3.8m Of Hoped-For $10m; Total Raised $32.1m; Tasfoods Rights Shortfall Raises $430k; Total $4.1m; Regeneus: Canada Patent For Sygenus Acne Treatment; MGC Launches Cannepil Application, Library Of Cannabinoids; AP Hemp: Up To 31% Oppose 668k Director Options; Memphasys: Felix Sperm Separator Sales ‘On-Track’; Perpetual Below 5% In Elders; Yarra Funds Takes 5% Of Elders; Yarra Funds Takes 7% Of Select Harvests; Tasplan Diluted To 11% Of Tasfoods; L1 Takes 12% Of Creso; AP Hemp Appoints CEO Neale Joseph M-D, Pauline Gately Chair; Creso Appoints Bruce Linton As Strategic Advisor

NSW Farmers: Agricultural Innovation Australia For R&D; Synlait Revenue Up 27% To $1.2b, Profit Down 8.5% To $69m; Seafarms Revenue Up 14% To $28m, Loss Down 17.5% To $25.5m; Select Harvests To Pay $129m For Piangil Almond; $120m Raise; Huon Share Plan Raises $2m, Total $66m; Tasfoods Retail Rights Raise $1.5m, Total $3.7m; Nanollose Invests $200k In Celluair Filtration; A2 Milk Forecasts Revenue Up To $1.75b; Regeneus Receives $677k R&D Tax Incentive; Pharmaust: Monepantel Selective For Cancer Cells; Regeneus Australian Patent For OA, MSC Biomarkers; Creso Requests ‘Capital Raising’ Trading Halt; Pendal Group Takes 5% Of A2 Milk; Huon CEO Peter Bender Increases, Diluted To 53%; Wexford Rise Takes 6.5% Of Australian Primary Hemp; Wide Open Requests ‘Capital Raising’ Trading Halt; Ridley: 1.8m CEO Quinton Hildebrand Shares AGM; Tasfoods Loses Director Alexander Beard

Nufarm Revenue Up 6.5% To $2.8b, Net Loss $456m; Clean Seas Hofseth North America, Asia Deal; Costa Pays $4.5m For 390ha Murray River Organics Wine, Citrus; Palla Pharma Sells Tasmania Property For $3m; Food Revolution Eridani ‘Marine Collagens’, $1m C-Mart Order; Pharmaust: $881k For Monepantel For Motor Neuron Disease; Pharmaust, Leiden Uni Test Monepantel For Sars-Cov-2, Ex-Vivo; Creso: Nova Scotia Liquor Corp Orders $187k Marijuana; Murray Cod Pleads Schultz, ‘Report’ To ASX 17% Query; Nanollose Requests ‘Capital Raising’ Trading Halt; Federal Court Orders Back THC Placement; Apiam To Release 2.9m Voluntary Escrow Shares; Ethical Partners Reduces To 7.7% Of Bega; JP Morgan Chase Below 5% In Tassal; Sumitomo Mitsui, Nikko Take 5% Of Tassal; Regal Funds Takes 9.7% Of Huon; PAC Partners Ceases Althea Holding; Food Revolution Appoints Jianping (Rocky) Zou Director; Opyl: Mark Ziirsen Director, Damon Rasheed Executive; Auscann Loses Director Dr Marcel Bonn-Miller

Fonterra Revenue Up 4% To $18.8b, Loss To Profit Of $660m; Clover Revenue Up 15% To $88m, Profit Up 24% To $12.5m; Australian Primary Hemp Marijuana Face Masks; Roots: Humboldt Takes Root Zone Tech To California; Auscann: Neuvis THC, CBD Capsules Meet Endpoints; Avecho Receives $615k R&D Tax Incentive; Perpetual Reduces To 7% In Bega; JP Morgan Chase Takes 7% In Tassal; AGC Asahi Glass Takes 7.5% Of Regeneus; Clean Seas Loses Director David Head; Cann Group Confirms Jenni Pilcher Director; Simon Robertson Replaces Synlait Director Bill Roest; Nufarm Loses CFO Paul Binfield

Abares: Winter Crop Up By 64%; NSW Farmers: Covid-19 Lamb Price Drops $4/Kg; Opyl Tells ASX: Covid-19 1st Use For AI Trial Software; Seafarms: WA Government To Upgrade Moonamang Road; Memphasys Receives $1.3m R&D Tax Incentive; Pharmaust: Elanco Drops 2018 Monepantel Option; Covid-19; TGA Joint Session Drops Marijuana CBD To O-T-C Schedule 3; Memphasys, Hydrix Good Design Gong For Sperm Separator; MGC: Up To $15m Mercer Equity-Drawdown Facility; Australian Super Takes 9.4% Of Huon; Kirman 2, Brian Sherman Take 5.7% Of Regeneus; Ex-Director Peter Margin Rejoins Bega As Deputy Chair; Helen Wiseman Replaces Elixinol Chair Paul Benhaim; Wide Open Loses Joint Co Sec Lydia Fee, Sam Wright Co Sec

Dr Boreham’s Crucible: Wide Open Agriculture; Federal $220k For Innovative Agriculture; Bubs Revenue Up 24.4% To $54.6m, Loss Down 78% To $7.8m; Food Revolution Revenue Up 19% To $35m, Loss Down 39% To $10m; Seafarms Revenue Up 14% To $28m, Loss Down 17.5% To $25.5m; Palla H1 Revenue Down 54.9% To $12m, Loss Up 121% To $9m; Elixinol H1 Revenue Down 54% To $8m, Loss Up To $81.6m; THC H1 Revenue Up 63% To $3.5m, Loss Down 3.2% To $5.6m; Murray Cod Revenue Up 13.7% To $4m, Loss To Profit Of $62k; Creso H1 Revenue Up 58% To $1.5m, Loss Up 177.3% To $17.4m; Ocean Grown Revenue Down 17% To $2.5m, Profit To Loss Of $4.6m; MGC Revenue Up 210% To $2m, Loss Up 124.6% To $19.4m; Cann Global Revenue Up 271% To $1.8m, Loss Down 12.8% To $8m; Terragen Revenue Up 56% To $1.5m, Loss Up 53.4% To $4.9m; Wide Open Record Revenue Of $1.45m, Loss Down 11% To $1.9m; Wattle Health Revenue Up 18% To $1m, Loss Up 470% To $59m; Bubs Raises $28.3m, Share Plan For $10m More; Food Revolution Juice Price Increases; Nufarm: $215m Impairment Charges For European Assets; Opyl: ‘A I Predicts Trial Results Including Covid-19 Studies’; Regeneus Pays CEO Leo Lee $325k Bonus For Kyocera Deal; Pharmaust, Obsidian Partner For Waste To Fuels Tech; Roots Pleads Schultz To ASX 42% Price Query; Vinva Takes 5% Of Bega; Yarra Funds Takes 5.6% Of Select Harvests; Spheria Takes 6.45% Of Ridley; SG Hiscock Takes 5.1% Of Althea; Janet Cameron Takes 19.98% Of Tasfoods; CVC Takes 17.4% Of Tasfoods; Cannpal Loses Director Max Johnston; THC Loses CEO Ken Charteris, Jarrod White Interim; Executives; MGC Appoints Evan Hayes Director, 2 Executives

NSW Farmers, Food Frontier, NFF Protein Industry Forum; Bega Revenue Up 5% To $1.5b, Profit Up 80% To $21.3m; Ridley Revenue Down 3.5% To $968m, Profit To $8.7m Loss; Costa H1 Revenue Up 7% To $612m, Profit Up 6% To $43.4m; Huon Revenue Up 20.5% To $340m, Profit Down 48% To $5m; Apiam Revenue Up 5.9% To $118.3m, Profit Up 36.2% To $4.3m; Clean Seas Revenue Down 13% To $40.3m, Profit To $14m Loss; Regeneus Revenue $1.7m, Loss Down 82% To $1.1m; AP Hemp Revenue Up 34% To $1.2m, Loss Up 512% To $5.9m; Cann Group Revenue Down 72% To $911k, Loss Up 55% To $17m; Huon Placement Raises $64m, Share Plan For $4m More; Ecofibre Completes $59m Texinnovate Acquisition; Kyocera Pays Regeneus $1.3m Progenza Milestone; Bubs: Beingmate To Manufacture Goat Milk Formula In China; Roots Raises $2.51m; Roots Takes RZTO To Alternative Meat Companies; Tasfoods Raises $650k, Rights Offer For $3.4m More; Aurora Cannabis Diluted To 12.3% Of Cann Group; Ridley Appoints Mick McMahon Chair, Rhys Jones Director; Clean Seas CEO David Head Retires, Robert Gratton Interim; Food Revolution Appoints CEO Tony Rowlinson M-D; Cann Global: Marion Lesaffre COO, Franc Zvonar Sales; Pharmaust: ‘Monepantel Suppresses Sars-Cov-2 Up-To 95%’; MGC: ‘Russia J-V For Artemic For Sars-Cov-2’

Cann Group Oversubscribed Plan Raises $25.9m, Total $40.2m; A2 Milk Revenue Up 33% To $1.6b, Profit Up 34% To $352m; Tassal Revenue Up 0.3% To $562.5m, Profit Up 18% To $69m; A2 Milk: Offers $246m To Acquire 75% Of Mataura Valley Milk; CSIRO, Future Feed Seaweed To Reduce Cattle Methane; Regeneus: US Patent For Sygenus For Skin Conditions; Althea: 740 New Marijuana Patients In July For $692k; Memphasys, Newcastle Uni Partner For IVF; Avecho: ‘TPM Increases Marijuana CBD Solubilization, In-Vitro’; Roots Requests ‘Capital Raising’ Trading Halt; Seafarms Pleads Schultz To 50% ASX Price Query; Lazard Reduces To 9.25% Of Ridley; Lazard Below 5% In Costa; Fonterra Appoints Teh-Han Chow Greater China CEO; MGC: ‘10-Patient Artemic For Covid-19 Data Meets Endpoints’

Regeneus: Kyocera $26m Progenza Knee Osteoarthritis Deal; Wide Open Supplies CSIRO 200kg Lupin For Plant-Based Protein; Farmers For Climate Action Fellowship Applications Open; Anatara, Uni Of New England Work On Poultry Enteritis; Ridley’s Novacq, Moolap $22.9m Impairments; Roots: Talgil To Improve Root Zone Control System; Creso: DHS Portugal, Spain Marijuana Distributor; MGC Appoints Lyphe UK Marijuana Distributor; Order; Ellerston Reduces To 6.4% Of Nufarm; Lazard Reduces To 5.45% Of Costa; Terragen To Release 1m ASX Escrow Shares; A2 Milk Appoints David Bortolussi M-D, CEO; All Change At Creso

Dr Boreham’s Crucible: Nufarm; Ridley Opens $47m Wellsford Feed Mill; Clean Seas Receipts Down 6.8% To $42.7m; THC H1 Receipts Up 122.9% To $3.2m; Creso H1 Receipts Up 314% To $2.9m; Regeneus Receipts Of $1.6m; Cann Global Receipts Up 54.4% To $1.3m; Allan Gray Takes 9% Of Nufarm; One Funds Management Takes 8% Of Terragen; Auscann Appoints Nick Woolf CEO; Regeneus Requests ‘Japanese Licencing Deal’ Trading Halt; MGC: ‘In-Vitro Study Backs Artemic For Covid-19’

NSW Farmers: Tighter Foreign Investment Review Over $5m; Nufarm: Canada Approves Nuseed Canola-Sourced Omega-3; Proagni Using Kangaroo To Improve Sheep, Cattle; Bubs Receipts Up 65.4% To $66.2m, Launches Vita Bubs Range; Tasfoods H1 Receipts Up 60% To $33m; Ecofibre Revenue Up 42% To $51m, Profit Up 119% To $13m; Ecofibre Pays $59m For Texinnovate; Murray Cod Receipts Up 15.5% To $4.2m; Pharmaust Receipts Down 7.7% To $3.5m; Ocean Grown Abalone Receipts Down 1% To $2.85m; MGC Receipts Up 27% To $2.1m; Terragen Receipts $1.6m; Wide Open Receipts $1.4m; Australian Primary Hemp Receipts Of $1.2m; Wattle Health Receipts Up 35% To $1.1m; Yarra Funds Below 5% In Elders; Elixinol Japan Marijuana Deal; Appoints Pharmacann; Elixinol AGM: 19% Opposition To Duff, Ellery Leaving Rights; MGC: Mice Survive Artemic For Sars-Cov-2 Toxicology Study; Cann Group Notes Convert To 17m Shares; Cann Global Rights Raise $2.2m Of Hoped-For $4.7m; John Gillam To Replace Nufarm Chair Donald McGauchie; Tassal Director Trevor Gerber To Retire; Terragen Appoints Travis Dillon Chair, Directors Go

Cannpal: Dermacann Safety, Efficacy For Dog Eczema; CSIRO, Pharmamark Omega-3 From Ocean Microbes; Seafarms: 3rd Prawn Generation; $150m Loan; Apiam: Revenue Up 6% To $118m, Profit Up 31% To $4.2m; Ecofibre Receipts Up 27% To $43.0m; Queensland Uni: Native ‘Stingless Bee’ Honey Low GI Sugar; Tasfoods 2nd ‘First Strike’ – 36% Oppose Remuneration Report; Wide Open: ‘Oat Milk This Year; Tasfoods Expects $3.5m Poultry, Dairy Impairment Charge; Nufarm Moves Financial Year To September 30; Factor To Acquire Longmile Vet Tech; David Brookes Chair; Avecho Pleads Schultz To ASX 86% Price Query; MGC: $1.4m For Cannvalate’s Medicinal Cannabis Clinic; MGC ‘Artemic Sars-Cov-2 Results’ Suspension; Clean Seas Appoints Kidder Williams Advisor; Roots Appoints Director Peter Hatfull

Cann Group Raises $14.3m, Plan For $10m More; Receipts Up 17%; Althea Full Year Customer Receipts $4.6m; Fonterra Revises 2019-’20, 2020-’21 Farmgate Milk Prices; Palla: $8m UK Contract; Norway Facility Applies For Approval; THC Share Plan Raises $1.5m, Total To $8.1m; Nanollose Supports Covid-Impacted Partner Grasim; Ecofibre: Two US Trials Of CBD For Neuropathy, Agitation; Pharmaust: Monepantel Dog Cancer Trial Report With Elanco; Auscann Unmarketable Parcel Facility; Avecho: 31% Opposition To Equity Incentive Plan; MGC Licence To Grow Marijuana For RMIT Research; Cann Global Releases 706m Shares From ASX Escrow; IFM Diluted To 16% In Clean Seas; Scobie Ward Takes 8.75% Of Terragen; L1 Below 5% In Creso; Cann Group Appoints Jenni Pilcher Director

Dr Boreham’s Crucible: Costa Group; Rural Bank: Positive Outlook, Watching China Diplomacy; Select Harvests: 2020 Crop In; Woolworths Adds Nut Products; Memphasys: Canadian Felix Approval Vests 11.2m Options; Ex-Chair Shane Noble Takes Tasfoods To Fair Work Commission; Roots Installs 3rd RZTO Hydro Grow System; Creso: Mernova $901k Israeli Marijuana Order; Althea: Concierge For Online Marijuana Sales; MGC Granted Australian Marijuana Import Licence; AMP Takes 5% Of Costa

Synlait Wins B Corp ‘Force For Good’ Certification; Wide Open, CBH Group Agreement For Carbon Neutral Grain; Ridley Opens Bendigo Feed Mill, Mooroopna To Close; Cann Group Receives $2m Victoria Regional Jobs Grant; Nufarm Ceases Insecticide, Fungicide, 2,4-D Herbicide; Ecofibre: US Marijuana Neuropathy Trial Starts; Cann Global Rights Offer For $4.7m; THC: Medleaf Pays $260k; Expects Canada, European Orders; MHC EGM: 23.5% Oppose Share Ratification; Elixinol 1.36m Oliver Horn, Helen Wiseman Rights AGM; Creso: 15m Mernova Shares For Sales Milestone; Pendal Group Below 5% In A2 Milk; Perpetual Takes 13% Of Costa; Gabor Takes 27.9% Of Seafarms; L1 Takes 7.4% Of Creso; Chair Wachtel, CEO Wernli Below 5%; David Hunnon, Chifley Take 12% Of Esense; Elders: Director Michael Carroll Resigns; Ridley Chair Dr Gary Weiss Extends To August; Food Revolution Loses Finance Director Joe Zhou

Fonterra To Pay More For Sustainable, Quality Milk; Wide Open Partners With Ethical Food Producers; Ecofibre: Chair Barry Lambert-Related $10m Loan; A2 Milk: Strategic Talks, Media Speculation; THC Raises $6.6m, Share Plan For More; Anatara: No Detach Partner By July; THC To Supply Marijuana To Medleaf NZ; Althea, Collective To Manufacture Marijuana Beverages; MGC: 3-Year GMP Licence For Slovenian Marijuana Facility; MGC Unmarketable Parcel Facility; Antanas Guoga Sells All 3.4m Opyl Shares; Peter McBride To Replace Fonterra Chair John Monaghan; Clean Seas Loses Director Helen Sawczak; Jim Cooper Replaces Terragen CEO Justus Homburg; On $301k

Wattle Health Chair Peter Biantes Loses Tax Registration; Wattle Health Loses Peter Biantes; NSW Farmers Oppose Beta Agonist For Cattle Feedlots; NSW Farmers Caution On Coal Seam Gas, Groundwater; Wide Open, CSIRO Work On Meat Substitute; Opyl Raises $739k; Memphasys: Felix Sperm Separator Sales ‘On-Track’; Roots: Hydro Grow Pays $17k For 3rd RZTO Order; Pharmaust: ‘WEHI Backs Monepantel For Sars-Cov-2 – In-Vitro’; Wattle Health: Corio Bay Ends Organic Dairy Milk Supply; Cann Group: CSIRO 325k Shares For Marijuana R&D; MGC Sells Nutraceuticals To Onassis For $9m Shares; Cann Global: ‘Marijuana Strain Stops MS In-Vitro, In Mice’; MGC, IM Cannabis To Sell Marijuana Cannepil In Israel; THC: Cannatrek To Supply Dried Marijuana Flower; Ellerston Capital Reduces To 8.1% Of Nufarm; GCI CSS, Hofseth & Nevera Take 9.4% Of Clean Seas; One Funds Takes 6.2% Of Murray Cod; Shannon Doecke Replaces Elders Co Sec Sanjeeta Singh

Abares: ‘Very Favorable’ Start Of Winter Crop Season; S&P: A2 Milk, Ecofibre Up; Auscann, Cann Group, Wattle Down; Food Revolution: ‘On-Track’ For $40m Revenue Guidance’; Creso Launches Cannaqix Marijuana In South Africa; Creso Completes Due Diligence To Sell Marijuana In Canada; Creso Welcomes Israel Marijuana Legalization Proposals; Fidelity Takes 5.4% Of Synlait; Norman Li, Careline Reduce To 35% Of Food Revolution; L1 Capital Takes 6.4% Of Creso; Jamber Increases, Diluted To 8.5% In Creso; Pharmaust Requests ‘Sars-Cov-2 Test Results’ Trading Halt; Cann Global 3rd ‘Research Initiatives’ Extension Suspension; Food Revolution Appoints Nick Stoikos Commercial Director

Wide Open Agriculture Placement Raises $3m; Ecofibre Withdraws H2 Guidance On ‘US Civil Unrest’; Fed Gov Extends Date For Wool R&D Levy Submissions; Creso: DHS To Distribute Cannaqix Marijuana In Brazil; THC Completes Tetra Medical Marijuana Acquisition; Clean Seas Raises $3m; Apiam Releases 920k Voluntary Escrow Shares; Perpetual Reduces To 11.9% Of Costa; One Funds Takes 5% Of Murray Cod; Elixinol Chair Paul Benhaim, Raw With Life Diluted To 28%; D&G, David Newman, Gabriel Ettenson Reduce To 6% Of Elixinol; Pharmaust: ‘Monepantel Suppresses Sars-Cov-2 50-95% In-Vitro’; Regeneus Loses 5-Year Director Dr Glen Richards; Tasfoods Appoints Craig Treasure Chair, Ben Swain Director; Abundant Completes ASX Delisting

Dr Boreham’s Crucible: Synlait Milk; Select H1 Revenue Down 6% To $94m, Profit Down 13% To $17m; Synlait Covid-19 Cuts Forecast Milk Price; MGC: Israel Phase IIb Cannepil Epilepsy Trial; Elixinol Rights Offer Raises $5.6m, Total $10.9m; Palla Terminates UK Customer Acquisition; Owed $3.5m; Palla Tells AGM: $1.3b EU Codeine Phosphate Market; Murray Cod: Lake Wyangan Fish Deaths Not Us; Shunho Terminates Elixinol Hemp Foods Acquisition; Cann Supplies IDT Marijuana Products To Astral, Iuvo; THC Prescribes 1st Australian Marijuana; Yarra Funds Reduces To 6% Of Elders; Perpetual Reduces To 6% Of Elders; Creso Requests ‘Capital Raising’ Trading Halt; Cann Global Extends ‘Research Initiatives’ Suspension; Tassal Appoints James Fazzino Director; Mark Licciardo Replaces Palla Co Sec Jaime Pinto; Costa CEO Harry Debney To Retire Within 9 Months; Pharmaust Requests ‘Sars-Cov-2 Pre-Clinical Results’ Halt

AVW Editorial: How Good Is China Bear Baiting?; Wide Open Licences Curtin Uni Lupin Vegan Protein; Roots: ‘RZTO Increases Asparagus Yield By 90%’; Bega: Kraft-Heinz Files To Appeal Judgement; Elders H1 Revenue Up 26% To $925m, Profit Up 87% To $52m; Loan; Nanollose Rights Shortfall Raises $361k; Total $738k; Roots Placement Raises $280k; Clover: ‘Strong Demand From Customers Due To Covid-19’; Wattle Health: SPC Replaces Broke ODFA For Corio Bay; Kyocera Pays Regeneus $1.5m For Progenza OA Due Diligence; Opyl: ‘Covid-19 Puts Focus On Digital Data’; Trading Halt; THC: Canndeo Marijuana Available By Script In Australia; Cann Global Takes Research Initiatives Halt To Suspension; Ellerston Reduces To 11% Of Nufarm; Macquarie Below 5% Of Nufarm; Perpetual Reduces To 8% In Bega; Nanallose: Maclaurin 6%, Moursounidis 6% Suzanne Cass 4.8%; Nufarm Loses Director Anne Brennan; Bega Director Jeff Odgers Resigns

NSW Farmers On Barley Tariffs; China-Australia Relations; Pharmaust: Monepantel ‘Success’, 1 Dog Tumor Reduced; Nanollose Rights Raise $376k Of Hoped-For $720k, Shortfall; China, EU Allow Roots Patent For Heat Exchange Stubs; Memphasys Share Trading Increases In Germany; Opyl, AAMRI Launch Best Practice Social Media Guide; CVS To Sell Ecofibre’s Marijuana Topical Products; Creso: ‘Legal Advice’ Halts Mernova Canada Marijuana Sales; THC Acquires Tetra Health For $3m In Cash And Equity; Elixinol: Marijuana Product Label Class-Action Dismissed; Creso Votes On 67% Directors Fees Hike To $500k; Share Issues; Perpetual Reduces To 7% In Elders; ECP, EC Pohl Increase, Diluted Below 5% In Costa; Lazard Asset Management Reduces To 12.5% Of Ridley; Roots Requests ‘Capital Raising’ Trading Halt; Wide Open Agriculture Requests ‘Licence’ Trading Halt; Thc: Jarrod White, Sonny Didugu In; Henry Kinstlinger Out; MGC Appoints KS Kim Artemic Distributor

Dr Boreham’s Crucible: Bubs Australia; CSIRO: Arista ‘High-Fibre Wheat’ Going Global; Elixinol: 1-For-2.51 Rights To Raise $11m At 48% Discount; Abundant Votes To Delist From The ASX; Bubs: Coles, Baby Bunting To Sell Baby Formula Products; Elixinol Sells Nunyara Land For $2.6m; Macquarie Reduces To 5% Of Nufarm; MFS Takes 7% Of Ridley; Janet Cameron Takes 17.6% Tasfoods; Scobie Ward Takes 8% Of Terragen; Pharmaust Requests ‘Trial Results’ Trading Halt; THC Requests ‘Acquisition’ Trading Halt; MGC Requests ‘Distribution Agreement’ Trading Halt; Auscann To Lose 12-Month CEO Ido Kanyon

April AVW-45 Up 11%, ASX Up 8.8%; NSW Farmers: Waive State Fees For Oyster Farmers; Huon: Covid-19 Hits April Sales, Guidance Withdrawn; Clean Seas YTD Sales Up 4%; Covid-19 Hits Q3 Sales Down 14%; Fonterra: Earlier Advance Rate Payments, Simpler Guidelines; Murray Cod Settles Hatchery Purchase; Qbiotics Euro Launch Of Stelfonta For Dog Cancer; Wattle Health: SPC $20m Spray Dryer Loan; MGC $3.5m Placement; THC Takes $4m Mitchell Loan; Elixinol Requests Capital Raising Trading Halt; Auscann THC, CBD Marijuana Study Begins Dosing; Tasmanian Alkaloids Supplies Marijuana To Avecho; Ecofibre: Hemp Black PPE Face Masks For The US; MFS Takes 5% Of Ridley; Perpetual Reduces To 9% In Bega; Wayne Johnston Replaces Costa CFO Linda Kow; Fonterra Appoints Holly Kramer Director; Avecho Appoints Dr Paul Gavin CEO, Dr Roksan Libinaki COO; Elixinol CEO Oliver Horn Starts On $395k; MGC Claims 2nd Israel Artemic For Covid-19 Trial Site

ABARES: Medium-Term Agriculture Prospects ‘Strong’; Seafarms Pleads Schultz To ASX 35% Query; A2 Milk: Covid-19 Little Impact, Expects $1.65b Revenue; Covid-19 Delays Synlait Land Dispute Court Hearing; Cann Group 5-Year Supply Agreement With Pure Cann; THC Canndeo Marijuana To Launch In Australia Europe; Creso Pays Cohen $409k, Takes $1m Lind Facility; IFM, Bonafide Global Fish Take 17% Of Clean Seas; Australian Tuna Fisheries Reduces To 6% Of Clean Seas; Scobie Ward Takes 6% Of Terragen; Costa Votes On Up-To $2.1m Harry Debney ‘Incentives’; MGC Requests Capital Raising Trading Halt; Elixinol: Oliver Horn In, Stratos Karousos Out, Helen Wiseman; MGC Claims ‘Marijuana Kills Glioblastoma In-Vitro’

Federal Appeal Court Backs Bega Peanut Butter Packaging; Seafarms Awarded 4-Star Best Aquaculture Practice; Costa Withdraws Previous 2020 Guidance; Avecho, Purisys Deal For TPM Marijuana; Creso, Highnoon, Route 2 Pakistan Marijuana Distributors; MGC: ‘Approval For Artemic Covid-19 Trial’; MGC: Swiss Micelle Deal ‘Nothing To Do With Covid-19’; Pharmaust: ‘WEHI Tests Monepantel Sheep Drench For Covid-19’; Creso Issues 10.8m Collateral Shares To L1 Capital; Tony Rowlinson Replaces Food Revolution CEO John Florey; Perpetual Reduces To 10% In Bega; Nissui Diluted To 13% In Seafarms; Janet Cameron Takes 12% Of Seafarms

Dr Boreham’s Crucible: Ridley Corp; Hofseth, Nevera, Berger Invest $5m In Clean Seas, Take 10%; Wattle Health Raises $5m; 70m Shares For SPC J-V; Creso Delivers $215k Of Anibidiol To Virbac; Althea’s Peak Processing Canada Marijuana Application; ASX Suspends MHC For Swiss Marijuana Covid-19 J-V Queries; Ocean Grown: Covid-19 Impacts Sales, Board Pay Cuts; MGC Reduces Salaries Up-To 50%; Perpetual Reduces To 9% Of Elders; Mason Takes 8% Of Wattle Health; Janet Cameron Takes 12% Of Seafarms; Elixinol: Benhaim Chair; Horn In; Duff, Ellery Out; Terragen Appoints Travis Dillon Director; Seafood Industry Loses CEO Jane Lovell

Wattle Health: Mason’s Blend & Pack Purchase Fails, Again; Nanollose Rights Offer For $720k; Tasfoods Withdraws Guidance, Cuts Some Operations; Wide Open: ‘Online Sales Offsets Retail Loss, Board Pay Cuts’; Nufarm Sells South America Business To Sumitomo; Palla UK Business Option Expires, Talks Continue; Pharmaust: Covid-19 Halts 3 Dog Trial Cites; Auscann To Start Thc-Cbd Dose Study; Creso Wins $896k Univo Israel Order For Canadian Marijuana; Abundant EGM To Delist From The Asx; Elixinol ‘Rebrands, Refreshes’ Products; Schroder Below 5% In Costa; Schroder Ceases In Nufarm; Perpetual Reduces To 11% Of Bega; Gabor Diluted To 22% Of Seafarms; Nomura Takes 8% Of National Veterinary; MGC 7th Marijuana Covid-19 J-V Suspension Extension; Antonio Meroni Replaces Abundant Director Seona Wallace

Nufarm H1 Revenue Down 12% To $901m, Loss Up 203% To $160m; Clover H1 Revenue Up 10% To $38m, Profit Up 3% To $4.6m; Seafood Industry: ‘Governments Should Waive Fees And Levies’; Seafarms Placement Raises $12.5m; Terragen, Nutrien Mylo Distribution Deal; Regeneus: US Progenza Patent, ‘Covid-19 Link’; Vetpartners Takes National Veterinary; Covid-19 Warning; Auscann Receives $1.2m Federal R&D Tax Incentive; Roots To Issue Everblu 4m CDIs; Creso Cannaqix Marijuana Instant Tea Launch; Creso Delivers 1st Cannaqix Shipment To South Africa; Avecho Defers AGM; ASIC Covid-19 Advice; A2 Milk Takes 19.8% In Synlait; Mitsubishi, First Sentier Reduce To 7.5% Of A2 Milk; Perpetual Reduces To 10% Of Elders; Yarra Funds Reduces To 7% Of Elders; Lazzard Asset Management Takes 7% Of Costa; Lakeville Capital Takes 7.6% Of National Veterinary; Paradice Investment Takes 9% Of Select Harvests; MGC 4th Daily Marijuana Covid-19 J-V Suspension Extension; Althea Extends 10m Shares Voluntary Escrow

Fonterra H1 Revenue Up 7% To $10.3b, Profit Up 596% To $496m; Synlait H1 Revenue Up 19% To $556m, Profit Down 30% To $26m; Bubs: ‘Covid-19 Doubles Infant Formula Production’; Murray Cod: $6.5m For Established Hatchery; Select Harvests: Month-On-Month Almond Shipments Up 40%; Kyocera Pays Regeneus $1.6m Progenza Milestone; Next Science: Products ‘Kill Covid-19-Like Viruses’, Sales Hit; Next Science Launches On-Line Acne Cream; Food Revolution Expects $40m Revenue, Demand Increases; National Vet EGM Approves Vetpartners Acquisition; Cann Global: Obsidian Refinances L1 Notes; MGC Requests ‘Swiss Covid-19 J-V’ Trading Halt; Perpetual Reduces To 12% Of Bega; Regal Funds Takes 8.5% Of Huon; Microequities Reduces To 7.7% In National Veterinary; Vinva Investment Below 5% In Select Harvests; Pendal Group Below 5% In Althea; Synlait CEO Nigel Greenwood Goes June 26

Dr Boreham’s Crucible: Qbiotics Group; Synlait $105m Dairyworks Acquisition Approved; Synlait Acquires 582ha Dunsandel Farmland For $25m; A2 Milk Expands Into Canada With Agrifoods; Mason Terminates Wattle Blend & Pack Acquisition; Cannpal CPAT-01 For Dog Osteoarthritis US INAD; MGC Doses 1st Patient In Cognicann Marijuana Trial; Food Revolution Delivers 1st Of $2.4m Hand Sanitizers; L1 Capital Takes 5.5% Of Creso, Ceases Substantial; Cann Global Requests ‘Institutional Investment’ Trading Halt; Ridley Chair Dr Gary Weiss To Retire; Paul Wright Replaces Memphasys Director Marjan Mikel; Angela Dixon Replaces Synlait CFO Nigel Greenwood; Auscann Appoints Dr Marc Russo Chief Medical Advisor; Neale Joseph Replaces Ap Hemp CEO Charles Mann, On $225k; Creso Appoints Jack Yu, Isaac Allen To Subsidiary Mernova

Bega H1 Revenue Up 14% To $741m, Profit Up 71% To $8.5m; Seafarms H1 Revenue Up 20% To $21.5m, Loss Down 7% To $12.3m; Food Revolution H1 Revenue Up 19% To $18.0m, Loss Down 48% To $1.8m; THC Revenue Up 80% To $4.8m, Loss Up 36% To $11.7m; Avecho Revenue Up 204% To $4.2m, Loss To $850k Profit; Creso Revenue Up 550% To $3.6m, Loss Down 9% To $15m; Abundant H1 Revenue Down 41% To $556k, Loss Up 43% To $1.4m; Wide Open H1 Revenue Of $491k, Loss Up 19% To $730k; Nufarm Clearance For $1.2b Nufarm Brazil Sale; National Veterinary Completes Acquisition, Takes Total To 107 Clinics; Regeneus, Kyocera $1.4m Progenza Deal, $4m Directors Loan; Next Science Bactisure Wins CE Mark; Wide Open Completes 5kl Oat Milk Production Trial; Roots, Finepro Collaboration For Off-Grid Temperature Control; Cohen Group Ends Creso Israel J-V; Potential Legal Action; Creso Appoints Farmagon Scandinavia Marijuana Distributor; MGC Extends, Amends Onix Brazil Distribution Agreement; THC Expands Medical Marijuana Supply For 6k Patients; Pharmaust Opens 2 More Dog Cancer Trial Centres; Abundant Applies To De-List From The ASX; Mitsubishi, First Sentier Reduce To 9% Of A2 Milk; Perpetual Takes 11% Of Elders; Lazard Asset Management Reduces To 6% Of Costa; Challenger Takes 5% In Clover; Lakeville Capital Takes 7% Of National Veterinary; Tassal Appoints Richard Haire Director; Clean Seas Appoints Gilbert Vergères Director; Fonterra Chair John Monaghan To Retire In November; Todd Richards Replaces Apiam Co Sec Sophie Karzis

A2 Milk H1 Revenue Up 32% To $773m, Profit Up 21% To $181.7m; Ridley H1 Revenue Down 7% To $487m, Profit Down 98% To $396k; Costa Revenue Up 6% To $1.0b, $33.8m Loss; National Vet H1 Revenue Up 30% To $69m, Profit Up 56% To $4m; Apiam H1 Revenue Up 0.4% To $56m, Profit Down 0.4% To $1.6m; Palla Pharma Revenue Up 18% To $54.8m, Loss Up 32% To $7.6m; Bubs H1 Revenue Up 39% To $27.1m, Loss Down 14% To $7.5m; Tasfoods Revenue Up 24% To $51m, Loss Up 155% To $3.5m; Clean Seas H1 Revenue Up 13% To $24m, Loss To $4.6m Profit; Elixinol Revenue Down 16% To $27.2m, Loss Up To $83.3m; Althea H1 Revenue $1.9m, Loss Up 253% To $8.4m; Ocean Grown H1 Revenue Down 14% To $1.5m, Profit To $1m Loss; Pharmaust H1 Revenue Down 9% To $2m, Loss Up 439% To $485k; Wattle Rights Raise $9m, Pham $16m, EGM Backs Blend & Pack; Bega Requests ‘Results Delay’ Trading Halt; Abundant Requests ‘ASX Delisting’ Trading Halt; Perpetual Takes 9.5% Of Elders; THC Requests ‘Marijuana Permit’ Trading Halt; A2 Milk Appoints Susan Massasso ‘CGBO’; Roots Appoints Dr James Ellingford Director

Abares: Crops Hit 66% By ‘Unfavorable Seasonal Conditions’; Evoke Ag 2020 Focus On Innovation, Collaboration; Perth In 2021; Livestock Labs Hopes For $8m For Embedivet Cattle Biosensor; Pham-Backed $25m Shortfall; Wattle To Buy Blend And Pack; Huon H1 Revenue Up 31% To $178m, Profit Down 16.5% To $22m; Bubs Increases Woolworths Deal To 400 Outlets; Ridley Buys Thai Ponds For $8m, Appoints Novacq CEO Sid Jain; UWA Led Technology For Better Pulse Crop Seeds; Roots: RTZO Increases Okra Yield By 78%; Food Revolution $2m Sanitizer For China Coronavirus Covid-19; Memphasys: ‘Felix Validation On-Track For Clinical Trial’; Ecofibre Launches 2 Ananda Marijuana Products; Opyl: Clinical Trial Predictor ‘Proof Of Concept’; Auscann Tests Low-Dose Cannabinoid Capsules; MGC Placement, Share Plan For $4m; Creso Milestone: To Pay Mernova $900k; 8.3m Shares Vest; Cann Global To Raise $419k; Vanguard Takes 5% Of Elders; Amber Schwarz, Jamber Take 11% Of Creso; Elders Appoints Matthew Quinn Director

Cannpal Down 14%; Tassal H1 Revenue Down 16% To $270m, Profit Up 24% To $41m; Synlait Profit Warning, A2 Milk Comment; Ridley Settles Legal Dispute: To Pay Baiada $1.9m; Roots: Appoints Cairo & Doutcher To Sell RTZO In Italy; Agrifutures Melbourne 2020 Evoke Ag ‘Sold Out’; National Veterinary: To Buy 4 New Clinics, Option On 5th; National Veterinary To Vote On Vetpartners Scheme; Abundant To Delist – Cites Price, Liquidity; Creso Marijuana Horse Feed; THC To Launch Canndeo Marijuana; Opyl, Huumun Digital Products Deal; Perpetual Takes 8% Of Elders; One Funds Management Takes 7% Of Terragen; Grandeur Peak Reduces To 6% Of National Veterinary Care; Lakeville Takes 5% Of National Veterinary Care; Roots Director Dror Nagel Resigns

Dr Boreham’s Crucible: Elders; Creso Takes $17.5m L1 Capital Convertible Note; Cann Group Convertible Notes Raise $8m; Roots Placement Raises $500k; Elixinol Receipts Down 8% To $33m, Asset Sales; Ecofibre H1 Revenue Up 118% To $29m, Loss To $7m Profit; Cann H1 Receipts $1.6m, Less Than 2 Quarters Cash; Opyl H1 Receipts Down 3% To $464k; Memphasys: ‘Felix Sperm Separator Positive KOL Feedback’; Barlev Buys $36k Roots RZTO For Marijuana; Creso Develops Oil-Free, Water-Based Marijuana Lozenges; Vanguard Takes 5% In Tassal

Dairy Plan: One National Body, All Services, Single Levy; Nanollose, Grasim Collaborate On Tree-Free Fibres; Synlait Increases Base Milk Price 4% To $7.01/KgMS; Tasfoods Receipts Up 27% To $49.5m; Bubs H1 Receipts Up 60% To $26m; Clean Seas H1 Receipts Up 17% To $25m; THC Receipts Up 83% To $4.7m; Pharmaust H1 Receipts Down 5.6% To $1.9m; Murray Cod H1 Receipts Up 12% To $1.8m; Ocean Grown Abalone H1 Receipts Up 4% To $1.5m; Nanollose Has Less Than Two Quarters Cash; Regeneus Has One Quarter Cash; MGC Has Less Than One Quarter Cash; Cann Group Cuts Staff 25%, Costs By $7m, Mildura Facility; Roots Requests Capital Raising Trading Halt; Creso Sells More Than 100,000 Cannaqix Packs; Ecofibre Appoints David Neu Ananda CEO

Federal $713k For Red8 Portable Abattoirs; Europe Okays Qbiotics Stelfonta For Dog Skin Cancer; Ausbiotech 2nd Australian Industrial Hemp Conference; Clean Seas Rights Raise Additional $2.4m, Total $15.3m; Wattle Health: 2nd Blend & Pack Rights Raise For $40m; Wattle To Refund 1st Rights Issue; Fonterra Completes $532m DFE Sale To CVC; Seafarms Appoints Primstar To Sell Prawns In Europe; Roots Registers Heat Stub Australian Design Patent; Anatara: Garp Pre-Clinical Studies; Elixinol Pleads Schultz To ASX 20% Fall Query; Creso: 3m Anibidiol Dog Doses Sold; New Marijuana Products; Cann Global Supplies T12 Hemp To Costco; THC To Sell MGC’s Canndeo Marijuana, 1st Purchase For $40k; THC: TGA Grants Southport Marijuana Facility Licence; Robert Lederer, Rtl Take 11% Of Anatara; Amber Schwarz, Jamber Reduce To 9% Of Creso; Clarification: Auscann Board Changes; AP Hemp Appoints Advisory Board; Creso Renews Everblu Corporate Advice Mandates; Correction: Vitalharvest

Bega Exec Chair Barry Irvin Returns; Facility Date Extended; Costa CFO Linda Kow Resigns; Gibson’s Settles Legal Action With Clean Seas For $15m; Thorney, Tiga Take 6% Of Ocean Grown Abalone; Seafarms To Offer Cash For CO2 Australia Shares; Perpetual Takes 13% Of Costa; Schroder Takes 5% Of Nufarm; Perennial Reduces To 6% Of National Veterinary; Bubs: ‘$12.4m Oversubscribed’ Share Plan Raises $5m; One Funds Takes 5% Of Terragen; Wattle Raises $11.7m Of Hoped-For $62m; Blend & Pack Deal; Costa: Vitalharvest Tumbarumba Farm Hit By Bushfire; Bega: Bega Valley Facilities OK Despite Bushfires; Cannpal To Use CSIRO’s Micromax Marijuana Encapsulation; Cann Group Pleads Schultz To ASX 21% Query; Cann Group: IDT To Extract Marijuana Resin For Oils; Pharmaust: Unity Ends Epichem Contract; Pharmaust: Epichem, DNDI Contract Extended; Creso To Release 500k Escrow Shares; Bega: ‘Bushfires Cost Up To 1.9m Litres Of Milk’; Elders Donates $100k To Bushfire Aid, No Properties Damaged; Wattle Health: Negotiating Blend & Pack Acquisition; A2 Milk Loses CTO Phil Rybinski; Avecho: Ex-Bioscience Managers Matt McNamara Director; Perpetual Takes 7% Of Elders; Wattle Health: Mason Agrees New $80m Blend & Pack Deal; Wattle Loses CEO, 2 Directors, Dr Tony McKenna Starts On $500k; Wattle Health, Chemist Warehouse Rethink Deal; Wattle Health, Nouriz: J-V Australife To Sell Dairy In 2021; Roots: Boaz Wachtel CEO, Sharon Devir Exec Director; Pharmaust Receives $713k Federal R&D Tax Incentive; Perennial Below 5% In National Veterinary Care; Escrow End Takes Elixinol’s Paul Benhaim, Raw With Life To 40%; Ecofibre H1 Receipts Up 86%; Creso Receipts Up 382% To $2.8m; Nufarm Expects H1 Ebitda Down 50% To $55m-$65m

$1bn Insurance Claims; 15k Properties Damaged; 11k Livestock Lost;‘100s Of Millions’ Lost To Tourism

Ag & Vet Weekly Summer Holidays; Dr Boreham: Terragen; Abares: ‘Climate Variability’ Cuts Farm Profits 22%; Vetpartners $250m National Veterinary Take Over; Synlait Joins New Zealand Debt Market, With $177m Bonds; Ocean Grown Abalone Rights Raise $2.9m; Regeneus Receives $50k Innovation Connections Grant; Memphasys Ships First Batch Of Felix Devices; Hot Dry Condition Reduce Costa Berries; Anatara: ‘Garp Enhances Anti-Inflammatories In Mice’; Palla Negotiates Loan Terms; Ends Karo Non-Opiate Deal For Codeine; Regeneus, AGC Terminate Japan Stem Cell J-V; Anatara Finalizes Garp Trial Protocol; Roots: ‘RZTO Increases Peas, Beans Yield’; Roots, Seach Partner On Marijuana RZTO Study; Cann Group, IDT 1st Commercial Marijuana Product; Auscann Completes Testing Of Marijuana Hard-Shell Capsules; Cann Global, Koegas South Africa Marijuana J-V; MGC Ships Marijuana Cognicann For Dementia, Alzheimer’s; Perpetual Takes 6.3% Of Elders; Pendal Group Reduces To 4.9%; Fonterra Takes 14% Of Chile’s Prolesur; Perennial Reduces To 8% Of National Veterinary Care; Invesco Quits National Veterinary Care; Jamber Takes 12% Of Creso; Elixinol To Release 78m ASX Escrow Shares; Ecofibre Releases 2.3m Escrow Shares; MGC Removed From BNY Mellon Pershing List; Fonterra Appoints Teh-Han Chow Interim China CEO; Elixinol Loses Executive Paul Benhaim, Continues As Director; Cann Group Loses Director Neil Belot; THC Appoints Angela Macquire COO

All The Dope On Medicine, Marijuana, Cannabis & Hemp

Terragen IPO Raises $20m Opens Up 4% At 26c; Murray Cod Placement To Raise $15m; Palla $4m Euro Codeine Deal; Roots Water Ways Distribution Deal; Terragen Great Land, Mylo Sales Up 45%; Native Title Holders Upgrade Seafarms’ Legune Station; Synlait Launches NZ Native Tree Planting Program; Elders Earns 36% Remuneration 1st Strike; Pharmaust Opens 2 More Dog Cancer Trial Centres; Australian Primary Hemp, Freshwater 2-Year Hemp Deal; Cann Global Olivia Newton-John Marijuana Formula Rights; Creso Africa Marijuana Cannaqix Launch By April 2020; Auscann Reinstated By Bank Of NY Mellon Pershing; Perpetual Takes 12% Of Costa; Exec Chair Norman Li Reduces To 35% Of The Food Revolution; Chair Sam Brougham, Stamina, Crofton Take 6.3% Of Terragen; Creso Releases 2m Voluntary Escrow Shares; Geoffrey Babidge Replaces A2’s Jayde Hrdlicka, On $1.6m; Ms Farrell, Ms Dahiya Replace Cann Group Co Sec, CFO Mr Baker; David Lilja Replaces Opyl Co Sec David Hwang

Dr Boreham’s Crucible: Memphasys; Abares: ‘Winter Crop Production Below 30mt’; CSIRO Develops Prawn Health Check; Victoria, Medipharm Open Wonthaggi Marijuana Plant; Agrifutures Prepares Melbourne 2020 Evoke Ag Conference; China Approves Synlait Auckland Formula Facility; Bubs Placement Raises $30m, Share Plan For $5m More; Wattle Health, Chemist Warehouse 10-Year Deal; Avecho To Market 6 TPM-Drugs; Wide Open Expands WA Dirty Clean Food Distribution; Elixinol Sells Elixinol Japan For $346k After Non-Compliance; Elixinol Class Action: ‘Products Correctly Labelled’; Ireland Approves MGC Marijuana Cannepil; Cannpal Removed From Pershing Marijuana Restricted List; Creso 1st Shipment Of Burleigh Heads Cannaqix 50; THC Southport Facility 1st Medical Marijuana; Nufarm 27% Oppose Chairman Donald McGauchie; Clean Seas 83% Oppose Placement Facility; 2nd Rem Strike; MGC 52% Blocks Founder Nativ Segev Rights, Strong Dissent; Roots Requests Canadian Market Entry Trading Halt; Bubs Releases 38m Nulac Foods Escrow Shares; Thorney Holdings Below 5% In Select Harvest; Allan Gray Takes 8% Of Nufarm; Perpetual Takes 10% Of Costa Group; Australian Ethical Takes 6% Of Palla Pharma; Wide Open Appoints Meerkats’ Ronnie Duncan Director

Federal $2m For Invasive Species Centre Phone Weed ID; Synlait $189m Bonds To Open December 9; Nufarm ‘Significant’ H1 Profit Warning; Seafarms: GFI For Sea Dragon Funds; Apiam Pays $4.65m For Grampians Animal Health; Apiam Distributes Zoono Disinfectant In Australia, US; Food Revolution: More Juice Co Juices, Ice Tea At Coles; Clean Seas, Gibson’s Continue Mediation; Bubs Relocates To Dandenong; Shareroot Name Change To Opyl, 100-To-1 Consolidation; Creso To Raise Up To $10m For Pharmacielo, Operations; Apiam 36% Oppose Director Options; Abundant 31.5% Oppose Top Cat Shares; Althea 22% Oppose 596k M-D Joshua Fegan Rights; Auscann, Aspen 3-Year Packaging Agreement; Australian Primary Hemp, Mycelium Mushroom-Hemp Deal; Cann Group Pleads Schultz To ASX 41% Fall Query; Seafarms Releases 80m Escrow Options; Roots Releases 18.8m CDIs, 1.3m Options From Escrow; Synlait Appoints Mark Toomey Operations Director

Dr Boreham’s Crucible: Clean Seas Seafood; CSIRO: ‘Synthetic Biology To Transform Agriculture’; 13 Seeds $6m IPO For Hemp Commercialization; Costa Retail Entitlement Raises $66m, Total $180m; Synlait Calls For Expressions Of Interest For $189m In Bonds; Clean Seas Rights Raise $9.6m Of Hoped-For $15.4m; Regeneus Shortfall Raises $755k, Total $5.5m; A2 Milk Predicts Strong Revenue Growth For The Year; A2 Milk Extends Synlait Supply Deal; Wattle Health $62m Rights Offer To Buy Blend & Pack, New CEO; Ocean Grown Abalone 1-For-8 Rights Issue For $2.9m; Memphasys Wins $549k ARC Grant For Cell Sorters; Memphasys Identifies 5 Countries For Initial Felix Sales; Cann Group ‘Stages’ Mildura Marijuana Facility; Pendal Takes 6% Of A2 Milk; Pendal Reduces To 5% Of Elders; Macquarie Group Takes 6% Of Elders; Health Employees Super Diluted Below 5% In Elders; Peters Investments Takes 28% Of Memphasys; Director Andrew Goodall Takes 23% In Memphasys; Executive Chair Alison Coutts Diluted To 11% In Memphasys; Washington Pattinson, Brickworks Diluted To 19.9% In Palla; Thorney, Tiga Increases, Diluted To 19% Of Palla

Palla Retail Rights Raises $10.1m, Total $30.7m; Federal $3.6m For Native Plants Training Centre; Elders Revenue Up 4% To $1.7b, Profit Down 4% To $69m; Ridley: Staff Cuts, Restructure To Save $5m; Ecofibre Hemp ‘Reduces Opioid Use For Chronic Pain’; Bubs $2.5m 2-Year Vietnam Goat Milk Deal; Creso Terminates Sale To Pharmacielo; Wide Open Agriculture To Launch Dirty Clean Foods In WA; Synlait: April 29 & 30 Supreme Court Date Confirmed; Elders $1m, 166k CEO Rights AGM; Anatara 46% Oppose Dr Ramsdale Rights; 10% Capacity Fails; Althea To Supply Marijuana For Advanced Cancer Symptoms; Althea UK Marijuana Licence; Nimbus German Distributor; THC Southport Marijuana Manufacture Permit; Elixinol Pleads Schultz, Japan Issue To ASX 17% Fall Query; MGC $25k Federal Grant; London Listing; Lazard Takes 7.5% Of Costa Group; Perpetual Takes 7.6% Of Costa; Perpetual Takes 5% Of Elders; Ocean Grown Releases 20m Shares From Escrow; Bega: Pete Findlay CFO, Colin Griffin General-Manager; A2 Milk Chief Marketing Officer Susan Massasso Resigns; Wide Open Agriculture Appoints Elizabeth Brennan Director; Fonterra: Head Of Personnel Deborah Capill Resigns; Industry Holds Melbourne March Medical Marijuana Meeting

Dr Boreham’s Crucible: Nanollose; Terragen $20m IPO For Soil Health Microbes; Organics Body Concern On GMO Senate Vote; Bubs, Alibaba $10m China Goat Milk Deal ; Wattle Health, Nouriz China dairy deal; Costa: Hail Hits 3 Citrus Farms, ‘Up To$6m Profit Warning’; Study Backs Ocean Grown Abalone Esperance Facility ; Fonterra AGM: 2 Shareholder Proposals Lost; Cann Group, Symbion Marijuana Deal; Food Revolution Mill Park Juice, Powder, Gel Facility; Cann Global Convertible Notes For $2.2m; Macquarie Group Below 5% In Nufarm; Perpetual Takes 5.2% Of Costa; Perpetual Takes 14.5% Of Bega; Washington H Soul Pattinson, Pengana Down to 23% In Clover; Sico Increased, Diluted To 7.7% Of Palla, In 2017; Creso Takes ‘Pharmacielo Acquisition’ Halt To Suspension; Ocean Grown Abalone: Ignazio Ricciardi Non-Executive; Elixinol Appoints Teresa Cleary Co Sec

Federal Government, Arc Medicinal Agriculture Research Hub; Federal Government Extends R&D Consultation; Bega: Drought, Competition Profit Warning ; Costa: ‘Weather Impacts Production’; $176m Rights Offer; Fonterra Responds To NZ Healthy Waterways Plan; Wide Open Agriculture S.E. Asia Meat Export Licence; Federal Court Approves Elders AIRR Acquisition; Ridley Withdraws Feed Trial Statement; National Veterinary Settles New Zealand Clinic Purchase; Clean Seas: Gibson’s Court Mediation -November 28; Althea Launches Cbd100 In Australia; Cann Global Opens Laos Marijuana Subsidiary; Bubs 4.8m Executive Chairman Dennis Lin Options AGM; Clean Seas 2nd Strike Vote, 518k CEO Rights AGM; Shareroot: Opyl Name Change, 100-To-1 Consolidation AGM; Macquarie Reduces To 5% Of Nufarm; Massachusetts Financial Takes 5% Of Ridley; Thorney, Tiga Take 21% Of Palla Pharma; Aphria Reduces To 5.25% In Althea; Creso Requests Pharmacielo Acquisition Trading Halt; Bega Loses Director Max Roberts; Nanollose Loses CSO Gary Cass; Chair Dr Wayne Best R&D; Auscann To Lose Dr Mal Washer, Cheryl Edwards

Dr Boreham’s Crucible: Elixinol Global; Pitt Street Ag & Vet Biotechnology Conference; Synlait To Buy Dairyworks For $105m; Fonterra Increases Farmgate Milk Price Range; Seafarms Completes North Queensland Ponds; Roots To Raise $820k In Placement; Roots, Nostromo Work On Solar-Powered Irrigation; Roots Tests RZTO To Increase Protein In Crops; Elixinol Investigates ‘Non-Compliant’ Japan Cannabidiol; Up To 19% Oppose Nanollose Placement; Clover CEO Peter Davey 136k Rights Agm; Costa Takes ‘Trading Outlook’ Halt To Suspension; Ocean Grown To Release 20m Escrow Shares; Ecofibre Wins Nasdaq O-T-C Code Eofbf; Challenger Below 5% In Clover; Antanas Guoga Takes 13% Of Shareroot ; Mark Kerr Takes 12.7% Of Avecho; Washington H Soul Pattinson Takes 23% Of Palla; Bubs: Dennis Lim Exec Chair;$150k, 4.7m Options; Food Rev: John Fitzgerald Out; Joe Zhou, Daniela Stojanoska In

Palla ‘Underwritten’ $31m Placement, Rights Offer; Clean Seas Notes To Raise $15m; Tassal Approved To Expand Queensland Prawn Farm; Terumo Hands Back Avecho (Phosphagenics) TPM-Propofol; Roots, Clearvue To Build Sustainable Greenhouses; Roots Cooling Boosts Cannabis Flowers 118%; Seafood Industry Australia Directions Conference; Awards; Anatara Bromelain Garp Effective For IBD, IBS, In Mice; Regeneus Receives $1.5m Federal R&D Tax Incentive; Cannpal To Release 50m Escrow Shares; Wide Open Agriculture Hemp Seed Trial; Ridley 1.1m M-D Performance Rights AGM; Regeneus CEO Leo Lee 15m Options AGM; Althea Completes Canada Peak Acquisition; Creso Delivers First Order Of 10% CBD Oil To Medleaf NZ; THC Receives S4, S8 Narcotics Licences For Marijuana ; Vanguard Takes 5% Of Bega; Schroder Takes 5% Of Costa; Macquarie Reduces To 6% Of Nufarm; Perennial Takes Odd Fellows 13.6% Of National Veterinary; Martino, Fanucci, Domenal Take 9% Of Food Revolution; Merchant Takes 11.5% Of Auscannat 15c; Canopy Ceases; Merchant Takes 12% Of Auscann At 30c; Pharmaust Colin La Galia Epichem CEO; Dr Keenan Director

Dr Boreham’s Crucible: Cannpal Animal Therapeutics; Federal $35m For Agriculture Research Centre; Federal $35m For Macquarie Uni Synthetic Biology Research; Wide Open Agriculture: $200k Maiden Q1 Sales; Roots: Cairo & Doutcher Italy Distribution Deal; Pharmaust Expects $1.5m Federal R&D Tax Incentive; Ellerston Reduces To 12% Of Nufarm; United Super Below 5% Of Nufarm; Regal Funds Reduces To 13% Of Apiam; James Schwarz, Jamber Below 5% Of Roots; Norman Li Takes 37% Of Food Revolution Through Careline; Fanucci, Domenal, Sandra Martino Take 9% Of Food Revolution; Aust Primary Hemp: Mann 12%, Hood 8%, Petricevic 7%; Fonterra Appoints Fraser Whineray COO; Synlait CFO Nigel Greenwood To Resign

Sumitomo Buys Nufarm South American Operations For $1.2b; Nufarm Revenue Up 14% To $4b, Profit Down 10% To $90m; Pharmaust Raises $2.4m; Kolabtree Has 10k Science Freelancers ; Seafarms Delivers 33t Black Tiger Prawns To Japan’s Nissui; Roots $87k RZTO Marijuana Deal; Alchemia Becomes Australian Primary Hemp ; Clean Seas Fitzgerald Bay Farm Delay; Wattle Health Takes Acquisition Trading Halt To Suspension; Abundant To Launch Two New Pain Relief Products; Pharmacielo, Creso Acquisition Scheme Meeting; MGC Passes 400 Cannepil, Mxp100 Prescriptions; Nanollose To Release 40m Escrow Shares, 25m Options; Schroder Increases, Diluted Below 5% In Elders; CEO Dr Chris Richards Increases, Diluted To 18% Of Apiam; Barry Lambert Takes 24% Of Ecofibre

Federal Agricultural R&D Inquiry; Fonterra Revenue Down 1.6% To $20b, Loss Up 209% To $605m; Fonterra DFE Pharma Share Sale Reduces Debt By $1b; Ridley Closes Murray Bridge Feed Mill; Roots Technology ‘Increases Cannabis Yield 40%’; Roots Heat Exchange ‘Stub’ Lowers Costs; Synlait $46m ANZ Environmental, Social, Governance Loan; Synlait Pokeno Facility Processes First Milk; National Veterinary Buys 2 Vet Clinics For $1.9m; Elixinol Appoints Harmonia Life Oy Finland Distributor; Alchemia Completes 1-For-20 Consolidation; Wattle Pleads Schultz, Bellamy Bid To ASX 29% Query; Creso Resubmits Pharmacielo Acquisition Scheme Booklet; Roots Issues 1.7m Convertible Note Shares; Hesta Below 5% In Nufarm; Washington H Soul Pattinson Reduces To 24% In Clover; Harry Karelis, Gemelli Below 5% In Auscann ; Race Strauss Replaces A2 Milk CFO Craig Louttit

Dr Boreham’s Crucible: Pharmaust; Abares Outlook: 5% Farm Production Fall; Climate Change; Bega Sustainability Report: Energy, Water, Diversity, Palm Oil; Clover Revenue Up 22% To $77m, Profit Up 33% To $10m; Tassal Share Plan Raises $17.4m, Total $125m; Roots Cooling ‘Increases Basil Yield 30% In Extreme Heat’; Alchemia To Be Australian Primary Hemp; Consolidation; Althea Peak Processing Acquisition EGM; Creso Takes Pharmacielo Trading Halt To Suspension; Creso Canada Marijuana Facility License; Lazard Takes 6.5% Of Costa; Industry Super Below 5% In Wattle Health; Fonterra Loses Director Simon Israel

Federal Government: ACCC to Investigate Murray Darling; ACCC Allows Elders AIRR Takeover; 37% Of Roots Oppose Blumenthal, Suburban, Horatio Stock; Pharmaust Starts Monepantel Dog Cancer Trial; Werribee Animal Hospital Joins Pharmaust Dog Cancer Trial; Abundant Shortfall Raises $1m; Total $1.4m; Seafarms Pleads Schultz To ASX 35% Query ; Memphasys 21m Directors Incentive, In Lieu Options EGM; Lazard Takes 5% Of Costa Group; CEO Anthony Crimmins, Top Cat Take 19.95% Of Abundant; Costa Asset Management Takes 9% Of Vitalharvest ; Ian Wilton Replaces Elders Chairman Michael Carroll; Bega Appoints Patria Mann Director

Dr Boreham’s Crucible: Anatara Lifesciences; Federal $240k Young Agricultural Researcher Grants; S&P Dow Jones Promotes Bubs & Synlait Milk, Demotes Ridley; Global Table Talks Food Disruption ; Sunfed’s Shama Lee Touts Yellow Pea Chicken Alternative; Food Revolution Revenue Down 12% To $29m, $16m Loss; Seafarms Group Down 6% To $24m, Loss Up 55% To $31m ; Pharmaust Revenue Up 32.5% To $4.4m, Loss Down 36% To $1.6m; Apiam Acquires Ace Laboratory For Up To $16m; National Veterinary Completes $5m Vetcentric Deal; Wattle Health Secures Funding For Blend & Pack; Food Revolution Pays $1.25m For Original Juice Co Black Label ; Careline Pays Food Revolution $5.4m; Memphasys Receives $1.1m Federal R&D Tax Incentive; Cann Global: EPCO To Distribute Chia Seeds In Vietnam; THC Rents 18ha Bundaberg Land, 6.6ha Facility For Marijuana; Perpetual Takes 13.45% Of Bega; Ethical Partners Takes 8% Of Bega ; Food Revolution Chairman Dr Tao Li, Careline Take 36%; ECP, Ec Pohl Take 5% Of Costa ; Grandeur Peak Takes 6% Of National Veterinary Care; Gabor Takes 24% Of Seafarms; Creso To Release 2.4m Voluntary Escrow Shares; Agrifutures’ Evoke Ag 2020 Applications Close On Friday; Auscann Appoints Dr Marcel Bonn-Miller Director; Nanollose Executives Take Pay Cut For Performance Rights

Bega Revenue Up 13% To $1.4b, Profit Down 59% To $12m; Huon Revenue Down 11% To $282m, Profit Down 64% To 9.5m; National Vet Revenue Up 44% To $118m, Profit Up 29% To $8m; Apiam Revenue Up 5% To $112m, Profit Down 4% To $3m; Clean Seas Revenue Up 11% To $46m, Profit Down 57% To $1.5m; Elixinol H1 Revenue Up 17% To $17.5m; Profit To $19m Loss; Cann Revenue Up 174% To $4m, Loss Up 131% To $11m; Ocean Revenue Up 46% To $3.5m, Loss To $1m Profit; Murray Cod Up 32% To $3.5m, Loss Up 304% To $1m; Regeneus Rights Raise $620k, $1.8m Underwritten; Wide Open Agriculture Claims July Sales Up 30%; Clean Seas Seafood Litigation Update; Elixinol Appoints 25thgroupbelgium,Luxembourg Distributor; Cann Increases Mildura Production Facility Capability By 40%; Cann Global T12 To Supply Vitahemp To Costco Australia; Cann Global, Pharmocann Marijuana Food, Cosmetics Deal; MGC Approval For Slovenian Medical Marijuana Research; Pharmaust Receives Monepantel Dog Trial Tablets; Cooper Below 5% In Bega; ASX Removes Bojun For Failure To Pay Fees; Ridley Loses Director Timothy Hart; Applications Open For Agrifutures’ Evoke Ag 2020 Conference

Dr Boreham’s Crucible: Regeneus; Tassal Revenue Up 16% To $561m, Profit Up 2% To $58m; Tassal Placement, Share Plan For $133m; A2 Milk Revenue Up 41% To $1.2b, Profit Up 47% To $272m; Ridley Revenue Up 9% To $1b, Profit Up 29% To $23m; Costa H1 Revenue Up 12% To $573m, Profit Up 1% To $41m; Tasfoods H1 Revenue Up 13% To $21m, Loss Up 46% To $2m; Elders Facilities Up $96m for AIRR Expansion, Working Capital; Clean Seas $6.6m Bonafide Placement, $15.4m Rights Notes; Wide Open Online ‘Dirty Clean Food’ Sales; Up To 44% Of Abundant EGM Oppose Ecomag Options; Creso: Pharma Dynamics Africa Cannqix10 Distributor; Creso: 1st Pharmacielo Colombian Marijuana To Switzerland; Yarra Funds Reduces To 8% Of Elders; Pendal Below 5% In Costa; Ridley CEO Quinton Hildebrand Starts On $700k; ASX Suspends Two Ag Techs For Failure To Pay Fees

Fonterra: ‘No Dividend, Loss Up, $820m Write-Down’; Nanollose, Codi To Develop Rayon Wipes; Abundant Share Plan Raises $345kof Hoped-For $2.5m; Regeneus Reduces Staff, Pay, Costs By 50%; Seafarms Expects To Complete Facility This Year; Fonterra: ‘2020 Dairy Assistance Less Than $3.1m’; MGC: Treats 100 Cannepil Patients, Tetra Deal; Alchemia To Become Australian Primary Hemp AGM; Leafcann Wins Australian Medical Marijuana Licences; Yarra Funds Takes 9.5% Of Elders; Schroder Below 5% In Nufarm; Commonwealth Bank Below 5% In Costa; Pendal Takes 5% Of Costa

Dr Boreham’s Crucible: Shareroot; Elders Rights Raise $32.7m, Takes Equity Raising To $137m; Biosciencemanagers $5.5m For CSIRO, Pharmamark Intencap; Creso, Medleaf NZ ‘Targets Not Material’; Anatara To Licence Detach Piglet Diarrhoea Treatment; Fonterra To Sell Portion Of Beingmate Shares; Mitsubishi Takes 7.5%Of A2 Milk; Sumitomo Mitsui Increases To 9.2% In Nufarm; Allan Gray Increases To 6.4% In Nufarm; Cooper Investors Decreases To 6.4% In Bega Cheese; Commonwealth Bank To Cease Substantial In Ridley